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1 Abstract 
Proteasomal degradation of proteins is one of many ways for a cell to regulate different processes to 
achieve cell homeostasis and correct functioning. It is especially important for cell cycle regulation, since 
it allows for timely, rapid degradation of proteins. Key players of proteasomal degradation are E3 ubiquitin 
ligases that transfer ubiquitin molecules to the respective substrate proteins, which ultimately lead to 
recognition by the proteasome and degradation of said proteins. A prominent E3 ubiquitin ligase that also 
has important tasks in cell cycle regulation is the SCF-complex. One part of the SCF-complex, the F-Box 
proteins, fulfill the role of substrate recognition subunits. 
Skp2 is one of the most characterized F-Box proteins in higher eukaryotes, with a broad range of different 
substrates. Perhaps the most important are p21, p27 and p57, cyclin dependent kinase inhibitors (CKI) that 
are responsible for inhibition of the activity of the CycE/Cdk2 complex. These CKIs are thereby exerting a 
regulatory function in the transition from G1- to S-Phase. In the cell cycle, SCFSkp2 does target the three 
CKIs for ubiquitination and subsequent proteasomal degradation, resulting in CycE/Cdk2 activity and 
beginning of S-Phase. Other substrates of Skp2 are for example Cdt1, necessary for the licensing of origin 
of replications and ordered DNA replication, or CycE, which activates the Cyclin dependent kinase 2. Skp2 
in Drosophila melanogaster is poorly characterized, in comparison. Only one substrate has been proposed 
up to date, the p21, p27 and p57 homologue Dacapo, although the data availability is not definite in this 
case. 
This thesis centers on the characterization of Skp2 in Drosophila Schneider cells and the search for new 
Skp2 interaction partners in the fly. This was achieved by analysis of the cell cycle distribution, live cell 
imaging experiments, biochemical interaction assays, mass-spectrometric analysis of Skp2 binding 
partners and protein stability analysis by flow cytometry, which was developed in the Sprenger group.  
Skp2 overexpression resulted in a longer G1-Phase, knockdown in faster transition from G1 to S. This result 
together with the impassivity of Dap stability upon modulation of Skp2 levels, the inconclusive interaction 
between Skp2 and Dap and the outcome that Skp2 enhanced the Dap cell cycle phenotype makes it highly 
unlikely that Dap is negatively regulated by Skp2. Instead, experiments showed that Cdt1 is probably a 
substrate of SCFSkp2 in Drosophila. The results also hinted that Cdt1 has to be phosphorylated for this 
interaction and experiments were undertaken to identify the responsible phosphorylation sites in Cdt1. 
For CycE on the other hand it was not possible to determine regulation of protein stability by Skp2 with 
certainty even though biochemical interaction could be seen. The mass-spectrometric analysis of Skp2 
binding partners did not identify new substrates of Skp2.  
In opposition to the state of knowledge, Dap seems to be not a substrate of the SCFSkp2 ubiquitin ligase. 
Cdt1 on the other hand seems to be a new target of Skp2 in D. melanogaster and further work will reveal 
the phosphorylation sites necessary for this relationship. These results shed new light on the role that Skp2 
has on the Drosophila cell cycle.  
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2 Kurzzusammenfassung 
Der proteasomale Abbau von Proteinen ist einer von vielen Wegen, wie eine Zelle die verschiedensten 
Prozesse für ein physiologisches Gleichgewicht und den korrekten Ablauf lenken kann. Insbesondere spielt 
er für die Regulation des Zellzyklus eine wichtige Rolle, da es dadurch möglich wird, Proteine zeitgenau 
und schnell abzubauen. Hauptbestandteil des proteasomalen Abbaus sind E3-Ubiquitin Ligasen, die 
Ubiquitin-Moleküle auf die entsprechenden Proteinsubstrate übertragen, was schlussendlich dazu führt, 
dass das Proteasom diese erkennt und abbaut. Eine bekannte E3-Ubiquitin Ligase, die auch wichtige 
Aufgaben während des Zellzyklus erfüllt, ist der SCF-Komplex. Ein Teil des SCF-Komplexes, die F-Box 
Proteine, sind verantwortlich für die Erkennung der Substrate. 
Skp2 ist eines der am besten untersuchten F-Box Proteine in höheren Eukaryoten und hat eine große 
Bandbreite an Substraten. Vielleicht die wichtigsten Substrate sind p21, p27 und p57, Inhibitoren von 
Cyclin-abhängigen Kinasen (CKI), die sich verantwortlich zeichnen für die Inhibierung der Aktivität des 
CycE/Cdk2 Komplexes. Diese CKIs üben dabei eine regulatorische Funktion beim Übergang von der G1- in 
die S-Phase aus. Während des Zellzyklus sorgt SCFSkp2 für die Ubiquitinierung und anschließendem 
proteasomalen Abbau, was zu Aktivität von CycE/Cdk2 und Beginn der S-Phase führt. Andere Substrate 
von Skp2 sind zum Beispiel Cdt1, notwendig für die Lizensierung von Replikations-Origins und geordneter 
DNA Replikation, oder CycE, welches die Cyclin-abhängige Kinase 2 aktiviert. Im Vergleich dazu ist Skp2 in 
Drosophila melanogaster nur wenig beschrieben. Bis jetzt ist nur Dacapo als Substrat vorgeschlagen, das 
Homolog zu p21, p27 und p57, jedoch ist in diesem Fall die Datenlage nicht eindeutig. 
In dieser Doktorarbeit werden die Effekte von Skp2 in Drosophila Schneider Zellen untersucht und neue 
Interaktionspartner von Skp2 ermittelt. Eingesetzt wurden hierzu Untersuchungen zur 
Zellzyklusverteilung, Live Cell Imaging Experimente, Untersuchungen zur biochemischen Interaktion, 
massenspektrometrische Analyse von Skp2 Bindungspartnern und Untersuchungen der Proteinstabilität 
mittels Durchflusszytometrie, ein Ansatz, der in der Arbeitsgruppe Sprenger entwickelt wurde.  
Überexpression von Skp2 resultierte in einer verlängerten G1-Phase, der Knockdown hingegen in einem 
schnelleren Übergang von G1 nach S. Dieses Ergebnis, zusammen mit der Erkenntnis, dass die Dap 
Stabilität unempfindlich gegenüber Veränderungen der Skp2 Level war, dass die Interaktion zwischen Skp2 
und Dap nicht eindeutig bestimmbar war und das Skp2 den Zellzyklusphänotyp von Dap verstärkte, zeigt, 
dass ein negativer Effekt von Skp2 auf Dap sehr unwahrscheinlich ist. Stattdessen zeigte sich, dass Cdt1 in 
Fliegen wahrscheinlich ein neues Substrat von SCFSkp2 sein könnte. Die Ergebnisse deuteten auch darauf 
hin, dass Cdt1 für diese Interaktion phosphoryliert sein muss und Experimente wurden ausgeführt um die 
verantwortlichen Phosphorylierungsstellen zu identifizieren. Für CycE hingegen war es nicht möglich eine 
Regulation der Proteinstabilität mit Sicherheit festzustellen, obwohl eine biochemische Interaktion 
ermittelt werden konnte. Die massenspektrometrische Analyse von Skp2 Bindungspartnern konnte keine 
neuen Substrate von Skp2 identifizieren.  
Im Gegensatz zum derzeitigen Wissensstand scheint Dap kein Substrat von SCFSkp2 zu sein. Auf der anderen 
Seite scheint Cdt1 als ein neues Substrat von Skp2 in D. melanogaster identifiziert worden zu sein. Weitere 
Experimente werden zeigen, welche Phosphorylierungsstellen in diesem Zusammenhang wichtig sind. 
Diese Ergebnisse werfen ein neues Licht auf die Rolle, die Skp2 im Zellzyklus von Drosophila spielt. 
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3 Introduction 
3.1. Principles of cell cycle regulation 
The cell cycle is a fundamental process in biology. Its purpose is to multiply the number of cells of 
organisms. After a cell receives an internal or external signal to start the division process, a molecular 
machinery is set into motion and the cell runs through a well ordered program which consists of certain 
distinct phases, typically G1-, S- and G2-Phase (combined also called interphase) and M-Phase (Figure 1). 
The cell cycle can show great plasticity, however. For example, during Drosophila melanogaster larval 
development, G1- and G2-Phases are absent in the beginning and the cell cycle only consists of alternating 
M- and S-Phases (Morgan, 2007). In the end, two daughter cells will emerge that are identical on the DNA 
level. If cells divide symmetrically, the two daughter cells will receive the same set of RNAs and proteins. 
If asymmetrical cell division occurred, the daughter cells will differ in their RNA and protein setting. This 
has great influence on the destiny of the two cells (Knoblich, 2010; Roubinet and Cabernard, 2014). After 
the cell cycle is completed, cells may directly undergo another round of replication, increasing the cell 
number further, or may exit the cell cycle by entering the so-called G0-state. Cells either stay in G0 until 
another division signal arrives or exit the cell cycle permanently for differentiation. Consequently, the cell 
cycle plays the most fundamental role in many different processes, from development and growth to 
wound healing and homeostasis (Morgan, 2007). 
 
Figure 1 General model of the cell cycle 
The prototypical model of the cell cycle consists of G1-, S-, G2- and M-Phase. Three important checkpoints are also marked: G1-S 
transition, G2-M transition and the transition from metaphase to anaphase (Hochegger et al., 2008). 
 
The processes of the cell cycle have to be strongly regulated to guarantee correct development and 
survival of organisms. For example, cells have to ensure that DNA replication occurs only once during the 
cycle. If some part or even the whole of the genome is replicated more than once during S-Phase, the 
molecular architecture of the daughter cells will be tremendously disturbed. Therefore, diverse control 
mechanisms exist for the different proteins that play important roles in the replication machinery.  
Besides DNA replication, many more aspects during the cell cycle have to be regulated. The beginning of 
a new cell cycle, the process of DNA replication itself, DNA damage control, the transition from G2 to M, 
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the assembly of the spindle during mitosis and the separation of sister chromatids are all monitored 
closely. Different checkpoints exist to control these processes. Checkpoints are molecular mechanisms in 
the cell cycle that monitor if certain requirements are met. If not, the checkpoint sends out molecular 
signals that first for all stop the cell cycle. Repair mechanisms may also be activated that remove the 
deficiencies. If this is not possible because the damage cannot be repaired, cell apoptosis is activated. 
The failing of checkpoints has severe consequences for single cells and the whole organism. DNA damage 
can accumulate, since DNA repair systems are unable to start working, leading up to severe mutations. 
Furthermore, the cell cycle itself may become unregulated, resulting in developmental deficiencies and 
the formation of tumors. Indeed, mutated cell cycle regulators are typical for cancer (Heo et al., 2016). 
Two of the most important aspects that cells have to regulate are the start of a new cell cycle, especially 
the transition from G1- to S-Phase, and the molecular regulation of DNA replication, especially the 
prevention of rereplication. 
3.2. The start of a new cell cycle and transition from G1 to S 
The cell cycle is unidirectional: once started, it is impossible to reverse this decision. Therefore, the start 
of a new cell cycle has to be regulated intensively. The so called “restriction point” (or “start” in the yeast 
system) is responsible for regulation of the beginning of a new cycle and the transition from G1- to S-Phase 
(Bertoli et al., 2013; Morgan, 2007).  
 
Figure 2 The start of a new cell cycle 
A new cell cycle starts if mitogens give the signal to activate Cyclin D/Cdk4, 6. This leads to phosphorylation of members of the 
pRB protein family and consequently either deactivation or activation of the respective E2F proteins. E2F1-3 serve as transcription 
factors, leading to G1/S gene expression, for example Cyclins E and A, and consequent Cdk activity. This results in a positive 
feedback loop by further phosphorylation of pRB proteins and enhanced G1/S gene expression. Finally, the transition to S-Phase 
and activation of DNA replication takes place (Morgan, 2007). 
 
The start of a new cell cycle (Figure 2) is set in motion by the appearance of external signals, called 
mitogens, or internal signals. These signals are leading to expression of the Cyclin D protein. Cyclin D binds 
to two Cyclin dependent kinases (Cdks), Cdk4 and Cdk6 and activates their kinase activity, thereby 
(Morgan, 2007). The primary target of Cyclin D/Cdk4 or 6 are members of the pocket protein family, 
specifically p107, p130 and pRB, which are regulators of the E2F protein family members. Proteins of the 
E2F family are either transcriptional inhibitors or activators of genes important for G1-Phase progression 
and consequently transition to S-Phase (Dyson, 1998). Unphosphorylated p107 and p130 can bind to E2F4 
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and E2F5 and thereby anchor both proteins in the nucleus where they act as inhibitors of G1 gene 
expression. Phosphorylation of p107/p130 leads to release of both E2Fs and consequently to their nuclear 
export, which obstructs their inhibitory effect (Bertoli et al., 2013). pRB on the other side, binds E2F1, E2F2 
and E2F3 (Lees et al., 1993) and inhibits their activity as G1 gene expression activators. Phosphorylation of 
pRB leads to release and DNA binding of E2F1-3 and ultimately expression of G1 genes (Dyson, 1998; Rubin 
et al., 2005). 
Perhaps the most important gene that is dependent on the E2F proteins is Cyclin E (Duronio et al., 1996; 
Helin, 1998; Ohtani et al., 1995; Sherr and Roberts, 1999). Cyclin E binds and activates Cdk2 and the Cyclin 
E/Cdk2 complex is in the center of the transition from G1 to S. First, CycE/Cdk2 kinase activity leads to a 
positive feedback with the pocket proteins, resulting in more phosphorylated p107, p130 and pRB and 
consequently a stronger Cyclin E expression and Cdk2 activity. The second important task of CycE/Cdk2 is 
phosphorylation of many different proteins, for example histone H1, p27, ORC6 and others, which 
culminates in the onset of DNA replication (Rizzardi and Cook, 2012; Sherr and Roberts, 1999). 
Thus, activity of CycE/Cdk2 is regulated by E2F dependent gene expression of Cyclin E and the complex 
formation of this protein with Cdk2. So-called cyclin dependent kinase inhibitors (CKI) accomplish an 
additional level of regulation. While cyclins are positive regulators of Cyclin-dependent kinases, CKIs are 
in analogy negative regulators. In mammals, three CKIs are regulating the activity of the CycE/Cdk2 
complex and consequently the G1-S transition: p21, p27 and p57 (Harper et al., 1993; Matsuoka et al., 
1995; Polyak et al., 1994). p21 has an important role in the DNA damage response, p27 is among other 
things responsible for cell cycle exit and p57 is essential for embryonic development (Starostina and 
Kipreos, 2012). These CKIs have to be inactivated and degraded for progression into S-Phase. 
The first step of CKI depletion is performed by a non-catalytic function of CycD/Cdk4. p21 and p27 are 
bound to CycE/Cdk2 in G1-Phase. However, CycD/Cdk4 is able to bind both CKIs and diminish thereby their 
grip on CycE/Cdk2. As a result, the Cdk2 activity starts to rise and since the two CKIs are themselves 
substrates of CycE/Cdk2 activity they are being phosphorylated (Polyak et al., 1994), which serves as a 
signal for ubiquitination and proteasomal degradation. This feedback loop results in lowered p21/p27 
concentration in G1 and increasing Cdk2 activity, leading to Cdk2 dependent gene expression of S-Phase 
genes and beginning of S-Phase. In S-Phase, an alternative degradation pathway for the CKIs by CRL4Cdt2 
starts, resulting in enhanced proteasomal degradation and maximized cyclin/Cdk activity. Section 3.7.3 
will deal further with the function and regulation of the CKIs.  
3.3. Regulation of DNA replication 
DNA replication, the process of doubling the genetic material of the cell, is the defining step of S-Phase. 
DNA replication starts at specific sites in the genome, the so-called origins of replication. While bacteria 
and Saccharomyces cerevisiae possess origins with a defined base sequence, in higher eukaryotes the 
surrounding DNA sequence and structure is the crucial aspect (Masai et al., 2010). Nonetheless, the 
general steps at the origin to start DNA replication are conserved.  
During telophase, the second to last step of mitosis, the origin recognition complex (ORC) starts to bind to 
the origins of replication. ORC stays at the origin during cytokinesis and G1 and serves as a binding site for 
the Cdc6 protein (Pozo and Cook, 2016). During G1-Phase the protein Cdt1 (Cdc10 dependent transcript 
1) accumulates in the cell (Nishitani et al., 2000; Nishitani et al., 2001). Cdt1 binds and transports the MCM-
complex (mini chromosome maintenance) to ORC-Cdc6 (Masai et al., 2010), which results in the so-called 
licensing of the origins. The ORC-Cdc6-Cdt1-MCM complex is also called the pre-replication complex. After 
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Cdt1-MCM is transported and bound to ORC-Cdc6, Cdc6 hydrolysis ATP, leading to binding of the MCM to 
DNA and release of Cdt1 from the pre-RC. Cdc6 is likewise released after ATP hydrolyzation (Randell et al., 
2006). MCM is the DNA helicase responsible for the unwinding of the DNA double strand, leading to the 
recruitment of the members of the DNA replication machinery. MCM alone is not active however, 
phosphorylation of S-Phase Cdks and Cdc7-Dbf4 lead to the recruitment of different factors, forming the 
pre-initiation complex. This complex is able to melt the DNA and start the synthesis of the two new strands 
(Masai et al., 2010; Morgan, 2007).  
It is crucial that during the cell cycle, DNA is only replicated once; re-firing of origins has to be prohibited. 
Tight control mechanisms for ORC, Cdc6, MCM and Cdt1 exist, ensuring that origins are not firing more 
than once. Cdc6 for example is phosphorylated by S-Phase cyclins and thereby exported from the nucleus, 
preventing ORC binding (Saha et al., 1998). Another example would be hOrc1, the biggest component of 
the ORC, which is strongly degraded in S-Phase (Mendez et al., 2002). The member of the pre-RC that is 
most regulated is probably Cdt1, underlining its importance and central status in DNA replication. Cdt1 is 
regulated by transcription, by proteasomal degradation and by binding to an inhibitory protein (see 3.7.4). 
3.4. Principal means of cell cycle regulation 
On a molecular level, cell cycle regulation is reduced to activity of different proteins at specific time points 
or time spans and specific locations. Regulation of protein abundance, activity and localization is the most 
basic task of cell cycle control.  
The above described mechanisms of two critical steps, the start of a new cell cycle and the licensing of 
replication origins, demonstrate the many ways of protein regulation during the cycle. The first way of 
protein regulation is of course gene expression. For example, S-Phase genes can only be transcribed if 
transcription factors are present that are themselves activated only during G1. Another example would be 
Cdc20, one of two important substrate recognition subunits for the APC/C. This protein is at least partly 
regulated by its expression pattern. Cdc20 mRNA accumulates in G2 and is degraded in G1, in agreement 
with its protein function as APC/C activator during mitosis (Fang et al., 1998). 
Localization is the second way for regulating protein activity. For example, the inhibitor E2F4 is localized 
in the nucleus upon binding to p130 and p107. This binding is interrupted through phosphorylation and 
E2F4 is shuttled in the cytoplasm, were it can no longer perform its inhibitory function (Gaubatz et al., 
2001). 
The third way for cell cycle regulation is the modification of enzymes and the resulting change in activity. 
The most important modification is probably phosphorylation or dephosphorylation. For example, MCM 
alone is not able to perform its DNA helicase activity. First, it has to be phosphorylated, which leads to 
recruitment of Cdc45 and GINS, a prerequisite of replication (Sheu and Stillman, 2006). Besides change of 
protein activity, phosphorylation can also play an important role in protein stability. As discussed below 
(see 3.7), phosphorylation is at least in some cases a necessary precondition for the substrate recognition 
of E3 ubiquitin ligases and their ubiquitin dependent proteasomal degradation. 
At the core of the cell cycle, regulation takes place with the help of small regulating molecules, which is 
the fourth regulatory mechanism. The most important of these molecules are cyclins that are only present 
at specific time spans in the cell and are positive regulators of cyclin dependent kinases (Morgan, 1995). 
Thus, Cdk activity is restricted to these specified time points. Another example would be the 
aforementioned cyclin dependent kinase inhibitors that have the reverse effect. CKIs are inhibitors of 
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Cyclin/Cdk complexes; binding to these complexes prevents the kinase activity. For example, both 
CycD/Cdk4 and 6 and CycE/Cdk2 are inhibited by various different CKIs, allowing for a tight control of the 
beginning of a new cell cycle (Sherr and Roberts, 1999). 
The last mechanism is the degradation of cell cycle proteins by the Ubiquitin-Proteasome system. Different 
proteins are degraded by this system at specific time points in the course of the cell cycle, making it one 
of the major means of cell cycle regulation in all steps (Bassermann et al., 2014). Among other things, the 
ubiquitin-proteasome system is responsible for the regulation of the sister chromatid separation after the 
connection of the spindle apparatus to all chromosomes (Peters, 2002). This is crucial for the even 
distribution of the chromosomes. Ubiquitination is also important for the degradation of cyclins after the 
cell cycle is completed (Glotzer et al., 1991). In addition, it is crucial for the transition from G1- to S-Phase 
(Rizzardi and Cook, 2012). Therefore, Ubiquitin-dependent regulation is essential for cell cycle control. 
3.5. The ubiquitin-proteasome system of degradation 
The ubiquitin-proteasome system is perhaps the most important mechanism for a cell to dispose of 
proteins. It enables cells to target only specific proteins for degradation at specific time points. Targeted 
protein degradation is a crucial step in numerous different cell tasks, therefore the scope of this system 
has a wide span, ranging from stress-response, ribosomal biogenesis, DNA repair mechanisms, embryonal 
development, immune response and of course cell division and control of the cell cycle (Jentsch et al., 
1991; Schulman and Harper, 2009). 
In principal, proteins are marked by ubiquitin through a cascade of three enzyme reactions. Afterwards, 
ubiquitin marked proteins are recognized, shuttled to the proteasome and disassembled. While the 
principal steps of this pathway are conserved, great variety exists regarding the proteins that are involved. 
The central molecule, ubiquitin, is a small polypeptide consisting of 76 amino acids with a molecular mass 
of 8.5 kDa that was discovered in 1975. It was named after the fact that it is present in most eukaryotic 
cells (Goldstein et al., 1975; Wilkinson, 2005). The most recognized function of ubiquitin is marking 
proteins for proteasomal degradation. A chain of polyubiquitin has to be formed on the target protein for 
this task. 
On a molecular level, the first step of ubiquitination is activation of ubiquitin through the activity of a 
Ubiquitin-activating enzyme E1. E1 forms a thioester bond with a ubiquitin molecule under consumption 
of ATP. E1 interacts with a ubiquitin conjugating enzyme (E2) and transfers the ubiquitin thereby. 
Ubiquitin-loaded E2 enzymes bind to the E3 ubiquitin ligases, the last family of enzymes in the cascade. 
The purpose of the E3 enzymes is to ligate the ubiquitin molecule to the respective substrates. Therefore, 
E3s can bind both the E2 enzymes and the substrates (Schulman and Harper, 2009). Different E3 ubiquitin 
ligases are responsible for different sets of substrates. After the substrate received the ubiquitin molecule, 
it stays at the ubiquitin ligase and more ubiquitin molecules are connected to it, often at the already 
attached ubiquitin. A ubiquitin chain is produced that serves as an internal mark for the cell on how to 
proceed further with the protein. 
The fate of the protein is dependent on how the single ubiquitin molecules of the chain are interconnected 
(Figure 3). The ubiquitin molecule has seven Lysine residues to which other ubiquitins could be attached. 
For example, a chain of Lys63 connected ubiquitins plays a part in signal transduction, receptor endocytosis 
and DNA repair mechanisms. Mixed chains of Lys29/Lys33 on the other hand have a role in the regulation 
of AMPK-related kinases by blocking their activation (Ikeda and Dikic, 2008). The most well-known function 
of ubiquitin is the degradation via the proteasome though. Ubiquitin chains that are interconnected on 
14 
 
their Lys48 are recognized by UBA-proteins (Saeki, 2017) and shuttled to the 26S proteasome were the 
target proteins are disassembled into amino acids and recycled for new protein synthesis. 
 
Figure 3 The fate of a substrate of a ubiquitin ligase in dependency of the ubiquitin linkage 
E3 ubiquitin ligases are marking their substrates with a chain of ubiquitin. The interlinkage of the ubiquitin molecules of the chain 
is deciding the fate of the substrate. The majority of ubiquitin molecules are linked together on Lys48, a signal for proteasomal 
degradation. The linkage between other lysines has different effects on the substrate protein (Komander, 2009). 
 
Eight E1 enzymes are proposed to exist in humans, their shared characteristic feature is an adenylation 
domain responsible for the binding of ubiquitin (Schulman and Harper, 2009). In Drosophila melanogaster, 
at least Uba1 is identified as an E1 (Schulman and Harper, 2009).  
The molecular domains that define the function of E2 ubiquitin conjugating enzymes are the HPN motif 
and conserved cysteine, proline and tryptophan at positions 87, 67 and 95 respectively. Proline and 
tryptophan are flanking the active center of the enzyme, thereby (Cottee et al., 2006). At least 40 proteins 
are considered E2s in humans (Ye and Rape, 2009), whereas it is thought that D. melanogaster has 25 
different E2 enzymes (Jones et al., 2002). 
Although the task of the different E3 ubiquitin ligases is altogether identical, this class of proteins is very 
variable regarding their structure. Two different families of E3 enzymes exist: the HECT and RING family. 
The HECT (homologous to E6-AP C-terminus) ubiquitin ligases are actively binding ubiquitin. After the E2-
ubiquitin complex binds to the HECT E3, ubiquitin is transferred to the HECT-domain of the E3-ligase and 
is forming a thioester intermediate with the cysteine in the active center of the HECT E3 (Metzger et al., 
2012). From there, it is attached to the respective substrate that is also bound on the HECT E3. Structurally, 
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HECT E3s are characterized by the HECT domain, located at the C-terminus, and consisting of two lobes. 
The N-terminal N-lobe interacts with the E2 ubiquitin conjugating enzyme, whereas the C-lobe, positioned 
at the C-terminus, contains the cysteine that is used for attachment of the ubiquitin (Huang et al., 1999). 
Around 30 HECT E3 ubiquitin ligases exist in mammals (Metzger et al., 2012). 
The larger group of E3 ubiquitin ligases are the members of the RING (really interesting new gene) family, 
with at least 600 genes encoding for an E3 RING ubiquitin ligase (Li et al., 2008). The difference to HECT 
E3s lies in the mode of ubiquitin transfer. Unlike HECT ubiquitin ligases, RING E3s do not bind ubiquitin 
themselves. Instead, their role is to bring the E2-ubiquitin complex and the respective substrate in spatial 
vicinity to each other and to catalyze the transfer of ubiquitin coming from E2 to the substrate. The motif 
responsible for E2 binding is a zinc-finger (Metzger et al., 2012). Because of their great number, RING E3s 
have a broader role in cells, including cell cycle control. Three of the most important RING E3s in this regard 
are the APC/C, the CRL4 and the SCF complex.  
3.6. Important members of the RING E3 ubiquitin ligase family  
Because of their great number and their different substrates, RING E3 ubiquitin ligase complexes exhibit 
large variability in their structure. Nonetheless, all ligases have certain elements that fulfill similar roles. 
There always is a scaffold protein, which serves as an interaction platform for all the other components. A 
protein with a zinc-finger motif is responsible for the connection with the respective E2 ubiquitin 
conjugating enzyme. An adapter protein binds to a so-called substrate recognition subunit (SRS). The SRS 
is responsible for substrate binding. Some of the RING E3 ubiquitin ligases are rather simple structured, 
for example CRL4 and the SCF complex (Figure 4). APC/C on the other hand is a large multi protein complex, 
consisting of 19 proteins in humans (Sivakumar and Gorbsky, 2015). 
 
Figure 4 Schema of Cullin RING ligases 
Cullin RING ligases are relatively simple constructed. They are built up of only four different proteins: a cullin scaffold, an RBX1 
RING finger and an adapter protein to which the substrate recognition subunit binds (Starostina and Kipreos, 2012). 
 
3.6.1. Anaphase Promoting Complex/Cyclosome 
The APC/C (anaphase promoting complex/cyclosome) is an unusual ubiquitin ligase because of its size. 
Whereas normally cullin RING ubiquitin ligases consist of around four different proteins, APC/C has 19 
subunits (see Figure 5), consisting of 14 different proteins, five of which are present in two copies each. 
The overall mass of the APC/C is 1.22 MDa (Sivakumar and Gorbsky, 2015). Why the APC/C consists of so 
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many subunits is still not clear and open for discussion. In principal, the complex is comprised of three 
domains. The platform subcomplex serves as a scaffold and interaction platform. The catalytic core 
subcomplex is responsible for ubiquitin-transfer if substrate and E2 is bound. The tetratricopeptide repeat 
subcomplex does also have scaffolding function and is also important for APC/C assembly and interaction 
with regulatory proteins (Sivakumar and Gorbsky, 2015). The co-activators of APC/C are either Cdc20 or 
Cdh1, which also play a role in substrate recruitment. The respective homologues in D. melanogaster are 
fizzy (fzy) and fizzy-related (fzr). 
 
Figure 5 Structure of the APC/C 
The APC/C is composed of 14 different proteins that can be subdivided in three different complexes. The platform subcomplex 
serves as a scaffold, the catalytic core subcomplex is responsible for the ubiquitin ligase activity and the TPR (tetratricopeptide 
repeat) lobe subcomplex has important functions in APC/C assembly and regulation (Sivakumar and Gorbsky, 2015).  
 
Cdc20 is responsible for APC/C activity from the beginning of the mitosis onwards to the end of metaphase. 
One of the prime substrates of APC/CCdc20 during metaphase is securin. After chromosome condensation, 
the sister chromatids are hold together by a protein complex called cohesin. For successful distribution of 
the sister chromatids, it is essential that cohesin is degraded before anaphase. Separase is the enzyme that 
is responsible for cohesin degradation. Since preliminary activity of separase would deeply disturb mitosis, 
it has to be thoroughly regulated. Securin is inhibiting separase activity. In Saccharomyces cerevisiae, 
APC/CCdc20 ubiquitinates securin, marking it for degradation and unleashing separase activity. This function 
of APC/CCdc20 is also present in vertebrates. However, the majority of cohesin is dissociated by another 
pathway in prophase and pro-metaphase in this case. Nonetheless, centromeric cohesin is not affected by 
this pathway and has to be removed upon APC/CCdc20-mediated ubiquitination of securin and subsequent 
activation of separase in anaphase in homology to the events in S. cerevisiae (Peters, 2002). 
Cdh1 is responsible for APC/C activity from anaphase until the end of G1-Phase. Cdc20 is a substrate of 
the APC/CCdh1 complex; thereby the APC/C is regulating itself to switch to other targets in the end of mitosis 
and the beginning of G1. Some of the most important targets of APC/CCdh1 are cyclins. Cyclin degradation 
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abolishes Cdk activity, which is necessary for the beginning of another cell cycle or quiescence (McLean et 
al., 2011). Cdk activity at the end of G1-Phase leads to Cdh1 phosphorylation, which prevents the binding 
to APC/C. Therefore, APC/C activity is shut off in S-Phase. Cdh1 is degraded by the proteasome in S-Phase. 
Both Cdc20 and Cdh1 use WD40 repeats as their substrate recognition motifs that form to a β-propeller 
and are able to interact with other proteins. APC/C substrates have conserved degron motifs that allows 
Cdc20 or Cdh1 to recruit them to the APC/C. In most cases this is either the D-Box or the KEN-Box 
(Sivakumar and Gorbsky, 2015).  
3.6.2. CRL4Cdt2 
CRL4Cdt2 (see Figure 6) is a cullin RING ligase that is specifically active in S-Phase and among other things 
responsible for ubiquitination and disposal of important regulators of G1-S transition. Cullin4 (Cul4) serves 
as the scaffold protein, its C-terminus is binding to the RING finger protein Rbx1. The E2-Ub complex is 
using Rbx1 as its docking site. The adapter-protein DDB1 binds to the N-terminus of Cul4. As already 
mentioned, adapter-proteins are the juncture of the substrate recognition subunit with the E3 ubiquitin 
ligase scaffold. Cdt2 is the SRS in CRL4Cdt2, responsible for recruitment of the substrates to the complex 
were ubiquitination takes place (Havens and Walter, 2011). 
 
Figure 6 Schema of CRL4Cdt2 
CRL4Cdt2 consists of the scaffold protein Cullin 4, the RING protein Rbx1 that binds the E2 and the adapter protein DDB1 to which 
the SRS Cdt2 binds. Substrates of CRL4Cdt2 have to be bound to the PCNA during S-Phase to be recognized by this complex. Picture 
adapted from Abbas and Dutta (2011). 
 
One peculiarity of the CRL4Cdt2 complex is its mode of substrate recognition. All substrates possess a PIP 
(PCNA interacting protein) degron, which enables them to bind to the proliferating cell nuclear antigen 
(PCNA) where they are recognized by CRL4Cdt2. The PCNA is a complex necessary for efficient DNA 
synthesis. DNA polymerases are not capable of DNA strand synthesis alone, since they are falling off the 
template strand easily. The ring-like structure of the PCNA enables them to bind to DNA efficiently and 
move freely on the strand. Therefore, the falling off is prevented and the efficiency of DNA replication 
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elevated (Morgan, 2007). PCNA is loaded onto DNA exclusively in S-Phase or if DNA damage occurred, 
thereby restricting the function of CRL4Cdt2 also to these incidences (Havens and Walter, 2009). Though 
there are variations, the PIP degron consists in principal of three elements. A PIP box is a conserved amino 
acid sequence that leads to recruitment onto the PCNA. The binding to the PCNA via the PIP-box is only 
weak though. Therefore, most but not all PIP degrons have additionally a threonine-aspartame motif that 
leads to high affinity binding. Lastly, there also exists a basic amino acid four residues downstream of the 
PIP-Box, responsible for CRL4Cdt2 binding (Havens and Walter, 2011). This rather special way of substrate 
recognition allows CRL4Cdt2 to mark its substrates efficiently for degradation in the beginning of S-Phase. 
CRL4Cdt2 has a number of substrates. For example, after transition to S-Phase, E2F1 is degraded via its PIP 
Box, since expression of G1 genes has to be prevented (Shibutani et al., 2008). The CKIs p21 and p27 are 
likewise degraded by the proteasome in S-Phase and though there are more regulatory mechanisms, they 
are also substrates of CRL4Cdt2 (Havens and Walter, 2011). This is also true for the respective homologue 
of p21 and p27 in Drosophila, the protein Dacapo (Dap) (Higa et al., 2006; Swanson et al., 2015). Another 
example is Cdt1 that is highly regulated in S-Phase since otherwise, re-replication would occur (Liu et al., 
2007). This regulation is performed at least partly by PIP degron mediated degradation (Havens and 
Walter, 2011). Dap and Drosophila Cdt1 will be discussed in greater length below (3.7.3.2 and 3.7.4.2). 
3.6.3. Skp1, Cullin, F-Box protein (SCF) complex  
The Skp1, Cullin, F-Box protein (SCF) complex has important roles in cell cycle regulation from G1 through 
S-Phase and up to G2. The reason for this broad role is the wide variety of different substrate recognition 
subunits that make the SCF highly versatile. The SCF was first discovered in yeast; its name is derived by 
some of its components, namely Skp1, Cullin1 and the F-Box protein (Feldman et al., 1997; Skowyra et al., 
1997). Cullin1 (Cul1) is the scaffold protein. Rbx1 is the RING protein and binds to Cul1. As already 
described, the task of the RING protein is to interact with the E2 ubiquitin conjugating enzyme loaded with 
ubiquitin and recruit it to the E3 (Willems et al., 2004). Skp1 is the adapter protein that binds a specific 
substrate recognition subunit. These subunits are called F-Box proteins in the case of the SCF-complex (see 
3.7). 
The SCF complex is tightly regulated. Assembly of the SCF is prevented by binding of the sequestration 
factor CAND1 to Cul1. CAND1 prevents the binding of Skp1 and the F-Box protein to Cul1, effectively 
disabling SCF activity. NEDD8 has to be attached to Cul1 to release it from its CAND1 inhibition. 
Furthermore, NEDD8 binding also increases the ubiquitin ligase activity of the SCF-complex, changes the 
structure to facilitate the attachment of the ubiquitin and allows the E2 enzyme wider access to the 
growing polyubiquitin chain (Skaar and Pagano, 2009). Besides, the presence or absence of respective F-
Box proteins also determines the ability of the SCF-complex to bind and ubiquitinate certain substrates.  
SCF subunits are overall highly conserved. Indeed, it is possible to rescue deficiencies of Skp1, Cul1 and 
Rbx1 in yeast with the respective human versions of the SCF-complex (Deshaies, 1999). The high 
conservation can also be observed in D. melanogaster. Drosophila Cul1 has 62% identity to the human 
homologue, Drosophila SkpA (homologue of Skp1) and Rbx1 have 76% and 91% respectively (Bocca et al., 
2001). The interaction of fly SCF was investigated by Yeast Two Hybrid and in vitro interaction assays in 
the same studies. In fact, it was accomplished to rescue yeast Rbx1 deficiency with expression of fly Rbx1, 
which also demonstrates the similarity between components of the SCF in different organisms. 
F-Box proteins of the SCF are of special interest, since they allow one protein complex to regulate a large 
number of different proteins. Indeed, faulty regulation of cell cycle F-Box proteins is often a cause of cancer 
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(Heo et al., 2016). This underlines that the regulation of F-Box proteins, their way of substrate recognition 
and especially their target substrates are important aspects for proper cell cycle progression. 
3.7. The F-Box protein Skp2 and its substrates 
3.7.1. Skp2 in mammals and humans 
The first F-Box protein that was identified is Cyclin F in 1994 (Kraus et al., 1994). This is also were the name 
of this protein class is derived from. All F-Box proteins have in common that they share a conserved, so 
called F-Box motif through which they can bind to the adapter protein of SCF-complexes (Kipreos and 
Pagano, 2000). F-Box proteins can be divided in three classes according to their way of substrate binding. 
The Fbxw proteins have WD40 repeats that are responsible for binding to their substrates. The Fbxl 
proteins possess leucine rich repeats that are fulfilling this role. Fbxo proteins on the other hand have 
various different sequence motifs for substrate binding (Heo et al., 2016). F-Box proteins may have a 
number of functions independently from the Ubiquitin-Proteasome pathway (Nelson et al., 2013); their 
main task is nonetheless the recruitment of substrates to the SCF (Skowyra et al., 1997). Therefore, they 
play a central role in regulation of proteins through the ubiquitin-proteasome system. A peculiarity of F-
Box proteins is that recognition of their substrates is primarily regulated by modification. This can happen 
in many different ways. For example, it may be necessary that a cofactor has to be bound on the substrate 
for recognition. Another possibility is that the degron motifs on the substrates have to be made accessible 
first. The most important mechanism is phosphorylation though, meaning that the phosphorylation status 
of the substrates are determining if they can be recognized and regulated by F-Box proteins (Skaar et al., 
2013). 
Around 69 proteins are considered F-Box proteins in humans, whereas it is estimated that D. melanogaster 
possess 27 (Skaar et al., 2009). Many F-Box proteins play important roles in cell cycle regulation (Zheng et 
al., 2016). Perhaps the most known F-Box protein in this regard is the S-Phase kinase associated protein 2 
(Skp2), a member of the Fbxl family. SCFSkp2 is extensively studied in the human system, since it is of 
importance for the regulation of several crucial cell cycle proteins.  
Skp2 was discovered in 1995 in a study that identified two interaction partners of Cyclin A/Cdk2 (Zhang et 
al., 1995). In 1998, it was found that Skp2 is in fact an F-Box protein of the SCF-complex, regulating the 
protein stability of Cyclin D and of the CKI p21 (Yu et al., 1998). This implies that Skp2 has an important 
part in the transition from G1- to S-Phase. Skp2 is regulated by several ways. A number of different 
transcription factors are supposed to be responsible for gene expression of Skp2, including, among others, 
E2F1 (Chan et al., 2010). On the other side, Skp2 is disposed of by APC/CCdh1 ubiquitination and subsequent 
proteasomal degradation (Bashir et al., 2004; Wei et al., 2004). Skp2 accumulates in late G1-Phase and is 
degraded in late M-Phase by APC/CCdh1 activity (Bashir et al., 2004; Kurland and Tansey, 2004; Wei et al., 
2004). Besides expression and degradation, Skp2 is also regulated by its localization and failures in this 
respect have severe consequences. While Skp2 resides in the nucleus under normal conditions, it was 
shown that phosphorylation by AKT/protein kinase B leads to nuclear export and accumulation in the 
cytoplasm (Lin et al., 2009b). The same study suggested that this is one reason of Skp2 dependent cancer 
formation. Indeed, it was also found that Skp2 is localized in the cytoplasm in aggressive lymphomas (Lim 
et al., 2002). Besides AKT signaling, evidence exists that links TGFβ-signaling to the localization of Skp2 in 
the nucleus, where it is targeted by APC/CCdh1 mediated proteasomal degradation (Hu et al., 2011). The 
protein Connexin 50 does also seem to have a role in the Skp2 localization. Connexin 50 binds and masks 
the Skp2 NLS sequence, which also leads to cytosolic accumulation. In this case, it was also found that Skp2 
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possesses auto-ubiquitination capability in these circumstances and takes care of its own degradation (Shi 
et al., 2015). 
There also seems to exist an unknown pathway of degradation. Application of the drug lovastatin results 
in a depletion of Skp2 protein levels. This drug has the ability to deplete the geranylgeranyl-isoprenoid 
intermediates of the cholesterol biosynthesis. It was speculated that consequently an unknown regulator 
of Skp2 could no longer be geranylgeranylated, which leads to Skp2 degradation. This pathway is 
dependent upon the N-terminus of Skp2 (Vosper et al., 2015). 
 
Figure 7 Atomic structure of Skp2 
Skp2 (red) is sickle shaped, whereupon the F-Box domain builds the handle and the leucine rich repeats the blade. The F-Box 
domain binds to Skp1 (dark blue) thereby forming the SCFSkp2 complex. Cks1 (light blue) associates to the blade and supports the 
binding of the substrate p27 (yellow, only partly depicted). Picture adapted from Hao et al. (2005). 
 
Another factor that is important for Skp2 activity is the small molecule Cks1. As already mentioned, some 
F-Box proteins require a cofactor for efficient substrate binding (Skaar et al., 2013). Cks1 is the cofactor 
that is at least in some cases essential for Skp2 activity. Cks1 is necessary for the recognition of the CKI p27 
by Skp2 in vivo and in vitro (Ganoth et al., 2001; Spruck et al., 2001).  
The atomic structure of Skp2 is described as sickle shaped. The handle of the sickle is thereby comprised 
of the F-Box motif and responsible for interaction with Skp1 and consequent recruitment of the protein to 
the SCF. The leucine rich repeats (LRR), the motif responsible for the binding of the substrates, are forming 
the blade of the sickle (Schulman et al., 2000). The role of Cks1 was elucidated by determining the atomic 
structure of both complexes (Figure 7). Cks1 binds to the LRR blade of Skp2 and supports the binding and 
recognition of p27 (Hao et al., 2005). 
Skp2 is extensively studied because of its role in cancer development. Indeed, it was shown that Skp2 
levels are increased in tissue samples of breast, colon and colorectal cancers (Fujita et al., 2008). Likewise, 
the knockdown of Skp2 led to reduced proliferation and invasiveness of osteosarcoma cells (Ding et al., 
2017). Skp2 is also considered a prognostic marker in cancer outcome; high levels are correlated with poor 
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prognosis in various different tumors, for example breast cancer (Zhang et al., 2016), gastric cancer (Wei 
et al., 2013), lung cancer (Zhu et al., 2004) and nasopharyngeal carcinoma (Wang et al., 2014). Skp2 was 
also already proposed as an object of cancer therapy (Bassermann et al., 2014). Indeed, many different 
medications are already tested that target Skp2 for cancer treatment (Chan et al., 2013; Ding et al., 2017). 
The reason for the importance in cancer research is the array of substrates that Skp2 regulates by 
ubiquitination. 
Skp2 has a multitude of different substrates in mammals (Heo et al., 2016). For example, TRUSS, one of 
the substrate recognition subunits of CRL4 (see 3.6.2), is a substrate of SCFSkp2. TRUSS is a regulator of the 
gene expression factor Myc, and disruption of the Skp2 dependent regulation does lead to cancer (Jamal 
et al., 2015). LKB1, an important kinase for the regulation of different functions in the cell is also the aim 
of Skp2 dependent ubiquitination. Quite unusually though, in this case the ubiquitination does not lead to 
proteasomal degradation but to activation of LKB1 (Lee et al., 2015). Another Skp2 substrate in humans is 
E2F1, one of the important transcription regulators for the start of a new cell cycle (Marti et al., 1999). 
Furthermore, Cyclin E, important for G1/S gene expression is targeted for degradation by Skp2 (Nakayama 
et al., 2000). The human ORC1 protein, the biggest subunit of the ORC complex, is another example for 
Skp2 mediated ubiquitination (Mendez et al., 2002). This shows that Skp2 has also important roles in 
replication control and the prevention of re-replication. The fact that Skp2 is also responsible for Cdt1 
ubiquitination underlines this result (Li et al., 2003). However, the function that is considered the most 
essential is the regulation of the three CKIs p21, p27 and p57 (Lu and Hunter, 2010). Skp2 is performing a 
direct control of the transition from G1-Phase to S-Phase therefore, a step that is extremely critical for the 
cell and the prevention of cancer development. 
3.7.2. Skp2 in Drosophila melanogaster 
Although Skp2 is studied extensively in mammals for its importance in cell cycle control and cancer 
research, not much is known about the homologue in flies. Drosophila Skp2 was discovered and described 
in 2011 together with Cks85A, the homologue of Cks1 (Ghorbani et al., 2011). According to this source, 
Drosophila Skp2 has 23% identity and 41% similarity in comparison to the human version. These 
percentages increase if the comparison is restricted to the functional parts of the protein, the F-Box and 
the LRRs (33% identity and 59% similarity). The role of Skp2 that the authors saw is maintenance of diploidy 
and growth promotion. Reducing the levels of Skp2 in flies has several different outcomes. Skp2 knockout 
leads to a delayed development in D. melanogaster larvae and ultimately to death early in the pupal phase. 
Growth is negatively affected as the number and ploidy of cells in salivary glands is reduced. Another effect 
was seen in larval brains. If Skp2 is eliminated, the overall size of the brains become smaller. At the same 
time, cells become larger and polyploid. Polyploidy is also seen in eye imaginal discs and wing imaginal 
discs if Skp2 is knocked out. Additionally, wing imaginal discs do also show increased apoptosis under these 
circumstances. These effects could be also seen in adult wings since Skp2 knockdown results in an 
increased distance between the wing hairs. The authors saw that the effects of Cks85A knockdown are 
comparable to Skp2 knockdown. This observation led to their consideration that both proteins work 
together. Indeed, they also saw biochemical interaction between Skp2 and Cks85A. In addition, they could 
show genetical interaction between both proteins in eye imaginal discs. It seems that Cks85A has a role in 
the substrate recognition process of Skp2. This is in accordance with mammalian SCFSkp2, where Cks1 also 
enables or at least supports Skp2 function. Co-IP experiments also showed an interaction between Skp2 
and SkpA, the homologue of Skp1 in D. melanogaster, demonstrating that Skp2 is indeed part of an SCF-
complex. Furthermore, interaction with Cyclin-dependent kinase 1 and 2 could also be detected. Although 
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it was not the focus of this paper, it was also tested if Skp2 knockout influenced the amount of Double 
parked (Dup, homologue of Cdt1, see 3.7.4) and Dacapo (Dap, homologue of p21, p27 and p57, see 3.7.3). 
Dup protein levels are not changed upon Skp2 knockout, which led the authors to assume that it is not a 
substrate in Drosophila. Dacapo levels are also not positively influenced by Skp2 knockout. It has to be said 
though that these Western analyses are only hints and cannot give definitive statements if Dup and Dap 
are targets of Skp2 ubiquitination, especially since both proteins are strongly regulated in the cell cycle by 
other mechanisms. 
The relationship between Skp2 and Dacapo was analyzed more thoroughly two years later (Dui et al., 
2013). Dui et al. (2013) proposed that Dacapo is a substrate of Skp2. They performed different biochemical 
assays, Western Blots, Co-IPs and ubiquitination assays, as well as genetical approaches on eye and wing 
development. Their result was that Skp2 ubiquitinates Dap for subsequent proteasomal degradation. 
However, one caveat of this study is that the authors did not consider the role of the PIP box mediated 
degradation of Dap and its cell cycle function. At least some of their results can also be explained by cell 
cycle shifts caused by altered Skp2 or Dap levels and consequent regulation by CRL4Cdt2. Up to now, these 
two sources represent the only serious studies that focus on Skp2 in D. melanogaster. Since their results 
differ regarding Dap being a substrate of Skp2, one of the starting points of this thesis was to clarify this 
issue. 
The overall topic of this work was to figure out if Drosophila Skp2 is responsible for the regulation of the 
fly homologues of p21, p27, p57, Cdt1 and CycE. These potential substrates will be discussed in greater 
detail in the next sections. 
3.7.3. Function and regulation of the G1-S CKIs 
3.7.3.1. Characterization of p21, p27 and p57 and their regulation by Skp2 
p21, p27 and p57 are members of the CIP/KIP (CDK interacting protein/kinase inhibitory protein) family of 
CKIs and responsible for inhibition of Cdk1 or Cdk2 activity in mammalians and thereby important for G1- 
to S-Phase transition. All three are well known substrates of the SCFSkp2 complex. 
p21 was discovered in 1993 in human cells as a potent inhibitor of the Cdk2 complex. Overexpression of 
p21 leads to disappearance of Cdk2 activity and consequently the transition from G1 to S does no longer 
take place (Harper et al., 1993). p21 can be activated under stress conditions, for example DNA damage or 
oxidative stress, and is thereby exerting an important function in cell homeostasis (Abbas and Dutta, 2009). 
SCFSkp2 is responsible for ubiquitination of p21 in vivo in G1-Phase (Yu et al., 1998) and in vitro (Bornstein 
et al., 2003). An important finding of this study is that addition of both Cks1 and CycE/Cdk2 is necessary 
for the ubiquitination of p21 by Skp2. The CycE/Cdk2 complex seems to have two tasks in this case. First, 
the authors could demonstrate that CycE/Cdk2 is necessary for the phosphorylation of p21. This 
phosphorylation facilitates the recognition through SCFSkp2 in accordance with the fact that Skp2 binds 
preferably to phosphorylated substrates. However, this general function of CycE/Cdk2 is not a prerequisite 
in this case, ubiquitination could still happen efficiently without phosphorylation. Nonetheless, CycE/Cdk2 
has to be present for the regulation of p21. Therefore, the second task of CycE/Cdk2 seems to be to build 
a physical interaction with p21, which is necessary for the recognition by Skp2. Besides ubiquitination 
through SCFSkp2, p21 is also a target of CRL4Cdt2, which regulates this protein in S-Phase (Abbas et al., 2008; 
Kim et al., 2008; Nishitani et al., 2008). Although p21 levels drop in S-Phase, the protein reaccumulates in 
G2 and M (Dulic et al., 1998). The reason is that p21 inhibits the activity of Cdk1, thereby delaying mitosis. 
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The authors speculated that this gives the cell time to integrate the signals of G2 checkpoints that are 
important for start of mitosis, thereby assuring proper control of the beginning of M-Phase. However, p21 
has to be degraded for complete Cdk1 activity and upkeep of the spindle assembly checkpoint in 
prometaphase (Amador et al., 2007). The same study showed that APC/CCdc20 is responsible for p21 
ubiquitination in mitosis.  
p27 was also discovered as an inhibitor of CycE/Cdk2 (Polyak et al., 1994). It is considered to be an 
intrinsically unstructured protein (Bienkiewicz et al., 2002). The crystal structure of p27 in complex with 
CycA/Cdk2 gave a general insight into how the CKIs are able to inhibit the function of cyclin dependent 
kinases (Russo et al., 1996). In the beginning, p27 binds to the CycA protein. After binding to CycA, a helix 
of p27 is becoming structurally unordered. If this helix is getting close to Cdk2, its structure is restored and 
binds the N-terminus of Cdk2. Consequently, parts of p27 that are mimicking the structure of ATP are 
occupying the catalytical center of the CycA/Cdk2 complex. This has two effects: already bound ATP is 
driven away from the Cyclin-Cdk complex and further ATP binding is abolished. Besides, since p27 also 
interacts with CycA, recruitment of phosphorylation targets is also prevented. 
Just like p21, SCFSkp2 also targets p27 for ubiquitination and consequent proteasomal degradation (Carrano 
et al., 1999). The same study also showed that p27 has to be phosphorylated at threonine 187 for 
interaction with Skp2. This phosphorylation is performed by Cdk2 activity (Sheaff et al., 1997). It was also 
observed that p27, just like p21, has to physically interact with CycE/Cdk2 for recognition by SCFSkp2 
(Montagnoli et al, 1999). Later on, it was shown that Skp2 is not able to bind to p27 without the addition 
of Cks1 in vitro (Ganoth et al., 2001) and in vivo (Spruck et al., 2001), underlining the importance of Cks1 
as a supporter molecule. p27 level are also rising under Skp2 knockout conditions in mouse cells and 
tissues, another hint that SCFSkp2 regulates p27 protein stability (Nakayama et al., 2000). 
Besides Skp2, p27 is regulated in multiple other ways. It was shown in rabbit reticulocyte lysates that the 
E3 ubiquitin ligase KPC is also responsible for ubiquitination of p27 in G1-Phase (Kamura et al., 2004). 
Furthermore, a knockdown of Cul4 or DDB1 also results in accumulation of p27, hinting to a possible 
regulation by CRL4Cdt2 via a PIP degron (Higa et al., 2006). 
p57 was discovered in a two-hybrid screen for interaction partners with cyclins and Cdks (Matsuoka et al., 
1995). The authors could show p57 binding to cyclin/Cdk complexes that are essential for the G1-S 
transition, for example CycE/Cdk2. Consequently, overexpression of p57 leads to a stop of the cell cycle in 
SAOS-2 cells. In the same publication, it was also observed that p57 expression is restricted to certain 
organs. This is a difference to p21 and p27 that are expressed in all tissues and organs. The authors also 
speculated that the task of p57 is to prevent restart of the cell cycle after cells become differentiated. Just 
like the other two CKIs, p57 is regulated by proteasomal degradation and SCFSkp2 is responsible for the 
ubiquitination. Phosphorylation does also have an important part in this regulation, since p57 has to be 
phosphorylated on a threonine at the C-terminus for Skp2 recognition (Kamura et al., 2003). 
3.7.3.2. Dacapo and the regulation by Skp2 in flies 
Instead of three CKIs that prevent the transition from G1 to S, D. melanogaster possesses only one, the 
protein Dacapo. Upon its discovery, it was shown that Dap bears sequence similarities to rat p21 (de Nooij 
et al., 1996). Furthermore, it was also shown that Dap could inhibit the activity of Cyclin E/Cdk2 in vitro. It 
does also prevent S-Phase in vivo in dependency of Cyclin E. The interaction with CycE/Cdk2 is specific, 
since Dap does not seem to interact with CycB/Cdk1 or CycA/Cdk1 (Lane et al., 1996). 
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One of the functions of Dap seems to be the prevention of cells from re-entering the cell cycle during 
embryonal development. Embryonic epidermal cells go through 16 complete cell cycles and arrest 
afterwards in the G1-Phase of cycle 17. A loss-of-function mutation of Dap seems to lead to an additional 
full cycle, resulting in a drastic increase of the embryonic cell number (de Nooij et al., 1996; Lane et al., 
1996). Conversely, overexpression of Dap results in a premature stop of the embryonic cell cycle after 
completion of mitosis 16 (Lane et al., 1996). Additionally, null mutants of Dap are lethal, underlining its 
importance in the fly development (de Nooij et al., 1996). In accordance with the inhibitory effect of Dap 
on CycE/Cdk2 activity, overexpression of Dap leads to G1 accumulation of wing imaginal disc cells as seen 
by flow cytometric analysis (Reis and Edgar, 2004). This effect was also seen in Drosophila Schneider cells 
in the Sprenger group (Bauer, 2011). According to this, Dap plays a prominent role in the transition from 
G1- to S-Phase in D. melanogaster and the corresponding cell lines. 
Just like the three mammalian CKIs, Dacapo has to be tightly regulated for correct cell proliferation control. 
While Dacapo should exercise its inhibitory function during G1-Phase, it would hinder the proper course 
of the cell cycle at the end of G1 and in S. Western Blot analysis showed that Dap levels are dependent 
upon the activity of CUL4, the scaffold protein of the CRL4Cdt2 E3 ubiquitin ligase (Higa et al., 2006). Indeed, 
it was shown that Dacapo does not only possess a PIP degron but that it is also degraded in S-Phase 
(Swanson et al., 2015). In case of F-Box mediated degradation, a PhD thesis in the Sprenger Group 
observed that Dap stability is negatively affected by activity of the F-Box protein Rca1 (Regulator of cyclin 
A1), the fly homologue to human Emi1 (Kies, 2017). This connection was seen by analysis of protein 
stability with flow cytometric methods, by Co-IP assays and by MS analysis.  
Although the binding and ubiquitination of the three CKIs is considered the essential function of Skp2 in 
mammals, this interaction is not studied well in flies. As already mentioned, the only two publications that 
deal with this topic come to different results. Ghorbani et al. (2011) could not see an increase of protein 
levels under Skp2 knockout conditions in larvae or brain/imaginal disc cells. However, Dui et al. (2013) 
came to different results. Among other things, Dap shows robust biochemical interaction with Skp2 and 
simultaneous Cks85A overexpression does increase this interaction further. Dap levels are also sensitive 
to modulation of Skp2 levels and overexpressing Skp2 leads to an enhanced portion of ubiquitinated Dap. 
These assays are neglecting some indirect effects, however and a final answer if Skp2 is really a regulator 
of Dap is not satisfactorily given, yet. 
3.7.4. Cdt1, an essential factor in DNA replication 
3.7.4.1. Cdt1 and its regulation 
As already mentioned (see 3.3), Cdt1 has the important responsibility to recruit the MCM helicase to the 
DNA, thereby completing the pre-replication complex. The formation of the pre-RC is a prerequisite for 
subsequent start of DNA replication. Cdt1 was first discovered in fission yeast as a protein that is 
dependent on Cdc10 for its expression, thereby making it cell cycle regulated (Hofmann and Beach, 1994). 
The primary function of recruiting the MCM was described later (Nishitani et al., 2000). Since Cdt1 has 
essential function in DNA replication, homologues can be found in S. cerevisiae (Devault et al., 2002), D. 
melanogaster (Whittaker et al., 2000), Xenopus laevis (Maiorano et al., 2000) and Homo sapiens 
(Wohlschlegel et al., 2000). All of these homologues have in common that they are essential for DNA 
replication (Morgan, 2007). 
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DNA replication is a critical step in the cell cycle, since mistakes can lead to severe effects and deregulation 
of cell division. Therefore, Cdt1 expression, activity and stability must be controlled and regulated by cells. 
Indeed, Cdt1 levels are increased in several cancer cell lines and cells overexpressing Cdt1 can induce 
tumor growth if injected in mice (Arentson et al., 2002). The authors of this study conclude that Cdt1 is an 
oncogene. They also showed that cells enter S-Phase faster if Cdt1 is overexpressed, which is in accordance 
with its biological function. The effects of Cdt1 overexpression are dependent on the used cell line 
however. It was found that Cdt1 overexpression leads to re-replication only in certain tumor cell lines. It 
seems that the effect of Cdt1 overexpression in these cases is increased recruitment of MCM to the DNA. 
This ends up in erroneous DNA replication resulting in the creation of ssDNA, which is a signal for activation 
of the DNA damage response system (Liu et al., 2007). 
Not all cell lines do react to the overexpression of Cdt1. However, a combined overexpression of Cdt1 
together with ORC1 and Cdc6, other members of the pre-replicative complex, results in overreplicating 
cells, regardless of the cell line (Sugimoto et al., 2009). This effect could also be seen in mouse embryonic 
stem cells, where the combined overexpression leads to origin re-firing, re-replication and DNA damage 
(Munoz et al., 2017).  
Cdt1 overexpression effects also the whole organism. Overexpression in mice results in increased cell 
numbers in mesenteric nodes and in rarer cases in massive adenopathy (Seo et al., 2005). The same study 
also performed Cdt1 overexpression experiments combined with p53 knockdown to prevent the activation 
of the DNA damage response system. Under these circumstances, mice fall ill on thymic lymphoblastic 
lymphomas and die prematurely. This suggests that Cdt1 is responsible for cell proliferation. Mouse 
embryos react to a combined overexpression of Cdt1 and Cdc6 with slowed development or even with 
degeneration and embryonic liver cells show an increase in DNA content. The same study also found that 
Cdt1 and Cdc6 overexpression leads to changes in the gastrointestinal tract, bone marrow, spleen and 
thymus, leading to morbidity and reduced life span in adult mice (Munoz et al., 2017). 
Cdt1 activity and regulation does also play an important role in many different kinds of cancers. Cdt1 is a 
factor of tumor development from the first stages of cancer formation. While initial Cdt1 overexpression 
activates cell protection systems, prolonged overexpression circumvents these mechanisms and leads to 
genomic instability and the enhancement of aggressive properties of cells (Liontos et al., 2007). Cdt1 does 
also play a role in the formation of lung cancer, since its mRNA and protein levels are increased in lung 
cancer tissue. In addition, overexpressed Cdt1 and Cdc6, together with mutated p53, results in poor 
prognosis for lung cancer patients (Karakaidos et al., 2004). Another example is breast cancer, where 
higher Cdt1 levels result in reduced survival time of patients and Cdt1 mRNA and protein levels are 
increased in breast cancer cell lines (Mahadevappa et al., 2017). 
Since Cdt1 stands in the center of DNA replication, it is not surprising that its activity and stability is 
thoroughly regulated in the course of the cell cycle. There are several mechanisms to regulate Cdt1. The 
protein Geminin binds to Cdt1 in vivo and in vitro and inhibits its ability to recruit MCM to the ORC-Cdc6 
complex (Wohlschlegel et al., 2000). Furthermore, Cdt1 is also degraded by proteasomal degradation. In 
C. elegans it was found that knockdown of Cul4, the scaffold protein of the CRL4Cdt2 ubiquitin ligase, leads 
to an arrest in S-Phase, because Cdt1 could no longer be removed from S-Phase cells (Zhong et al., 2003). 
Indeed, it could be shown that CRL4Cdt2 is responsible for ubiquitination of Cdt1, leading to proteasomal 
degradation (Nishitani et al., 2006). The finding that PCNA is required for this degradation and the locating 
of the PIP degron at the beginning of the N-terminus are in accordance with this finding (Senga et al., 
2006). It seems that this regulatory mechanism is conserved. In Schizosaccharomyces pombe two PIP 
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degrons are responsible for the proteasomal degradation of Cdt1 (Guarino et al., 2011). In addition, the 
original PIP degron was actually found and described in the X. laevis Cdt1 (Havens and Walter, 2009). 
Finally, Cdt1 is also a substrate of SCFSkp2, which regulates it in S- and G2-Phase (Li et al., 2003; Nishitani et 
al., 2006). Cdt1 needs to be phosphorylated to be recognized by Skp2 as well (Li et al., 2003), which is in 
concordance with substrate modification being the signal for Skp2 mediated degradation. Subsequent 
studies found that the CycA/Cdk1 and CycA/Cdk2 complexes are responsible for Cdt1 phosphorylation, 
priming it for ubiquitination by SCFSkp2 (Sugimoto et al., 2004). In addition, it was possible to identify the 
phospho-sites that need to be phosphorylated for Skp2 binding, a threonine at position 29 (Takeda et al., 
2005) and presumably also the serine at position 31 (Nishitani et al., 2006). It has to be noted however 
that investigations differ in the importance of the Skp2 mediated degradation. Takeda et al. (2005) saw 
that a Cdt1 mutant that is no longer able to bind to Skp2 is still degraded like wild type Cdt1, speaking 
against a strong impact of SCFSkp2 regarding Cdt1 regulation. On the other hand, both Senga et al. (2006) 
and Nishitani et al. (2006) found that Skp2 mediated degradation is redundant and independent from 
CRL4Cdt2, underlining the importance of this mechanism. 
There also seems to exist a certain cross talk between Geminin and the proteasomal degradation of Cdt1. 
Association of Geminin to Cdt1 results in an increase of Cdt1 stability and a model was created were 
Geminin binding protects Cdt1 in S-, G2- and M-Phase from proteasomal degradation, at least to a certain 
extent. This mechanism ensures the persistence of basal Cdt1 levels in S-Phase and takes care of the re-
accumulation of Cdt1 during G2- and M-Phase, which makes origin licensing from telophase onwards 
possible (Ballabeni et al., 2004). Indeed, it was found that Geminin protects Cdt1 explicitly from 
degradation by SCFSkp2 during mitosis (Tsunematsu et al., 2013). 
3.7.4.2. The Cdt1 homologue in D. melanogaster 
The homologue of Cdt1 in Drosophila is called Dup (double parked), since mutation of this gene not only 
results in a disablement of DNA replication but also in mitotical arrests during embryogenesis, thereby 
“parking” at two different points of the cell cycle (Whittaker et al., 2000). Dup shares sequence homology 
to other Cdt1 homologues, specifically to S. pombe, Arabidopsis thaliana, C. elegans and mouse and human 
versions. Another observation in this study was that Dup co-localizes with the ORC complex, in accordance 
with the behavior of its homologue. Furthermore, mutation of Dup results in a number of defects that are 
all linked to malfunctioning DNA replication. For example, DNA replication fails in S-Phase of embryonic 
cycle 16 if Dup is mutated (Whittaker et al., 2000). While maternal factors take care of correct progression 
of the DNA replication machinery, they are depleted after cycle 15 and the mutated version of Dup is 
unable to recruit the Drosophila MCM helicase to the DNA. Astonishingly, these cells are still capable of 
entering mitosis 16 where the cell cycle then stops. Ultimately, this results in embryonic death. The authors 
also used a second mutation of Dup that does not result in embryonic lethality and it was possible to 
investigate effects in adult individuals. It seems that this Dup version leads to reduced DNA amplification 
during oogenesis. Conversely, a simple overexpression of Dup does not lead to critical defects in fly 
development. Ubiquitous Dup overexpression leads to normal fly development and overexpression 
exclusively in the Drosophila eye leads only to a weak rough eye phenotype (Lee et al., 2010).  
Regulation of Dup seems to be similar to Cdt1 in mammals for the most part. The Drosophila version of 
Geminin is able to interact biochemically and genetically with Dup (Quinn et al., 2001) and leads to 
prevention of re-replication in S-Phase caused by Cdt1 over activity (Mihaylov et al., 2002). Besides protein 
inhibition, Dup is also regulated by degradation. It was shown that two independent mechanisms are 
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responsible. The first mechanism does not rely on Dup phosphorylation for its degradation, the second 
mechanism only takes care of phosphorylated Dup, which is performed by CycE/Cdk2 (Thomer et al., 
2004). 
Later on, it became clear that in homology to Cdt1 the phosphorylation independent mechanism is based 
upon CRL4Cdt2 degradation with the help of a PIP degron. Knockout of Cul4, the scaffold protein of CRL4, 
results in higher levels of Cdt1 in follicle cells (Lin et al., 2009a). Geminin knockdown results not only in re-
replication but also in degradation of Cdt1 in Drosophila S2 cells (Hall et al., 2008). The authors speculated 
that both effects are connected. Increased re-replication leads to DNA damage and activation of the DNA 
damage checkpoint, which also targets Dup via the PIP degron. The PIP degron may be the main 
mechanism for Dup regulation. While overexpression of Dup alone does not show prominent effects, 
ubiquitous overexpression of a PIP degron deleted version results in embryonic death and in severe 
developmental effects in the eye, when expressed there (Lee et al., 2010). This indicates that cells are able 
to cope with an excessive amount of Dup, as long as the S-Phase degradation is still intact. 
The protein responsible for the phosphorylation dependent pathway of Dup degradation is not known yet. 
It was already shown that CycE/Cdk2 potentially targets 10 phosphorylation sites in the Dup protein, since 
mutations of all of these sites results in a Dup version with increased stability (Thomer et al., 2004). In 
analogy to higher eukaryotes, it is possible that this mechanism is proteasomal degradation after 
ubiquitination by SCFSkp2. As already mentioned, Cdt1 is a substrate of SCFSkp2 in other species and needs 
to be phosphorylated for this procedure. Furthermore, the phenotype of Dup overexpression – increased 
size of the nucleus and increased amount of apoptosis (Thomer et al., 2004) – is similar to some of the 
effects of Skp2 knockout (Ghorbani et al., 2011). Although Ghorbani et al. (2011) could not detect an 
increased amount of Dup under Skp2 knockout conditions, they exclusively concentrated on the 
endogenous protein, which is still under the control of its PIP-degron. This leaves the possibility of Skp2 
regulation open, especially if it is not the main mechanism. Another hint is that the knockdown of Skp2 in 
plasmatocytes resulted in an accumulation of the Cdt1 signal, determined by fluorescence imaging 
(Kroeger et al., 2013). However, this study is solely based on fluorescence signals and fluorescence 
microscopy. A thorough investigation of Cdt1 stability in dependency of Skp2 with different methods did 
not happen, yet.  
3.7.5. Cyclin E, an important regulator in G1- and S-Phase 
3.7.5.1. Cyclin E in humans and mammals 
The protein Cyclin E (CycE), has important regulatory function during G1- and S-Phase. Right from the start 
of its discovery, it was seen that CycE is capable of binding to Cdk1 and Cdk2 and in accordance with the 
conventional function of a cyclin is able to activate the kinase activity (Koff et al., 1991). In this publication, 
signs for high conservation of Cyclin E, at least regarding its function, were also observed. For example, 
human Cyclin E can interact with Cdc28 the S. cerevisiae homologue of Cdk1. Subsequent research 
identified Cdk2 as the main interaction partner for CycE (Koff et al., 1992). Therefore, it is an important 
regulator of S-Phase transition (see 3.2). Surprisingly, in contrast to other species, CycE/Cdk2 activity is not 
necessary for the progression of the cell cycle of continuously cycling cells (Geng et al., 2003). Indeed, 
these authors showed that mice with CycE knockout are developing largely normal and cell proliferation 
does also happen without problems. It was found however, that CycE/Cdk2 activity is necessary for 
quiescent cells to reenter the cell cycle.  
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A change in Cyclin E activity exercises dramatic effects in the control and regulation of the cell cycle. 
Overexpression of CycE results in less G1 cells, whereas S and G2 cell number is increased. The reason for 
this change in cell cycle distribution is a drastically shortened G1-Phase (Ohtsubo and Roberts, 1993). 
Overexpression of CycE also leads to changes in the number of chromosomes in rat embryo fibroblasts 
and human breast epithelial cells (Spruck et al., 1999). It seems that this increase in chromosomal 
instability is linked to the longer S-Phase, associated with CycE overexpression, since failures in the 
replication of the chromosomes occur. This links CycE to the formation and development of tumors. 
Cyclin E/Cdk2 activity targets many proteins during the cell cycle for phosphorylation (Siu et al., 2012). 
Cyclin E dependent phosphorylation is not only regulating the expression of S-Phase genes but also stability 
of different proteins in G1- and S-Phase. For example, as already mentioned, it plays a role in the 
phosphorylation and ubiquitination of the three CKIs p21, p27 and p57 (see 3.7.3.1). The human Orc1 
protein was also identified as a substrate for phosphorylation by CycE/Cdk2, though a direct consequence 
for protein stability was not found in this case (Mendez et al., 2002). The authors speculated that CycE 
marks Orc1 for recognition by Skp2, but that other F-Box proteins are also able to interact with Orc1 
regardless of its phosphorylation status. An interesting case for Cyclin E dependent regulation is Cdc6 in 
quiescent cells. Phosphorylation by CycE/Cdk2 protects Cdc6 from ubiquitination through APC/CCdh1 and 
proteasomal degradation. This allows Cdc6 to accumulate and is one factor that allows cells reentering of 
the cell cycle (Mailand and Diffley, 2005). Interestingly, it seems that besides its Cdk2 activating role, Cyclin 
E does also possess other activity, since a kinase dead mutation was still able to stimulate cell cycle 
reentering. Kinase dead CycE is able to bind to DNA, which would give a starting point to explain this 
observation (Geng et al., 2007). 
Expression of CycE is regulated by E2F1 (Ohtani et al., 1995). As already described (see 3.2), there exists a 
positive feedback loop: mitogen-signaling results in initial phosphorylation of pRB and E2F1 activity, which 
leads among other things to CycE expression. CycE activity leads to hyperphosphorylation of pRB and 
consequently to stronger E2F1 activity and CycE expression.  
Cyclin E is degraded during S-Phase by several mechanisms. It was observed that CycE/Cdk2 has auto-
phosphorylating activity, resulting in phosphorylation of CycE at threonine 380. Eventually, this leads to 
ubiquitination and proteasomal degradation in S-Phase (Won and Reed, 1996). Furthermore, it seems that 
only free, unbound Cyclin E is susceptible to ubiquitination. Binding to Cdk2 protects CycE from 
proteasomal degradation (Clurman et al., 1996). 
Later on, it was realized that a second phosphorylation site (threonine 62) is also important for 
ubiquitination and that the SCFFbxw7 complex is responsible for this ubiquitination (Koepp et al., 2001; 
Strohmaier et al., 2001). These results are confirmed by experiments regarding CycE stability in knockin 
mice that also show that both phosphorylation sites are necessary for the regulation by Fbxw7 (Minella et 
al., 2008). Fbxw7 is not the only F-Box protein that regulates CycE stability however. Experiments showed 
that Skp2 is also able to recognize and ubiquitinate Cyclin E, resulting in its proteasomal degradation. In 
accordance with the data regarding Fbxw7, Skp2 can only target free CycE. Cdk2 binding seems to protect 
CycE from degradation also in this case (Nakayama et al., 2000). 
3.7.5.2. Cyclin E function and regulation in Drosophila melanogaster 
Just like its mammalian counterpart, Drosophila CycE does also interact with and activate Cdk2. However, 
unlike CycE in higher eukaryotes, it seems to be directly responsible for entry into S-Phase in D. 
melanogaster (Knoblich et al., 1994). This makes Drosophila CycE one of the most important regulators for 
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the transition of G1 to S. Another important function of CycE in flies is the regulation of endocycles. 
Endocycling cells and tissues, for example salivary glands, depend upon the oscillation of E2F1 and CycE. 
While E2F1 is responsible for CycE expression, CycE brings cells into S-Phase where E2F1 is degraded by 
CRL4Cdt2, which resets the system for the next endocycle (Zielke et al., 2011).  
The regulation of CycE in D. melanogaster is for the most part similar to that in higher eukaryotes. 
Expression of Cyclin E is also regulated by the activity of the E2F1 fly homologue (Duronio et al., 1996). In 
case of the degradation of CycE, it was seen that the F-Box protein Archipelago (Ago), the fly version of 
Fbxw7, is also responsible for CycE ubiquitination, leading to proteasomal degradation. Loss of Ago 
increases the number of cells in S- and G2/M-Phase and stabilizes Cyclin E in fly eyes (Moberg et al., 2001). 
Stabilization of CycE after Ago knockdown is also seen in Drosophila S2 cells (Koepp et al., 2001). Evidence 
exist that the protein Minus plays a supporting role in the binding of CycE through Ago (Szuplewski et al., 
2009), something that is not known in mammals. This Ago dependent degradation links CycE regulation 
with the cell response to metabolic stress. The reduction of ATP-levels in cells leads ultimately to activation 
of p53 and expression of Ago, resulting in CycE instability and stop of the cell cycle in G1, which prevents 
cells from proliferation if growth conditions are not ideal (Mandal et al., 2010). Interestingly a study found 
hints that CycE stability is also connected to the presence of Cul4 in Drosophila (Higa et al., 2006). Since 
Cul4 is the scaffold protein of the CRL4 complex, this opens up the possibility of further, unknown 
regulation. Indeed, regarding the importance of Cyclin E in Drosophila for the beginning of S-Phase, it 
seems probable that its stability is not only regulated by SCFAgo but by a number of different mechanisms. 
One of these candidates could be Skp2. 
3.8. Aim of the thesis 
The aim of this thesis was to obtain a deeper insight into the substrates and tasks of the F-Box protein 
Skp2 in Drosophila melanogaster. Since current literature does not give a final answer to the question if 
the CKI Dacapo is a substrate of SCFSkp2 this will be the first potential substrate that is analyzed. Special 
care will be taken to concentrate specifically on the effects of Skp2 on Dap. All disturbing factors, namely 
the G1 stop that Dap exerts when overexpressed and the degradation in S-Phase by CRL4Cdt2, will be 
excluded by use of mutations that do not show these effects any longer. A thorough investigation, that 
incorporates Dap effects and alternative degradation mechanisms, has not happened in Drosophila yet 
and will hopefully help to clarify the role of Skp2 regarding Dap. 
The second potential substrate that will be investigated is Drosophila Cdt1. Just like with Dap, mutations 
will be designed and created that exclude cell cycle effects and degradation by CRL4Cdt2 in S-Phase. Again, 
the aim is to focus solely on the effects that Skp2 has on Cdt1 stability. Since Cdt1 is a crucial factor in DNA 
replication it is of interest to completely understand its regulation during the cell cycle. Experiments that 
focus specifically on Skp2 regulating Cdt1 have not happened yet and they will give further insight into the 
regulation of this important member of the origin licensing machinery.  
The last potential substrate will be CycE, where first experiments regarding its regulation by SCFSkp2 will be 
performed. In these experiments, it will be tried to minimize the dramatic effect of CycE overexpression 
on the cell cycle to exclude indirect effects on stability that these shifts might have. CycE is a decisive factor 
for the transition into S-Phase in D. melanogaster and it is important to learn about its regulation for a 
better understanding of cell cycle regulation. 
Besides these targeted approaches, an MS-analysis of Skp2 binding partners will also be performed to find 
new, unconsidered substrates for ubiquitination by the SCFSkp2 complex. 
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The first experiments however will be conducted to learn about the phenotypes of Skp2 overexpression 
and knockdown, primarily in Schneider cells. A Skp2 mutant, lacking the F-Box will also be investigated. 
The effects of these treatments on the cell cycle distribution will be important for the assessment of new 
substrates for Skp2. An experiment will also be performed to investigate if stability changes of potential 
substrates upon Skp2 overexpression or knockdown are caused directly or indirectly. 
Methodically, this thesis will focus on a new approach developed in the Sprenger group to measure relative 
protein stability in living cells during the cell cycle by flow cytometry. This method has the advantage to 
measure protein stability in a relatively uncomplicated way in a massive number of cells. Besides, changes 
of cell cycle distribution, rescue experiments, live cell imaging and co-immunoprecipitations for analysis 
of biochemical interaction will also be applied. 
Skp2 is one of the most intensive studied F-Box proteins in mammals. In comparison, the state of 
knowledge in D. melanogaster is relatively meager. Finding new targets for Skp2 in flies will give greater 
insight into the Drosophila model system regarding cell cycle and DNA replication control and may reveal 
new aspects of the F-Box protein Skp2. 
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4 Material and Methods 
4.1. Material 
4.1.1. Chemicals 
 
Table 1 Chemicals 
Chemical Distributor 
Molecular Biology 
1 kb Gene ruler DNA Ladder Mix Thermo Fischer Scientific 
Ampicillin  Carl Roth GmbH + Co. KG 
ATP (100 mM)  New England Biolabs 
Bacto Agar BD Bioscience 
Bacto Trypton BD Bioscience 
Bacto Yeast Extract BD Bioscience 
CTP (100 mM)  New England Biolabs 
dNTP mix (dATP, dCTP, dGTP, dTTP)  New England Biolabs 
DTT (1,4‐dithiothreitol)  AppliChem GmbH 
EDTA (ethylenediaminetetraacetic acid)  Fluka 
Ethanol  Carl Roth GmbH + Co. KG 
Ethidium bromide  SERVA Electrophoresis 
Glycerol  Carl Roth GmbH + Co. KG 
GTP (100 mM)  New England Biolabs 
Hydrochlorid acid Merck KGaA 
Isopropanol Merck KGaA 
Kanamycin  AppliChem GmbH 
Potassium Acetat Merck KGaA 
Purple Loading Dye (6x) New England Biolabs 
Restriction buffers 10x New England Biolabs 
Sodium chloride Carl Roth GmbH + Co. KG 
Sodium dihydrogen phosphate Fluka 
Sodium hydrogen phosphate Fluka 
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Sodium hydroxide Gerbu Trading GmbH 
Spermidine Sigma‐Aldrich Chemie GmbH 
T4 ligase buffer 10x New England Biolabs 
Tris (tris(hydroxymethyl)aminomethane)  Carl Roth GmbH + Co. KG 
Ultrapure Agarose  Invitrogen GmbH 
UTP (100 mM)  New England Biolabs 
Cell Culture 
CuSO4 AppliChem GmbH 
FBS PAN Biotech 
FuGENE HD  Promega Corporation 
Penicillin 100X  Invitrogen GmbH 
Schneider`s Drosophila medium  Invitrogen, PAN Biotech 
Sodium chloride Carl Roth GmbH + Co. KG 
Sodium dihydrogen phosphate Fluka 
Sodium hydrogen phosphate Fluka 
Streptomycin 100X  Invitrogen GmbH 
Trypan Blue  Sigma‐Aldrich Chemie GmbH 
Trypsin/EDTA (ethylenediaminetetraacetic acid)  PAN Biotech 
FACS 
EDTA  Fluka 
Hoechst 33342  Sigma‐Aldrich Chemie GmbH 
Sodium azide Sigma‐Aldrich Chemie GmbH 
Sodium chloride Carl Roth GmbH + Co. KG 
Sodium dihydrogen phosphate Fluka 
Sodium hydrogen phosphate Fluka 
Trypsin SERVA Electrophoresis GmbH 
Tween20  Carl Roth GmbH + Co. KG 
Co-IP/SDS-PAGE/Western Blot 
Acetic acid Merck KGaA 
Acrylamide 30%/bisacrylamide  Carl Roth GmbH + Co. KG 
APS (ammonium persulfate)  Merck KGaA 
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beta‐Mercaptoethanol  Fluka 
Bromphenol blue  SERVA Electrophoresis GmbH 
Coomassie Brilliant Blue Sigma‐Aldrich Chemie GmbH 
EDTA  Fluka 
EGTA (ethylene glycol tetraacetic acid)  Sigma‐Aldrich Chemie GmbH 
Gloria skimmed milk powder Nestle 
Glycerol Carl Roth GmbH + Co. KG 
Glycine  AppliChem GmbH 
HEPES (2‐[4‐(2‐hydroxyethyl)piperazin‐1‐
yl]ethanesulfonic acid)  
AppliChem GmbH 
Methanol  Carl Roth GmbH + Co. KG 
Precision Plus Protein All Blue Prestained Protein 
Standard  
Bio-Rad Laboratories, Inc. 
Protease inhibitor cocktail Bimake.com 
SDS (Sodium dodecyl sulfate) Carl Roth GmbH + Co. KG 
Sodium acetate Merck KGaA 
Sodium chloride Carl Roth GmbH + Co. KG 
Sodium dihydrogen phosphate Fluka 
Sodium fluoride  Fluka 
Sodium hydrogen phosphate Fluka 
TEMED (tetramethylethylenediamine)  Fluka 
Tris (tris(hydroxymethyl)aminomethane)  Carl Roth GmbH + Co. KG 
Triton X‐100  Fluka 
Mass spectrometric analysis 
Acetonitrile Sigma-Aldrich Chemie GmbH 
Ammonium bicarbonate (NH4HCO3) Fluka 
Liquid nitrogen  AG Schneuwly (University of Regensburg) 
Trypsin Gold, Mass Spectrometry Grade Promega Corporation 
Fly Experiments 
Dpx Sigma-Aldrich Chemie GmbH  
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4.1.2. Kits 
 
Table 2 Kits 
Kit Distributor Purpose 
FLAG Immunoprecipitation Kit Sigma‐Aldrich Chemie GmbH Co-IP for Mass Spec 
Invisorb Spin DNA Extraction Kit Stratec Biomedical AG Clean Up PCRs 
MSB Spin PCRapace Stratec Biomedical AG Clean Up Gel Fragments 
PureYield Plasmid Midiprep system Promega Corporation Midi Preparations 
 
4.1.3. Solutions and buffers 
 
Table 3 Solutions and buffers 
Solution/Buffer Components Concentration 
Ampicillin stock solution Ampicillin 
 
in 50 % ethanol 
50 mg/ml 
APS solution 10 % APS 
 
in H2O 
10 % (w/v) 
Coomassie staining solution Coomassie Brilliant Blue G250 
Methanol 
Glacial acetic acid 
 
in H2O 
0.01% 
50% 
10% 
dNTP mix (2mM each) dNTP mix 
 
in H2O 
2 mM 
Easy Prep buffer Tris, pH 8.0 
EDTA, pH 8.0 
Sucrose 
Lysozyme 
RNase A 
10 mM 
1 mM 
150 mg/ml 
2 mg/ml 
0.2 mg/ml 
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BSA 
 
in H2O 
0.1 mg/ml 
IP Lysis buffer HEPES, pH 7.5 
NaCl 
EGTA 
NaF 
Triton X‐100 
Glycerol 
 
in H2O  
 
For use, Protease inhibitor mix is freshly added. 
50 mM 
150 mM 
1 mM 
10 mM 
1 % (v/v) 
10 % (v/v) 
IP Washing buffer HEPES, pH 7.5 
NaCl 
Triton X‐100 
Glycerol 
 
in H2O 
50 mM 
150 mM 
1 % (v/v) 
10 % (v/v) 
Kanamycin stock solution Kanamycin 
 
in H2O 
50 mg/ml 
Laemmli running buffer 10X Tris 
Glycin 
SDS 
 
in H2O 
250 mM 
9.46 M 
10 g/l 
LSB 2X Tris, pH 6.8 
SDS 
Glycerol 
Bromophenol blue 
beta‐Mercaptoethanol 
 
in H2O 
120 mM 
4 % (w/v) 
20 % (v/v) 
0.04 % (w/v) 
10 % (v/v) 
LSB 2X, non‐reducing Tris, pH 6.8 120 mM 
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SDS 
Glycerol 
Bromophenol blue 
 
in H2O 
4 % (w/v) 
20 % (v/v) 
0.04 % (w/v) 
Milk powder solution Skim milk powder 
Sodium azide 
 
in PBS 
5 % (m/v) 
0.01 % (m/v) 
MS Trypsin Solution Trypsin Gold, Mass Spectrometry Grade 
 
in 50 mM NH4HCO3 
30 % (v/v) 
MS Washing Solution I AcN 
 
in 50 mM NH4HCO3 
25 % (v/v) 
MS Washing Solution II AcN 
 
in 50 mM NH4HCO3 
50 % (v/v) 
MS ioadacetamide solution Iodacetamide 
 
in 50 mM NH4HCO3 
5 mg/ml 
 
MS DTT DTT for MS 
 
in 50 mM NH4HCO3 
1 mg/ml 
 
NTP mix (25 mM each) NTP mix 
 
in H2O 
25 mM 
PBS NaCl 
Na2HPO4 
NaH2PO4 
pH 
 
in H2O 
130 mM 
7 mM 
3 mM 
7.2 
PBT Tween 20 
 
0.1 % (v/v) 
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in PBS 
Phusion HF Buffer not specified 
 
 
 
5x 
Resolving gel (SDS PAGE) For 10 ml resolving gel: 
 
Gel H2O (ml) Acrylamide 30%/ 
Bisacrylamide 
(μl) 
1.5 M 
Tris/HCl 
pH 8.8 
(μl) 
10 % 
SDS 
(μl) 
10 % 
APS 
(μl) 
TEMED 
(μl) 
8 % 4.7 2.7 2.5 0.1 100 10 
12% 3.4 4.0 2.5 0.1 100 10 
15% 2.4 5.0 2.5 0.1 100 10 
 
 
SDS solution 10 % SDS 
 
in H2O 
10 % (w/v) 
Stacking gel (SDS PAGE) For 10 ml stacking gel: 
 
Gel H2O (ml) Acrylamide 30%/ 
Bisacrylamide 
(μl) 
1.5 M 
Tris/HCl 
pH 6.8 
(μl) 
10 % 
SDS 
(μl) 
10 % 
APS 
(μl) 
TEMED 
(μl) 
4% 6.1 1.3 2.5 0.1 100 10 
 
Stacking gel was stored as 50 ml stock solution without APS and TEMED. 
 
TAE buffer Tris, pH 8.0 
EDTA 
 
in H2O 
40 mM 
10 mM 
Transcription buffer 5X (T7) HEPES, pH 7.5 
Spermidine 
80 mM 
2 mM 
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DTT 
NTPs (ATP, CTP, GTP, UTP) 
MgCl2 
 
in H2O 
10 mM 
3 mM 
12 mM 
 
Transfer buffer 3 (Western 
blot) 
Methanol 
Tris, pH 7.5 
EDTA, pH 8.0 
Sodium acetate 
SDS 
 
in H2O 
20 % (v/v) 
40 mM 
2 mM 
20 mM 
0.05 % (v/v) 
Trypsin/EDTA in PBS Trypsin 
EDTA 
 
in PBS 
0.05% 
0.02% 
 
0.1 M 
 
All solutions and buffers in kits were used as described in the respective manuals. 
4.1.4. Proteins and Enzymes 
 
Table 4 Proteins and enzymes 
Proteins Distributor Purpose 
Phusion DNA polymerase AG Thomm (homemade) PCR 
Restriction endonucleases New England Biolabs Restriction (cloning) 
RNase A AppliChem GmbH EasyPrep buffer 
RNase Inhibitor  AG Medenbach (homemade) In vitro transcription 
Shrimp Alkaline Phosphatase 
(rSAP)  
New England Biolabs Dephosphorylation (cloning) 
T4 DNA Ligase  New England Biolabs Ligation 
T7 RNA polymerase Thermo Scientific In vitro transcription 
 
39 
 
4.1.5. Media and agar plates 
 
Table 5 Media and agar plates 
Medium/Agar Plate Components Concentration 
LB agar plate Bacto Agar 
 
In LB medium (autoclaved) 
 
Solution is boiled for casting 
plates. Before adding any 
antibiotic, the solution is first 
cooled down to 50°C. 
1.7 % (w/v) 
LB medium (autoclaved) BactoTrypton 
Bacto Yeast Extract 
NaCl 
pH 
 
in H2O 
10 g/l 
5 g/l 
10 g/l 
7.2 
Schneider’s Drosophila complete 
medium 
GIBCO FBS 
Penicillin/Streptomycin 
 
in Schneider’s Drosophila 
Medium 
10 % (v/v) 
1% (v/v) 
 
Ampicillin was used as 100 µg/ml; Kanamycin was used as 50 µg/ml. 
 
 
 
40 
 
4.1.6. Antibodies 
 
Table 6 Primary antibodies for Co-IP and Western Blot analysis 
Antigen Number Source Western Blot Co-IP Distributor Purpose 
FLAG 374 Mouse 1:5000 1:300 Sigma Precipitation, 
analysis 
HA 373 Mouse 1:2000 1:300 Covance Precipitation, 
analysis 
 
Table 7 Secondary antibodies for Co-IP and Western Blot analysis 
Antigen Number Source Fluorochrome Dilution Distributor Purpose 
Mouse 367 Goat IRDye 800 1:5000 Li-Cor, Inc. analysis 
 
4.1.7. Oligonucleotides 
Oligonucleotides used for cloning and sequencing are not listed but can be found in the database of the 
Sprenger Group. Amplification of DNA for dsRNA production was performed with SPO_288 (Sequence: 
5’TAGGCCTTAATACGACTCACTATAGGG3’). 
4.1.8. Plasmids 
 
Table 8 Plasmids 
Plasmid Name Promotor Nickname Purpose 
pFSR-0092 pBSII Bluescript KS+ - 
 
Bluescript 3 
pFSR-0400 MtPro-HA-NLS-GFP(G) MtPro HA-NLS-GFP(G) 9 
pFSR-0419 MtPro-HA-CycE MtPro HA-CycE 1 
pFSR-0804 T7-Skp2-T7 - - 2 
pFSR-0814 MtPro-4XFLAG-DmSkp2 MtPro 4XFLAG-Skp2 9 
pFSR-0845 T7-hygromycin-T7 - - 2 
pFSR-0859 T7-Amp-T7 - - 2 
pFSR-0864 MtPro-HA-NLS-Cdt1_Del-102-
609-3XCHE 
MtPro Cdt1-1-101_3XCHE 9 
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pFSR-0871 MtPro-GFP(G)-Skp2 MtPro GFP(G)-Skp2 9 
pFSR-0951 MtPro-3xHA-Cks85A-SV40UTR MtPro 3xHA-Cks85A 1 
pFSR-0952 PubPro-4xFLAG-Skp2-ryUTR PubPro 4xFLAG-Skp2 1, 5, 6, 7 
pFSR-0967 ActPro-GFP(G)-Dap-GloACUTR actPro(S) GFP-Dap 1 
pFSR-1004 pUbPro-HA-Dap-ryUTR PubPro HA-DAP 1, 5 
pFSR-1023 PubPro-Cks85A-ryUTR PubPro - 1 
pFSR-1069 PubPro-Skp2 4xFLAG ryUTR PubPro - 1 
pFSR-1071 actPro 3xChe MtPro-GFP-CycE 
SV40 UTR 
actPro -  7 
pFSR-1072 actPro(L)-mChe-dT2A-HA-NLS-
GFP(G)-GloACUTR 
actPro(L) CHE-T2A-HA-NLS-
GFP 
1 
pFSR-1077 PubPro-4xFLAG-Skp2_Del-
175-223-ryUTR 
PubPro  1 
pFSR-1150 actPro(L)-mChe-dT2A-HA-NLS-
GFP(G)-Cdt1_Del-601-743-
GloACUTR 
actPro(L) CHE-T2A-GFP-Cdt1 
15-600 
1 
pFSR-1179 actPro(L)-HA-NLS-BamHI-XbaI-
CHE-ddT2A-HA-NLS-GFP 
actPro(L) BX-CHE-ddT2A-GFP 1 
pFSR-1180 actPro(L)-HA-NLS-CHE-BamHI-
XbaI-ddT2A-HA-NLS-GFP 
actPro(L) - 1 
pFSR-1185 actPro-CHE-CycE-T2A-HA-NLS-
GFP 
actPro(L) - 1 
pFSR-1194 PubPro-Skp2-1-500-hairpin PubPro Skp2 Hairpin 1 
pFSR-1204 actPro(L)-HA-NLS -GFP-ddT2A-
HA-NLS-CHE-BamHI-XbaI 
actPro(L) GFP-ddT2A-CHE-BX 1 
pFSR-1214 actPro(L)-HA-NLS -GFP-ddT2A-
HA-NLS-BamHI-XbaI-CHE 
actPro(L) GFP-ddT2A-BX-CHE 1 
pFSR-1222 pUbPro-HA-Cdt1-1-600-ryUTR PubPro - 6 
pFSR-1238 actPro(L)-HA-NLS-GFP-ddT2A-
HA-NLS- CHE-Dap-dCDI 
actPro(L) GFP-ddT2A-CHE-
Dap-dCDI 
1 
pFSR-1247 actPro(L)-HA-NLS-Che-
Cdt1_Del-1-15-Del-301-743-
actPro(L) Che Cdt1 15-300 1 
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T2A-HA-NLS-GFP(G)-
GloACUTR 
pFSR-1248 MtPro-Hygro-Hairpin MtPro Hygro Hairpin 1 
pFSR-1270 actPro(L)-HA-NLS-CHE-CycE-
ddT2A-HA-NLS-GFP 
actPro(L) CHE-CycE-ddT2A-
GFP 
1 
pFSR-1275 pUbPro-HA-Slmb-vhh-GFP-
ryUTR 
PubPro  1 
pFSR-1281 T7 Cdt1 nt1406-nt1800-T7 - Cdt1 dsRNA 2 
pFSR-1282 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del601-742-
ddT2A-HA-NLS-GFP 
actPro(L) Che Cdt1 15-600 1 
pFSR-1283 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del_226-743-
ddT2A-HA-NLS-GFP 
actPro(L) Che Cdt1 15-225 1 
pFSR-1284 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del264-743-
ddT2A-HA-NLS-GFP 
actPro(L) Che Cdt1 15-263 1 
pFSR-1285 actPro(L)-HA-NLS-CHE- 
Cdt1_Del1-169_Del301-743-
ddT2A-HA-NLS-GFP 
actPro(L) Che Cdt1 170-300 1 
pFSR-1288 actPro(L)-HA-NLS-GFP-ddT2A-
HA-NLS-CHE-Dap 
actPro(L) - 1 
pFSR-1300 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del264-
743_S111A-ddT2A-HA-NLS-
GFP 
actPro(L) Che Cdt1 15-263 
S111A 
1 
pFSR-1301 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del264-
743_T158A-ddT2A-HA-NLS-
GFP 
actPro(L) Che Cdt1 15-263 
T158A 
1 
pFSR-1302 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del264-
actPro(L) Che Cdt1 15-263 
S168A 
1 
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743_S168A-ddT2A-HA-NLS-
GFP 
pFSR-1303 actPro(L)-HA-NLS-CHE-
Cdt1_Del1-15_Del264-
743_S226A-ddT2A-HA-NLS-
GFP 
actPro(L) Che Cdt1 15-263 
S226A 
1 
pFSR-1310 actPro(L)-Cdt1-mCHE-dT2A-
Deopt-HA-NLS-GFP 
actPro(L) - 1 
pFSR-1319 actPro(L)-Cdt1-15-763-mCHE-
dT2A-Deopt-HA-NLS-GFP 
actPro(L) - 1 
pFSR-1363 actPro(L)-HA-NLS-GFP-ddT2A-
HA-NLS-Che-Dap_Del-38-44-
RAR-_Del-103-150-G_Del-184-
188-SV40UTR 
actPro(L) - 1 
pHT-013 HA-SkpA in RmHARW2 MtPro HA SkpA 5,6,7 
pOT-233 pUC-19 - - 8 
 
1) FACS cell cycle and stability analysis 
2) in vitro transcription of dsRNA 
3) empty DNA for transfection 
4) Mass spectrometric analysis of Skp2 binding partners 
5) Co-IP between Skp2 and Dap 
6) Co-IP between Skp2 and Cdt1 fragments 
7) Co-IP between Skp2 and CycE 
8) Intermediate cloning 
9) Live cell imaging  
4.1.9. Bacterial strains 
 
Table 9 Bacterial strains 
Strain Genotype 
DH5 α F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 
φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK–mK+), λ– 
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4.1.10. Eukaryotic cell lines 
Drosophila Schneider cells (S2R+) were used for cell cycle analysis, flow cytometric stability analysis, co-
immunoprecipitations and MS-analysis.  
4.1.11. Fly Strains 
 
Table 10 Fly Strains 
Strain Information 
UAS-HA-Skp2 Skp2 overexpression 
en::gal4 engrailed driver line 
attp-86F Control cross 
 
4.1.12. Equipment 
 
Table 11 Equipment 
Equipment Distributor 
µ-Slide 8 Well ibidi GmBH 
Acrylamide gel apparatus Bio-Rad Laboratories, Inc. 
Agarose gel electrophoresis apparatus HE33 Hoefer, Inc. 
Anti-FLAG Affinity Gel bimake.com 
Axio Observer.Z1 (inverted)  Zeiss 
AxioCam MRm Rev3  Zeiss 
Axygen 200 µl Maxymum Recovery pipette tips Corning Inc. 
Axygen MCT-060-L-C Microcentrifuge Tube 0.6 ml Corning Inc. 
Caps with holes for 0.5 ml Axygen Cups selfmade 
Caps with holes for 1.5 ml Cups selfmade 
CaptiveSpray nanoflow electrospray source Bruker Daltonics 
Cell culture incubator  Hereaus 
Cell culture roller TC‐7  New Brunswick Scientific 
Centrifuge 5418 (on the bench) Eppendorf 
Centrifuge 5402 (for Co-IPs) Eppendorf 
Centrifuge Heraeus Multifuge 1S (for midi preps) Thermo Scientific 
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Centrifuge RotoFix 32A (for cell culture) Hettich 
Clean bench  Ceag Schirp Reinraumtechnik 
Clean bench Mars Safety Class 2  SCANLAF 
Electrophoresis power supply EPS 200 Pharmacia Biotech 
Electrophoresis power supply EPS 300 Pharmacia Biotech 
Electroporation apparatus Easyject Prima  Equibio 
FastPette V2 Pipette Controller Labnet 
Flow cytometer CyFlow space  Partec 
Freezer C760  New Brunswick Scientific 
Fuchs‐Rosenthal Counting chamber (16 mm², 0.2 
mm cell depth)  
Hausser Scientific 
Halogen lamp 100 W   
Heating block (Digital Dry Bath, dual position)  Benchmark Scientific 
Heating System ibidi GmBH 
HT 200 ibidi GmBH 
I-3020 Applied Scientific Instrumentation 
Incubator Heraeus B 5050 E  Heraeus 
Incubator Sanyo MIR‐153  Sanyo 
Inverted microscope CKX41 (equipped with 
Reflected Fluorescence System with Light Source X‐
Cite 120Q) 
Olympus 
MaXis plus UHR‐QTOF System  Bruker Daltonics 
MF-Millipore Membrane Merck KGaA 
NuPAGE 4-12% Bis-Tris Protein Gels Thermo Fischer Scientific 
Odyssey Infrared Imaging system  LI‐COR 
PerfectBlue Semi‐Dry Electro Blotter  Peqlab 
Plan-APOCHROMAT 20X  Zeiss 
Protein G Plus-Agarose Beads Santa Cruz 
Sieve (2 cm² diameter)  Own production 
SimplyBlue SafeStain Thermo Fischer Scientific 
Spectrophotometer / Fluorometer DS‐11 FX+  DeNovix 
Spinning disk unit (CSU-X1)  Yokogawa  
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Thermocycler GTC96S Cleaver  Scientific Ltd 
ThermoMixer F1.5  Eppendorf 
Tube 3.5 ml, 55 x 12 mm, PS 
(FACS sample tube) 
Sarstedt AG & Co. KG 
UV Crosslinker  Stratalinker 
UVP GelStudio PLUS Analytik Jena AG 
Water purification system ELGA 
 
All other used equipment and consumables (e.g. beakers, reaction tubes, freezers, …) were considered 
non-critical and are not mentioned.  
4.1.13. Lasers and Light Sources 
 
Table 12 Lasers and Light Sources 
Name Wavelength [nm] Power Fluorescent dyes 
Flow Cytometer  
UV-LED 365 - Hoechst 
Sapphire 488-20 Laser 488 20 mW GFP 
Sapphire 561-100-CW Laser 561 100 mW Cherry 
Spinning Disk Microscope  
OPSL Laser  488 100 mW GFP 
Diode Laser 561 40 mW Cherry 
4.1.14. Filters 
 
Table 13 Filters 
Filters Fluorescence Equipment 
Bandpass-Filter BP527/30 GFP flow cytometer 
Bandpass-Filter BP455/50 Hoechst 33342 flow cytometer 
Bandpass-Filter BP488 FSC/SSC flow cytometer 
Longpass-Filter LP590 mChe flow cytometer 
ET Bandpass 605/70  mChe Spinning disk microscope 
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4.1.15. Software 
 
Table 14 Software 
Software Developer Source Application 
Canvas Version 11 ACD Systems of 
America, Inc 
n.a. Figures 
ContigExpress Invitrogen n.a. Sequencing analysis 
dsCheck n.a. Naito et al., 2005 Check for off targets of 
dsRNA 
Endnote X7.5 Thomson Reuters n.a. Citation 
FCS Express 4.07 De Novo Software n.a. FACS data analysis 
FileMaker Pro 15 FileMaker, Inc. n.a. Data base management 
ImageJ n.a. Schneider et al., 2012 Image analysis 
Origin 2017 (64-bit) Origin Lab Corporation n.a. Figures, statistics 
PAST n.a. Hammer et al., 2001 statistics 
Vector NTI Advance 11.5.4 Invitrogen n.a. Plasmid design 
 
4.2. Methods 
4.2.1. Cloning Methods 
4.2.1.1. PCR 
PCR was used for DNA amplification. Table 15 shows the used PCR reaction mix.  
Table 15 PCR Reaction Mix 
Component Volume/Amount 
DNA 100 ng 
Forward Primer (100 pmol/l) 1 µl 
Reverse Primer (100 pmol/l) 1 µl 
5xHF Phusion Buffer 10 µl 
dNTPs (2mM) 5 µl 
Phusion Polymerase (2U/µl) 0.5 µl 
H2O -> add 50 µl 
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Table 16 shows the PCR program. 
Table 16 PCR program 
Step Temperature Time Cycles 
Initial Denaturation 96°C 30 sec  
Denaturation 96°C 10 sec 
25 Annealing Variable 20 sec 
Extension 72°C Variable 
Final extension 72°C 5 min  
Storage 4°C ∞  
 
Annealing Temperature was chosen according to the primer base composition and calculated with the 
online tool “Tm calculator” from ThermoFischer Scientific 
(https://www.thermofisher.com/de/de/home/brands/thermo-scientific/molecular-biology/molecular-
biology-learning-center/molecular-biology-resource-library/thermo-scientific-web-tools/tm-
calculator.html, retrieving date: 24.05.2018). 
Extension time was chosen in dependency of the length of the PCR product according to the speed of 
Phusion-Polymerase, which was estimated as 40 seconds per kilobase. 
4.2.1.2. DNA Clean Up 
DNA Clean Up was used for purification of PCRs or for enrichment of low concentrated plasmids. The MSB 
Spin PCRapace was used. 
50 µl DNA (for example the PCR reaction mix) was mixed well with 250 µl binding buffer. The sample was 
transferred to a Spin Filter and centrifuged 2 min at 11000 g. The filtrate was removed and the sample was 
centrifuged again for 3 minutes to remove excess buffer. The Spin Filter was placed in a new tube and the 
desired volume of H2O (e.g. 30 µl for PCR clean ups) was added directly to the filter. After 1 minute of 
incubation at room temperature, the DNA was eluted by centrifugation for 1 min at 11000 g. 
4.2.1.3. Restriction for cloning 
DNA vectors and inserts were restricted with enzymes overnight at 37°C. Up to 5000 ng of vector and 
insert DNA was used for restriction. 1 µl of each restriction enzyme and 3 µl of the correct buffer was 
added to the DNA. The reaction was filled-up with H2O to 30 µl. 
If the insert was a PCR product, it was purified (see 4.2.1.2) and afterwards the whole 30 µl were used for 
restriction. The complete restriction setup had a volume of 35 µl in this case. 
4.2.1.4. Dephosphorylation 
To minimize the number of religated vectors during cloning, dephosphorylation was used after restriction 
in some cases. 
1.5 µl of shrimp alkaline phosphatase (rSAP) was added to the digest after restriction was finished. The 
reaction was incubated at 37°C for 30 min and then heat inactivated at 65°C for 5 min. 
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4.2.1.5. Agarose gel electrophoresis 
Agarose gel electrophoresis was used for separation of DNA bands, which was necessary for gel fragment 
isolation (see 4.2.1.6), screening of Kochlysates (see 4.2.1.11) and quantification of DNA bands (see 4.2.1.7 
and 4.2.1.13). 
Gels were casted by heating up 40 ml of TAE buffer together with 0.4 g of agarose in a microwave. 40 µl 
of ethidium bromide (EtBr, concentration 10 mg/ml) was added and gels were cast in the gel sleds. Samples 
were mixed with 6x Loading Dye and pipetted in the gel pockets. 5 µl of 1 kb Gene ruler Mix was also 
loaded on one gel lane. The gel run was performed for 45 min at 90 V. If necessary, documentation was 
performed at UVP GelStudio PLUS. Images were saved digitally for later analysis (e.g. quantification). 
4.2.1.6. DNA Gel extraction 
For isolation of digested DNA fragments, the restricted DNA was separated by agarose gel electrophoresis 
(see 4.2.1.5). The desired band was cut out with a scalpel, transferred in a reaction tube and weighed. 
DNA Gel extraction was performed with the Invisorb Spin DNA Extraction Kit. 500 µl Gel solubilizer was 
added to the agarose fragment (in case the weight of the fragment exceeded 150 mg, 1000 µl were added 
instead). The tube was heated at 50°C until the gel was completely solubilized. 250 µl (or respectively 500 
µl) of Binding Enhancer were added to the reaction. The whole sample was loaded onto a Spin Filter and 
centrifuged for 2 min at 11000 g. The filtrate was discarded and 500 µl Wash Buffer were pipetted on the 
filter. After another centrifugation (1 min at 11000 g) the filtrate was discarded. This washing step was 
repeated once. For removal of last traces of Wash Buffer, centrifugation was performed for 4 min at full 
speed. Afterwards the Spin Filter was put into a Receiver Tube, 30 µl of water was put on the center of the 
filter and incubated for 5 min at room temperature. For eluting the DNA, the Spin Filter was centrifuged 
for 1 min at 11000 g. 
4.2.1.7. Quantification of vector and insert  
Concentration of vector and insert DNA was determined by agarose gel quantification. One tenth of the 
eluted DNA was mixed with loading dye and loaded onto a gel. After the gel run and documentation (see 
4.2.1.5) the digital images were analyzed with ImageJ. The intensities of the vector and insert DNA bands 
were quantified with the help of the intensity of the DNA ladder bands as a reference. 
4.2.1.8. Ligation 
A typical ligation setup consisted of 2 µl of Ligation buffer, 1 µl of T4 DNA Ligase and vector and insert 
DNA. A molar ratio of vector to insert of 1:3 was used. Up to 100 ng of vector DNA and the equivalent 
amount of insert DNA was inserted into the ligation. If necessary, water was added to a volume of 20 µl. 
To estimate the number of self-ligating vector later, a control ligation was also set up, with no insert DNA 
in it. This was necessary for the estimation of the number of colonies to be screened. 
Incubation was performed at room temperature for at least 2.5 hours. If incubation was performed over 
night or over the weekend, the ligations were put on 18°C. Afterwards, transformation was conducted (see 
4.2.1.10). 
4.2.1.9. Site directed mutagenesis 
Site directed mutagenesis (Weiner et al., 1994) was used for introducing point mutations in proteins. A 
PCR was performed as described in 4.2.1.1 with a mutagenesis primer. These primers contained the 
desired mutation.  
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After PCR, a DpnI restriction was performed. DpnI is a four cutter and exclusively cuts methylated DNA. 
Therefore, most of the un-mutated PCR template was removed. 1 µl of DpnI was added to the PCR and 
the sample was incubated at 37°C for one hour. 
To remove the high amount of salt that would disturb the following transformation (see 4.2.1.10), dialysis 
against water was conducted. The sample was pipetted onto a dialysis membrane in a petri dish filled with 
de-ionized water. After one hour, the sample was removed and transformation was conducted. 
4.2.1.10. Transformation 
Electroporation was used for transforming Escherichia coli with cloned plasmids. The E. coli strain DH5α 
was used for transformation, aliquots (100 µl each) of which were stored at -80°C. The bacteria were slowly 
thawed on ice and diluted with 100 µl of H2O. 100 µl of the bacterial suspension was mixed with 1 µl of 
the ligation mix and transferred in an electroporation cuvette. All steps were performed on ice. Before 
putting the cuvette in the electroporator, it was dried. Electroporation took place with 2500 V. Directly 
afterwards 1 ml of LB0 was applied to the transformed bacteria.  
If the plasmid contained Ampicillin resistance, cells were directly platted on LBAmp plates. If the resistance 
was Kanamycin, cells were put at 37°C for one hour, since in this case it was necessary that the resistance 
is developed before platting. 
In either case, 100 µl were platted on LB plates. Incubation was performed overnight at 37°C. 
4.2.1.11. Screening of colonies with Kochlysates 
Colonies were screened for successful cloning with the Kochlysate method (Berghammer and Auer, 1993). 
Colonies were picked from the plate and transferred to 2 ml of LBAmp- or LBKan-Medium. These Kochlysate 
cultures were incubated at 37°C over night. 
On the next day, 1.5 ml of the bacterial culture was transferred in a reaction tube and centrifuged with full 
speed for 4 min. The supernatant was discarded and the cell pellet was resuspended with 50 µl of Easy 
Prep Buffer. Afterwards, lysis was performed by putting the reaction tubes for 1 min at 100°C. After that, 
samples were immediately cooled down by putting them on ice for 1 min. In a final step, centrifugation 
took place for 15 min at full speed. Plasmid DNA was now in the supernatant. 
A test digest with fitting restriction enzymes revealed if the colony was positive or negative. 5 µl of the 
plasmid DNA was mixed with 1 µl buffer, 0.5 µl of each restriction enzyme and 3 µl H2O. Incubation took 
place for 1 hour at 37°C. The digest was analyzed by gel electrophoresis (see 4.2.1.5).  
4.2.1.12. Midi Preps 
Midi preps were performed for receiving highly concentrated, clean DNA. The PureYield Plasmid Midiprep 
system from Promega was used. Midi cultures, at least 50 ml of LB with fitting antibiotics, were inoculated 
with 100 µl of the positive Kochlysate culture. If Ampicillin was the antibiotic, it was necessary to wash the 
Kochlysate culture with LBAmp before inoculation. Otherwise, traces of β-Lactamase originating from 
transformed E. coli and responsible for the resistance of the bacteria against Ampicillin, would end up in 
the Midi culture, which would lower the selection pressure and significantly reduce the DNA yield. 
Therefore, cells were centrifuged at 4000 rpm for 4 min, the supernatant was discarded and 1 ml of LBAmp 
was applied to the cell pellet. Centrifugation was repeated, the supernatant again discarded and the pellet 
resolved in 100 µl of LBAmp, which was used for inoculation. Since Kanamycin worked in a different fashion, 
this procedure was not necessary and inoculation happened right away. In either case, incubation took 
place at 37°C overnight. 
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On the next morning, the Midi culture was transferred to a 50 ml reaction tube and spun down at 4500 rpm 
for 10 min. The supernatant was discarded and the pellet was resuspended in 3 ml of Cell Resuspension 
Solution. For cell lysis, 3 ml of Cell Lysis Solution was applied, the sample was inverted 5 times and 
incubated for 3 min. Directly afterwards, 5 ml of Neutralization Solution was pippeted into the reaction 
tube and mixed by inverting 5 times. The mix was centrifuged at 4500 rpm for 25 min for precipitation, the 
plasmid DNA was in the supernatant afterwards.  
The supernatant was filtered through a sieve to get rid of cell debris. Thereafter, the sample was loaded 
onto a binding column which was attached to a vacuum pump. Vacuum was applied, the sample was 
sucked through the column, whereby the DNA stuck to the binding membrane. The DNA was washed by 
applying 20 ml of Wash Buffer. The vacuum was again applied until the column was completely dry. To 
ascertain that the ethanol completely vanished, the column was transferred in a fresh 50 ml reaction tube 
and centrifuged for 1500 g for 1 min. 
To elute the DNA, the column was again transferred in a new 50 ml reaction tube. 600 µl of sterile water 
was applied to the volume. Elution took place by centrifugation at 1500 g for 2 min. The DNA was now 
ready for quantification. In the end, samples were stored at -20°C upon usage. 
4.2.1.13. Quantification of Plasmid DNA 
Two methods were used for DNA quantification: a photometric quantification with the 
Spectrophotometer/Fluorometer DS‐11 FX+ and gel quantification. 
For the photometric quantification, 1 µl of DNA was used. The photometer analyzed the quality of the DNA 
(the 260 to 280 ratio) and the concentration. 
If a plasmid was only used for further cloning, only the photometric concentration was used. If, however, 
the plasmid was to be used in transfection, the more thorough quantification method by an agarose gel 
was applied. Since it is only possible to quantify DNA fragments precisely, the first step was to digest the 
new plasmid. If possible, restriction enzymes were chosen, which produce an 1100 bp band that was used 
for quantification. Around 50 – 100 ng of plasmid DNA (according to the photometric quantification) was 
used for digestions together with 1 µl buffer and 1 µl of each enzyme. H2O was used to fill up the volume 
to 10 µl. Restriction took place at 37°C for at least 1 hour. After gel electrophoresis (see 4.2.1.5) the digital 
gel image was analyzed with ImageJ. 
The principal quantification was done with the intensity of the DNA ladder as reference (as in 4.2.1.7.) 
However, since the plasmid was bigger than the quantified DNA band alone, a correction factor had to be 
implemented. The size of the whole plasmid in basepairs was divided by the size of the quantified 
fragment. This ratio was multiplied with the quantified concentration of the fragment. The result was the 
concentration of the whole plasmid that was later used for transfection (see 4.2.3.5). 
4.2.1.14. Blunt end cloning  
In certain cases, direct cloning did not work for unspecified reasons. In these cases, an intermediate cloning 
step was performed. As a result, the insert was present in an intermediate plasmid in high purity and 
concentration. Subsequent cloning with this intermediate plasmid was generally successful. 
After PCR for amplification of the insert (see 4.2.1.1), a DpnI digest was performed (as described in 4.2.1.9). 
The restriction was purified by the DNA Clean Up procedure (see 4.2.1.2); elution took place in 25 µl H2O. 
For the actual blunt end cloning reaction, 3 µl of the DpnI digested, purified PCR insert was mixed with 2 µl 
pOT-233 (already cut with SmaI), 2 µl Cutsmart Buffer, 2 µl 10mM ATP, 0.5 µl of SmaI and T4-DNA Ligase 
and 10 µl H2O. Ligation took place for 2 hours at 24°C. SmaI creates blunt ends in the digest. Likewise, 
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phusion polymerase creates PCR products with blunt ends. In the above reaction, the PCR insert attached 
to the SmaI cutted vector and the T4 ligase ligated them together. However, the ligase also religated the 
cutted vector. To prevent a high amount of religations, SmaI was also present in the reaction. Every 
religated vector was immediately cut open by SmaI. This did not affect the desired plasmids, since the 
SmaI site vanished if the insert was ligated to the vector. 
In the end, the PCR product was cloned efficiently into an intermediate vector. Subsequent steps were 
transformation (see 4.2.1.10), screening by Kochlysates (see 4.2.1.11), Midi prep (see 4.2.1.12) and 
quantification (see 4.2.1.13).  
Afterwards the intermediate vector was used for subsequent cloning.  
4.2.1.15. Sequencing 
The success of cloning was controlled by sequencing. Sequencing was performed at Microsynth Seqlab or 
Eurofins Genomics. 
Table 17 shows reaction setups for both companies. 
Table 17 Reaction for sequencing 
 Microsynth Seqlab Eurofins Genomics 
Plasmid DNA 1200 ng 500 ng 
Primer 0.3 µl 0.3 µl 
H2O to 15 µl to 10 µl 
 
4.2.2. in vitro transcription (IVT) 
Gene knockdown could be achieved either by transfecting hairpin constructs or by applying dsRNA to the 
cells. in vitro transcription was used for synthesizing dsRNA. 
For in vitro transcription, a gene fragment was cloned to a vector that contained a T7 Promotor upstream 
and downstream of the fragment. A PCR with primer SPO-288 was conducted (see 4.2.1.1). This resulted 
in amplification of a piece of DNA containing the fragment and both T7 sites. After clean up (see 4.2.1.2) 
the in vitro transcription was started. The reaction consisted of 10 µl of the purified PCR, 10 µl of T7 
Transcription buffer, 1.5 µl of the RNAse inhibitor, 5 µl of NTPs, 22 µl of H2O and 1.5 µl of T7 RNA 
Polymerase. The reaction took place overnight at 37°C. 
The samples were quantified as described in 4.2.1.7, as were the corresponding PCR products. The 
quantified band of the IVT sample consisted of DNA from the PCR product and dsRNA of the IVT. To obtain 
only the dsRNA concentration, the gel concentration of the PCR product was subtracted from the IVT 
sample. Samples were stored at -20°C upon usage. 
4.2.3. Cell culture 
4.2.3.1. Cell Cultivation 
Drosophila S2R+-cells were grown in 75 cm2 cell culture flasks, containing 12 ml Schneider’s Drosophila 
complete medium. Incubation took place at 27°C, cells were split twice a week (see 4.2.3.2). 
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4.2.3.2. Cell Split 
To prevent overgrowth and ensure constant, optimal proliferation conditions, cell split took place twice a 
week. Old cell medium was discarded and cells were washed once with 5 ml of PBS. For loosening the cells 
from the flask bottom, 5 ml of Trypsin/EDTA solution was applied to them and incubated for 2 min. 
Trypsin/EDTA solution was resuspended until the cells were detached. The cell suspension was transferred 
in a 15 ml reaction tube and centrifuged at 1200 rpm at 2 min. Trypsin/EDTA solution was discarded and 
the cell pellet was resuspended in 8 ml Schneider’s Drosophila complete medium. 2 ml were used for 
inoculating a new cell culture flask. The rest was used for seeding 12-well or 6-well plates (see 4.2.3.4). 
4.2.3.3. Determining cell concentration 
Since it was necessary to seed always a constant number of cells, cell concentration had to be determined, 
for which the Fuchs Rosenthal cell counting chamber was used. 20 µl of cell suspension was mixed with 80 
µl of Trypan Blue, to exclude all dead cells (living cells are not stained by Trypan Blue and appear white 
under the microscope).  
The counting chamber consisted of 256 squares. The number of living cells in 16 of these squares was 
counted under the microscope. For determination of the cell concentration, the average cell number of 
the 16 squares was multiplied with 0.32. The result was the concentration of cells in 106 cells/ml. 
4.2.3.4. Cell seeding 
Cells were seeded after the concentration determination (see 4.2.3.3) in either 12-well plates (for FACS 
analysis and live cell imaging) or 6-well plates (for Co-IP studies and the MS analysis). For 12-well plates 
140000 cells were seeded in 1.5 ml Schneider’s Drosophila complete medium per well. For 6-well plates 
600000 cells were seeded in 3.0 ml Schneider’s Drosophila complete medium per well. 
4.2.3.5. Transfection 
Transfection of cells was done one day after seeding (see 4.2.3.4). For a 12 well plate, a total amount of 
200 ng was transfected. In most cases, 50 ng was used from every plasmid that should be transfected. If 
the 200 ng were not reached (for example because only three plasmids were transfected), pFSR-0092, 
which is an empty vector without promoter site, was used to compensate the difference. This was 
necessary to ensure constant transfection efficiencies. In case of 6-well plates, 600 ng of DNA was used in 
total, the amount of the single plasmids varied usually between 200-300 ng in dependency of the used 
construct. 
According to their concentration (see 4.2.1.7), the volume of each plasmid was calculated and pipetted to 
Schneider’s Drosophila medium (without FBS and Pen/Strep). For 12-well plates, the transfection had a 
total volume of 75 µl and for 6-well plates 150 µl. FuGENE HD was used as the transfection reagent, 0.7 µl 
were used for transfecting a 12-well and 2 µl for a 6-well. Transfection mixes were vortexed for around 7 
seconds directly after addition of FuGENE. After 15 minutes of incubation time, the transfection mix was 
pipetted into the respective wells. The plate was lightly shaken after transfection for dispersion of the 
transfection mixture. 
4.2.3.6. Induction with CuSO4 
If plasmids contained Metallotheonine-Promotors, expression had to be induced by exposition to heavy 
metals, e.g. CuSO4. CuSO4 was applied to the cells to a final concentration of 500 µM directly after 
transfection.  
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4.2.3.7. Applying dsRNA for knockdown experiments  
For gene knockdown experiments, either plasmids with a hairpin construct or in vitro transcribed dsRNA 
(see 4.2.2) was used. Hairpin plasmids were transfected as described above (see 4.2.3.5); dsRNA on the 
other hand was applied directly to the cells. For FACS analysis (see 4.2.6), dsRNA was applied directly after 
transfection to the cells. For live cell imaging experiments (see 4.2.7), dsRNA was put to the cells directly 
before the start of the microscope run. For the analysis of the phenotype of a prolonged Skp2 knockdown 
(see 5.1.4), dsRNA was added twice, once directly after transfection, and a second time 3 days later. In this 
case, incubation lasted 3 days longer. In all cases, dsRNA was used to an end concentration of 5 nM. 
4.2.4. Co-IP and Western Blots 
4.2.4.1. Co-Immunoprecipitation (Co-IP) 
Co-IPs were performed to test for biochemical interaction between potential binding partners. They were 
carried out roughly 48 hours after transfection. To preserve potential binding between proteins, all steps 
were performed on ice, or at 4°C respectively. 
To receive enough cell material, transfections (see 4.2.3.5) were always performed twice in two wells of a 
6-well plate. The bait protein was tagged with a 4xFLAG, 3xHA or HA epitope, the target protein was tagged 
accordingly with FLAG or HA. A Co-IP setup consisted always of a negative control (the target protein 
without the bait), a positive control (the bait protein and a confirmed interaction partner) and the actual 
test sample (bait and target protein together). If possible, bait and target protein were under polyubiquitin 
promotors, for strong expression. 
As a first step, cell medium was removed from the 6-well plates and 500 µl of cold PBS was applied on 
every well. Cells were removed from the bottom with a cell scratcher and transferred in 2 ml reaction 
tubes, identical samples were pooled in the same tube. Samples were centrifuged for 10 min at 2000 rpm. 
Afterwards, the supernatant was discarded and cells were resuspended in IP lysis buffer, containing a 
protease inhibitor mix. Incubation took place 20 min, after 10 min, reaction tubes were inverted once for 
stirring. Afterwards, 100 µl of the supernatant was saved at 4°C for later Western Blot analysis (see 4.2.4.2 
and 4.2.4.3). This was the input, which confirmed that the proteins were expressed. The remaining 900 µl 
of the supernatant was used for the actual Co-IP. 
Two kinds of agarose beads were used for the protein precipitation: Protein G Beads and FLAG-tagged 
beads. The FLAG-tagged beads were used for Dap pull down for example, since it turned out that 
precipitation of Dap worked only with these beads efficiently. 
In case of Protein G beads, FLAG or HA antibody was given to the Co-IP in a dilution of 1:300 (see Table 6). 
The samples were incubated under rotation for 30 min at 4°C. This led to antibodies bound to the bait 
protein. This was not necessary for the FLAG-tagged beads, since the antibodies were already present on 
the beads in this case. 
The Protein G beads had to be washed before application to the Co-IP. For washing, 30 µl beads per sample 
were mixed with 1 ml of IP Lysis buffer. After centrifugation (1000 rpm for 30 sec), the supernatant was 
discarded completely. This step was repeated once. Finally, beads were resuspended in IP lysis buffer 
(including protease inhibitors), in 30 µl per sample. 
After the antibody was bound to the bait proteins, 30 µl of beads were applied to the Co-IP. This led to 
binding of the bait protein – antibody complex to the beads since protein Protein G binds antibodies 
efficiently. If the target protein interacted biochemically with the bait protein, it will have been also located 
at the beads, therefore. Incubation took place for 1.5 – 2 hours at 4°C under rotation. To get rid of unbound 
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proteins, a washing step was performed in the end. Samples were centrifuged at 1000 rpm for 30 sec, the 
supernatant was completely discarded and the beads resuspended in IP Washing buffer. This step was 
repeated once. Finally, 40 µl of 2xLSB was applied to the beads and 100 µl directly to the input. All samples 
were boiled for 5 min at 100°C. This led to protein denaturation and, in case of the Co-IP, elution from the 
beads. Samples were either directly analyzed on a Western Blot (see 4.2.4.2 and 4.2.4.3) or stored at  
-20°C.  
In case of FLAG tagged beads, it was not necessary to incubate samples with antibodies since they were 
already linked to the beads. After washing the beads, they were applied directly to the samples and all 
steps were performed as described above. It was possible to minimize IgG band background in the Western 
Blot analysis in this case. Co-IPs were incubated with 20 µl of 2xLSB without β-Mercaptoethanol and boiled 
for 5 min at 100°C. This led to elution of proteins from the beads. Antibodies were still co-eluted from the 
beads, but to a lesser amount. The samples were centrifuged for 30 sec at 1000 rpm and the supernatant, 
including the proteins, were transferred in new reaction tubes. Now, 20 µl of 2xLSB with β-
Mercaptoethanol was pipetted to the samples and the boiling was repeated, this led to protein 
denaturation. 
4.2.4.2. SDS-PAGE 
To separate protein samples, SDS-polyacrylamide gel electrophoresis was used. Gels were casted and ran 
in a PAGE Gel System by BioRad, in which 7 ml of resolving gel and 3 ml of stacking gel was used. 
Electrophoresis was performed at 200 V. The gel percentage and running time varied depending on protein 
size, since it had to be avoided that IgG-bands of the used antibodies (see 4.2.4.1) would mask important 
protein bands. Normally, gels were either 8% or 12% and ran for 60 – 70 min.  
4.2.4.3. Western Blot analysis 
Western Blot was used for transferring proteins on a nitrocellulose membrane and subsequent antibody 
staining was used for making them visible.  
A semi-dry blotting system was used. A blotting sandwich was built in the blotting chamber. This sandwich 
consisted of a Whatman Paper (approx. 5.5 – 8.5 cm) as the lowest layer. A nitrocellulose membrane (5.5 
– 8.5 cm) was put on top. The SDS-PAGE Gel was the next layer and finally another Whatman Paper 
completed the sandwich. Whatman Paper and membrane were soaked in Western Transfer Buffer 3. 
Blotting was performed at 70 mA per blotting sandwich for 90 minutes. 
After blotting, blots had to be blocked to prevent unspecified antibody binding later on. Blots were 
transferred to Blocking Buffer and incubated for at least 1 hour shaking at room temperature. Blots were 
washed two times with PBS-T. Subsequent antibody staining took place in 5 ml PBS-T. The antibodies were 
used in an appropriate dilution (see Table 6), incubation took place overnight at 4°C on a shaker. On the 
next day the primary antibody was discarded and blots were again washed two times with PBS-T. Again, 
5 ml PBS-T were used for staining with the secondary antibody. The IR Dye 800 anti-mouse from Licor was 
used in a dilution of 1:5000 (see Table 7). Incubation took place for 2 hours at room temperature in the 
dark on a shaker. Afterwards, the secondary antibody was discarded and the blots were washed again two 
times with PBS-T. Blots were put into 5 ml PBS-T and shaken for 30 min at room temperature to minimize 
antibody background. Finally, blots were stored in PBS-T at 4°C and scanned on a Licor odyssey scanner. 
ImageJ was used for visual processing of the blots. 
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4.2.5. MS analysis of Skp2 binding partners 
4.2.5.1. Sample Preparation 
Mass spectrometric analysis was performed to obtain a broader idea of Skp2 binding partners. 4xFLAG 
Skp2 was overexpressed in Schneider cells and precipitated, using the same protocol as in the Co-IP studies 
(see 4.2.4.1). In this case, however, the Lysis and Wash Buffers of the Flag immonuprecipitation kit was 
used since these buffers were optimized for FLAG precipitation. Furthermore, FLAG tagged beads were 
used as described in 4.2.4.1. It was checked that 4xFLAG Skp2 was expressed and precipitated by Western 
Blot analysis (see 4.2.4.3). Schneider cell lysate without Skp2 overexpression was used as a control, to 
eliminate hits that only bound unspecifically to the beads. 
For protein separation, a commercial NuPAGE 4-12% Bis-Tris gradient gel was used to reach optimal 
separation. 
Coomasie-staining was used for making the proteins visible before gel extraction. The gel was washed 3 
times for 5 minutes shaking in H2O and stained for 1 hour shaking in SimplyBlue SafeStain Coomasie G-250 
solution (Thermo Fischer Scientific). The stained gel was destained by washing 3 times for five minutes 
shaking in H2O and by incubation in H2O shaking over night at room temperature. 
A sterile scalpel was used to cut bands out of the gel. Fragments were transferred to 2 ml Eppendorf 
Reaction Tubes and washed with 2 ml NH4HCO3 shaking for 1 hour. Gel pieces were dried by incubating 
them with 1 ml MS washing buffer 1 and 2 for 30 minutes each and with 200 µl of Acetonitrile (AcN) for 
10 minutes. In all steps, samples were shaken and the supernatant discarded. Finally, the gel fragments 
were lyophilized for 30 minutes. 
For reduction of cysteine, gel fragments were incubated with 200 µl of MS DTT at 56°C for 35 minutes. 
This step was performed to ascertain complete digestion of the proteins through trypsin later on. Blocking 
of reduced cysteine was achieved by incubation with MS Iodacetamide solution at room temperature in 
the dark for 35 minutes. Another drying of the gel pieces was done as described above. 
In-gel protein digest was performed by applying MS Trypsin solution and incubation for 10 minutes at 
room temperature. Either 20 or 40 µl Trypsin was added, until the fragments got transparent. 20 or 50 µl 
of NH4HCO3 were applied to the fragments respectively, and the digest was conducted overnight at 37°C.  
The supernatant, containing the digested proteins, was collected in fresh 0.5 ml Axygen reaction tubes for 
every sample. The gel fragments were washed twice with 100 µl NH4HCO3 at 37°C for 1 hour each. The 
supernatant was transferred in the same tubes as above. Finally, fragments were washed with 100 µl of 
MS washing buffer 2 at 24°C for 20 min and the supernatant was again pooled into the Axygen Cups. For 
all the above steps, Axygen low binding tips were used since they were optimized for minimal 
contamination of the tip material. 
The supernatant was lyophilized overnight and afterwards stored at -20°C until mass spectrometric 
analysis. For lyophilization, reaction tubes with self-made holes in the tube cap was used. Sample 
preparation was done in the lab of Dr. Astrid Bruckmann, which also took care of primary sample analysis. 
Mass spectrometric data was compared with the Uniprot KB data base. 
4.2.5.2. Analysis of mass spectrometric data 
After the MS run, the obtained data had to be organized and adjusted. Two protein lists were created: all 
the protein hits found in the Skp2 precipitation sample and in the control sample. The hits were ordered 
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by an automatically calculated score value. Every sample with a score below 100 was discarded from 
further analysis, since it was deemed as not reliably detected. 
The proteins in the Skp2 list were verified with the control list to exclude proteins that bound unspecifically 
to the beads or were a contamination during the sample preparation (e.g. keratin). All proteins that were 
found solely in the Skp2 list were considered real hits, as were proteins that were in both lists, but had a 
score 300 points higher in the Skp2 list in comparison to the control list. 
4.2.6. Flow cytometric analysis of the cell cycle and protein stability 
4.2.6.1. Principal Idea 
Flow cytometry was used to analyze cell cycle distribution of Schneider cells and potential changes upon 
protein overexpression and knockdown. Furthermore, an assay developed in the lab (Polz, 2017) was used 
to determine protein stability by flow cytometry. With this assay, stability changes of hypothesized Skp2 
substrates were observed by either Skp2 overexpression or knockdown. If stability would be diminished 
or increased respectively, this would be a clear hint for a Skp2 regulation of the mentioned substrate. 
4.2.6.2. Sample preparation 
After transfection (see 4.2.3.5), cells were incubated two to three days before analysis. It was assumed 
that stability experiments would show the same results after both time spans. Nonetheless, to exclude 
this source of variability, all Cdt1 related experiments were analyzed after roughly 48 hours and all Dap 
experiments after roughly 72 hours. 
In most cases, cell cycle distribution was visualized, either for observation of the effects of the treatments 
or for analyzing protein stability in the three distinct cell cycle phases, G1, S and G2/M. Hoechst staining 
was used for the visualization. Hoechst binds to the DNA and is stimulated by the UV LED in the flow 
cytometer. The more DNA a cell possesses, the stronger is the Hoechst signal, making a distinction 
between G1-, S- and G2/M-Phase possible. 6 µl of Hoechst stock solution was pipetted to every well. The 
plate was incubated for 15 minutes at 27°C afterwards. The medium was discarded and a mixture 
consisting of 1 ml Trypsin/EDTA solution and 6.4 µl Hoechst was applied to every well. This led to removal 
of the cells from the well bottom and insured constant Hoechst staining at the same time. Cells were 
resuspended in the well for complete removal and transferred to FACS sample tubes. 
4.2.6.3. Fluorescence activated cell scanning (FACS) 
For the actual measurement, sample tubes were inserted into the flow cytometer. Schneider cells were 
separated from cell debris by their forward and side scatter. Excitation and detection of fluorescence was 
done by lasers, filters and fluorescence detectors (see Table 12 for specifications). Samples were analyzed 
with a speed of 800-900 events per second. It was counted until 270000 events were recorded or, if this 
was not possible, until the whole sample was analyzed. 
4.2.6.4. Cell cycle analysis and export of stability data with FCS Express 
Visualization and primary analysis of FACS data was performed with the program FCS Express (Version 
4.07.0020). Two tasks were fulfilled: first, the cell cycle distribution was visualized and analyzed by 
calculating the ratio of G1 to G2 cells. Second, data for protein stability determination was prepared and 
exported for analysis in Origin (see 4.2.6.5). 
It was necessary to process the data, since strictly speaking, the flow cytometer was only measuring events 
which consisted of air bubbles, cell debris, cell cluster and actual cells. Events were selected and filtered 
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by using gates. In this way, only non-clustered Drosophila cells were analyzed. The cell cycle distribution 
of gated cells was visualized and the number of cells in certain areas were determined by markers. In this 
way, the ratio of G1 to G2 cells was calculated.  
 
Figure 8 Analysis of flow cytometry data with FCS Express 
Gates and markers that were used to analyze cell cycle distribution and preparation of samples for Origin analysis. Drosophila 
S2R+-cells were transfected with a T2A control vector, expressing both GFP and mChe (not shown). (A) Density plot of FSC against 
SSC. Gate 1 shows the population of S2R+-cells. (B) Density plot of Hoechst intensity (FL2) against width of events in the Hoechst 
channel (FL2-W). Gate 2 is used to isolate single cell events. Gates 1 and 2 are used to determine the cells for exportation to Origin. 
(C) Histogram of cells that were in Gate 1 and Gate 2, showing the cell cycle profile of all single cells in the sample. (D) Density 
plot of GFP intensity against FSC. Shown here are untransfected cells to determine the GFP background (not more than 0.5% of 
GFP background events are in Gate 3). (E) Same as D but shown with transfected cells. Gate 3 determines GFP positive cells, 
equivalent to transfected cells. (F) Histogram of cells that are in Gate 1, Gate 2 and Gate 3, showing the cell cycle profile of all 
single GFP positive cells in the sample. This histogram was used to analyze the cell cycle profile of transfected cells if GFP was used 
as a transfection control (same procedure was performed if mCherry was the control, with a mChe gate). (G) G1 and G2 markers 
to determine the number of cells in G1 and G2/M-Phase. FSC: forward scatter; SSC: side scatter. 
 
Figure 8 shows the process in an example. In plot A, the forward scatter (FSC) is plotted against the side 
scatter (SSC). This diagram was used to separate Schneider cells from cell debris with Gate 1. Figure 8B 
shows the Hoechst signal in relation of the FL2-W paramater (width of signal of events in the Hoechst 
channel). Gate 2 was used to separate single cells from cell doublets or clusters. Both gates combined 
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delivered all single Drosophila cells, which were used for analysis (see Figure 8C as an example of cell cycle 
distribution). For protein stability analysis, the collected data of these cells, especially the fluorescence 
intensity of GFP, mCherry (mChe) and Hoechst, was exported as a comma-separated value file (.csv) and 
afterwards processed in Origin (see 4.2.6.5). 
For cell cycle analysis, separation from transfected and untransfected cells had to be performed. Every 
experiment had one fluorescence protein that served as a transfection control. As an example, in Figure 8 
GFP is the control. A GFP gate (Gate 3) was used to get rid of untransfected cells. The gate was set so that 
no more than 0.5% of all cells were inside if the untransfected cells were viewed. Figure 8D shows this 
procedure, the signals were background, originating from either Hoechst staining or the laser itself. Plot E 
shows the same gate, but with transfected cells. A combination of Gate 1, Gate 2 and Gate 3, depicted as 
a histogram against the Hoechst fluorescence intensity showed the cell cycle distribution of all single, 
transfected cells (Figure 8F). 
S-Phase in Schneider cells is not resolved well. Therefore, a clear separation of G1 and G2 cell peaks is not 
possible. Consequently, the starting point of the G1 marker was set at the maximum turning point of the 
G1-peak, the end point was the minimal turning point of the S-Phase. This marker was shifted, so that the 
end point landed on the maximum turning point of G1. Likewise, the starting point of the G2 marker was 
the minimal turning point of S-Phase, whereas the end was the maximum turning point of G2/M. Shifting 
the marker forward to the maximum turning point of the G2/M-peak resulted in the determination of the 
G2/M cells (see Figure 8G). Since the distribution of the G1- and G2-peaks are symmetrical, these two 
markers consisted of half of the cells in G1 and G2/M, from which the G1/G2 ratio was calculated. 
For analysis of the cell cycle distribution, the ratio of G1/G2 was calculated for all replications. Data was 
depicted as boxplots. 
4.2.6.5. Relative protein stability analysis with Origin  
Protein stability analysis based upon comparison of fluorescence intensities of GFP and mCherry in cells. 
The flow cytometer can detect the fluorescence intensities of every single cell. Therefore, it is possible to 
determine the ratio of GFP and mChe fluorescence intensity of every transfected cell in a well. It is known 
that GFP and mChe alone are stable in the cell cycle, hence the ratio of GFP and mChe fluorescence is 
constant if the correct expression system is used. If a protein of interest that is degraded in the course of 
the cell cylce is tagged with either GFP or mChe, the respective fluorescence intensity will be decreased. 
The intensity of the other fluorophore will be unaffected and can serve as the reference. 
For example, if the protein of interest (“X”) is tagged with mChe, the ratio of the logarithmic intensity of 
the mChe fluorescence to the logarithmic intensity of the GFP fluorescence can be calculated as 
log(𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑚𝐶ℎ𝑒 𝑋)
log (𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝐺𝐹𝑃)
. Since the GFP intensity is not affected, this ratio is representative for the relative 
protein stability of the protein of interest “X”. It is possible to identify substrates of Skp2 with this assay. 
The supposed substrates are the proteins of interest (“X”) in the above example. If Skp2 is responsible for 
the ubiquitination, an overexpression will lead to an increased degradation of “X” and consequently a 
decreased intensity of mChe. As a result, the ratio will be smaller under these overexpression conditions 
in comparison to normal Skp2 levels. Likewise, Skp2 knockdown should lead to the contrary effect: less 
degradation of “X” and increased intensity of mChe resulting in a greater ratio. 
In a first step, FCS Express was used to identify cells and filter out cell debris, cell clusters and air bubbles 
in the data gathered by the flow cytometer (see 4.2.6.4). However, FCS Express is not capable of a direct 
comparison of single cell fluorescent intensities, so Origin 2017 was used since this software could perform 
the necessary computer calculations. After the .csv files were loaded into Origin, the software determined 
a background GFP or mChe threshold according to the untransfected cells. Every cell above this threshold 
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was considered transfected and taken into analysis. This was necessary, since the export of data described 
above did not eliminate any background events. Upon this threshold, all cells were divided into positive 
and negative cells. The transfection efficiency was calculated by dividing the number of positive cells 
through the complete cell number. If transfection efficiencies were under 10 %, the sample was considered 
as not fit for analysis and excluded. 
 
Figure 9 Analysis of relative protein stability data by Origin 
Principles of relative protein stability analysis of flow cytometric data with Origin. (A) Determination of G1-, S- and G2/M-Phase. 
Cell cycle distribution of fluorescent negative cells of a sample. Origin determines the two maxima and the minimum. These values 
are adjusted manually if necessary. (B) Depending on the values in A, cells are sorted as G1 (red area), S (green area) and G2/M 
(yellow area). (C) Origin calculates the ratio of mChe (“FL3”) and GFP (“FL1”) fluorescent intensity for every transfected cell in the 
sample and displays it as a boxplot. The line inside the box and the number indicates the mean value of the sample, which was 
used as an index of stability. (D) Stability indices of the reproductions were recorded, statistically analyzed and also displayed as 
boxplots. Analysis was conducted on all transfected cells, G1, S and G2/M (called “G2” for simplicity) cells respectively, according 
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to the areas in B. Values were normalized on the stability of the protein of interest. (E) Schema of a T2A construct. GFP and mChe 
are translated under one promotor in a stoichiometric ratio, since the T2A site leads to ribosome skipping. Proteins of interest can 
be tagged with GFP or mChe either N- or C-terminally. (F) Ratio of GFP and mChe fluorescence intensity remains stable using the 
T2A system. 
 
In most cases, it was desired to analyze protein stability in the different cell cycle phases. Therefore, it was 
necessary to determine the G1- and G2/M-peak and the S-phase valley. The software created cell cycle 
profiles of the untransfected cells of every sample as a reference (see Figure 9A) and automatically 
determined and marked the two maximum and the one minimum turning points. Every profile was 
inspected and manually corrected if the positioning was not correct. Origin sorted the transfected cells 
according to these three values in a G1, S and G2 (comprising of G2- and M-Phase cells) population, 
whereas G1 was set between 200 Hoechst fluorescent units before the G1-peak and the peak itself. S was 
defined as the region +/- 100 Hoechst fluorescent units around the minimum, and G2 started at the G2/M-
peak and ended 300 Hoechst fluorescent units after the peak (see Figure 9B). As already described, the 
G1, S and G2/M cell distributions are symmetrical. Therefore, the defined populations were considered 
representative and are called G1-, S- and G2-phase from now on. 
Stability analysis was performed on “all” cells, meaning all transfected cells in a well, regardless of the cell 
cycle phase they were in, and on the G1-, S- and G2-Phase. An exception was the analysis of direct or 
indirect effects of F-Box protein overexpression and knockdown effects (see 5.2). In this case, Hoechst 
could not be used, since it created high background in the GFP channel, which impeded stability analysis 
if the protein of interest was GFP tagged, as it was the case here. In this case, cell cycle analysis was not 
possible and stability was determined only for all transfected cells, regardless of their cell cycle phase. 
Origin depicted the stability data as box plots, in which every box plot represented one sample and every 
data point of a box plot was one measured cell. For a more detailed explanation of the method and the 
used macros, see Polz (2017). Origin calculated for every boxplot the average value of the fluorescence 
intensity ratios of every transfected cell in the sample (see Figure 9C). This average was used as the stability 
index. Reproductions were performed in the same week and over several weeks. The stability indices of 
the different treatments (for example Skp2 overexpression, CycE overexpression, combined Skp2 and CycE 
overexpression, Skp2 knockdown, …) were recorded and statistical analysis (see 4.2.9) was performed on 
them, in order to identify potential influences of the treatments on the protein stability. This data was also 
depicted as boxplots (see Figure 9D). The box represented the interquartile range (all data points between 
the 25th and 75th percentile). The whiskers represented the last data point that was in between the so 
called Upper and Lower Inner Fence. These fences were defined as the 75th percentile plus 1.5 times the 
interquartile range or as the 25th percentile minus 1.5 times the interquartile range respectively. The line 
represented the median, the square the average. For reasons of comparability, all stability indices were 
normalized. In case of the controls, samples were normalized to the control plasmid alone (e.g. mChe 
stability), in case of the test, normalization was performed on the stability of the protein of interest (e.g. 
mChe Dap), or in some cases to the protein of interest under CycE overexpression conditions for 
experimental reasons (see the result sections for details).  
One important aspect of this method was that it depended strongly on constant expression of GFP and 
mCherry. The T2A system was used for expressing the fluorescent proteins in these kinds of experiments. 
This system allowed expression of two different proteins on one plasmid under only one promotor. A T2A 
sequence resided in between two DNA sequences (see Figure 9E). If the ribosome reaches the T2A 
sequence, translation stops and the first protein is released, without the ribosome leaving the RNA. 
Afterwards, the ribosome starts translating the second protein. As a result, the expression of GFP and 
mChe is in a stoichiometric proportion and the ratio of fluorescence intensity remained reliably stable for 
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the controls (see Figure 9F). A caveat of this method is that proteins are slightly changed in this process. 
17 aa of the T2A sequence are fused on the C-terminus of the protein upstream of the T2A sequence and 
1 aa (a proline) on the N-terminus of the protein downstream. All proteins of interest were cloned into 
T2A plasmids specifically designed for flow cytometric stability analysis (Polz, 2017), allowing for 
determination of their relative protein stability. The proteins of the different treatmens were not 
expressed by the T2A system, but resided on independent plasmids (see Table 8) that were co-transfected. 
Previous results hinted that the T2A expression system becomes unreliable with expression levels either 
too low or too high. In these cases, the ratio of upstream and downstream protein is no longer 
stoichiometric and protein stability analysis becomes impossible. Therefore, these boundary conditions 
were excluded from the analysis. Expression levels were determined by analysis of the fluorescence 
intensity of the reference protein. In general, an expression level between 100 and around 560 (102.00 – 
102.75) fluorescence units was deemed as fitting for analysis. If not otherwise mentioned, all stability data 
layed in this range. However, in case of the Cdt1 project (see 5.4) it turned out that results varied strongly 
if a different range was used. In case of these results, two expression level ranges are shown, the usual 
range and a much lower expression level range between around 17 and 100 (101.25 – 102.00) fluorescent 
units. This phenomenon was solely seen in the Cdt1 project, in all other cases, the analysis of the high and 
the low level showed similar results. 
In all experiments, controls were performed to exclude the possibility that the overexpression or 
knockdown of proteins were influencing the GFP or mChe stability. Therefore, any stability changes on the 
protein of interest was solely caused by protein overexpression or knockdown.  
4.2.7. Live cell imaging 
Live cell imaging was used to determine the length of the G1-Phase at Skp2 overexpression or knockdown 
conditions.  
4.2.7.1. Preparation of cells 
Cells were seeded and transfected as described in 4.2.3. After around 48 hours, cells were trypsinized, 
transferred in an IBIDI well plate and put under the microscope. For knockdown experiments, dsRNA was 
applied at this point to the cells.  
An IBIDI heating system was used to incubate the cells at constant 27°C. Cells were observed for around 
96 hours.  
4.2.7.2. Handling of the microscope 
For live cell imaging, the Axio Observer Z1 microscope (Carl Zeiss) was used, with a plan-apochromat 
objective (20x magnification). GFP was detected with an OPSL-Laser at 488 nm and 100 mW, Cherry with 
a diode laser at 561 nm with 40 mW. A spinning disk laser system (Yokogawa Electric Corporation) was 
used to minimize photo bleaching.  
An automatic table made multi position images possible. Pictures were taken every 15 minutes with 
transmitted light, and the GFP and mCherry lasers. For each picture, three z-stacks were recorded. It was 
checked if the cells were still in focus on the morning of the day after the start of the experiment. If needed, 
the focus was adjusted. 
Images were processed with ImageJ for analysis. 
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4.2.7.3. Determination of G1 length with cell cycle markers 
G1 length was determined by overexpression of a cell cycle marker, being a protein that is degraded on a 
defined time point during the cell cycle but does no longer have an effect on the cell cycle. This marker is 
tagged with a fluorescence protein, which makes the degradation and re-accumulation visible. 
 
Figure 10 Determination of G1 length with a cell cycle marker 
Principle of determining G1 length with live cell imaging and Cdt1 1-101 3xCherry as a cell cycle marker. (A) Schema of 
Cdt1 1-101 3xCherry. Because of the deletion, this marker does not affect the cell cycle. However, it is still degraded in S-Phase 
because of the PIP-degron. 3xCherry makes it visible under a microscope. (B) Images from live cell imaging. Anaphase was easily 
recognized and determined as the end of mitosis (row 2). S-Phase starts when Cdt1 1-101 3xChe is degraded (rowes 4 and 5). The 
difference in both time points is the length of G1-Phase. 
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As a cell cycle marker, Cdt1 1-101 3xCherry was used (see Figure 10). This marker did not have any cell 
cycle effects because of the deletion, but still contained the PIP-degron, which leads to rapid degradation 
in S-Phase (Havens and Walter, 2009).  
For this experiment, anaphase was defined as the end of mitosis since it could be easily recognized in the 
images. Consequently, cells were observed from anaphase until the vanishing of the Cherry signal, 
equivalent to Cdt1 1-101 degradation and onset of S-Phase (see Figure 10). The number of frames in 
between were counted. Since a frame was taken every 15 minutes, this number, multiplied by 15 gave the 
length of G1 in minutes. As with FACS protein stability analysis, the data was pictured as box plots as 
described in 4.2.6.5. 
4.2.8. Fly Experiments 
4.2.8.1. Fly rearing and crossing 
Flies were reared in food vials with fly food (containing cornmeal, agar, soy meal, molasses, malt flour, 
yeast and nipagin as a fungicide). For optimal growth conditions, flies were kept at 24°C, a relative 
humidity of 65% and a 12-hour light/dark cycle. Vials were sealed with a rubber foam plug. Flies were 
flipped twice a week in fresh food vials. 
Crosses were performed to combine genetically elements of two different fly strains. Virgins and males of 
both strains were collected and pooled in a fresh vial. Offspring hatched after ca. 9 days and could be 
screened and analyzed or crossed further. Offspring was collected until 18 days after the cross, since from 
this point on, the F2 generation hatched and the genotype of flies could not be determined safely. 
4.2.8.2. UAS/Gal4 system 
The UAS/Gal4 system was used for ectopic gene expression restricted to certain tissues, e.g. wings or eyes. 
Driver lines, e.g. eng:Gal4, expressed the Gal4 protein only in specific tissues. These lines were crossed 
with flies that expressed the construct under a UAS (“upstream activating sequence”) promotor. UAS is 
normally not active but is activated upon presence of Gal4. Therefore, tissue specific expression was 
possible. 
4.2.8.3. Wing preparation 
The eng:Gal4 driver line was used for expression in fly wings. Crosses were performed and the wings of 
the offspring dissected in EtOH. Only wings of male individuals were used. Wings were transferred to 
microscopic slides. Mounting was performed with Dpx. After drying overnight, samples were ready for 
microscopic imaging. 
A CKX41 microscope (Olympus) with a CCD camera was used for imaging. Images were taken with a 
2.5x magnification for overview and a 5x magnification for details. 
4.2.9. Statistical analysis 
Statistical analysis was performed with PAST (Hammer et al., 2001). All data was tested for normal 
distribution with the Shapiro-Wilk test. If normal distribution was fulfilled, a two-tailed t-test was used for 
testing of significant differences. If not, the Mann-Whitney U-Test was used instead. 
An exception was the analysis of FACS protein stability data (see 4.2.6.5) of the respective Skp2 substrates. 
The Mann-Whitney U-Test was to imprecise to detect significant changes. This was seen by analyzing the 
stability of Dap dCDI with CycE overexpression. This Dap version still contains a functioning PIP-degron. 
Simultaneous CycE overexpression should lead to an enhanced degradation of this construct since cells 
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shift strongly in S-Phase. Nonetheless, the Mann-Whitney U-Test showed a non-significant difference. 
Therefore, the t-test, which is much sharper, was used in analyzing these experiments regardless of normal 
distribution. 
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5 Results 
5.1. Skp2 phenotypes in Schneider cells and flies 
5.1.1. Overview 
The F-Box protein Skp2 has many substrates in the mammalian organism, ranging for example from the 
cyclin dependent kinase inhibitors (CKI) p21 (Bornstein et al., 2003; Yu et al., 1998), p27 (Carrano et al., 
1999; Nakayama et al., 2000; Sutterluty et al., 1999) and p57 (Kamura et al., 2003) to cyclins (e.g. Cyclin E 
(Nakayama et al., 2000)) and E2F1 (Marti et al., 1999) and even to parts of the replication machinery (Li et 
al., 2003; Mendez et al., 2002). Hence, Skp2 is an important part of various different cellular processes. 
The Drosophila melanogaster Skp2 is poorly studied in contrast. The gene was characterized with knock 
out/knockdown studies in Drosophila larvae salivary glands, brains, eyes and wings (Ghorbani et al., 2011; 
Dui et al., 2013). Up to date, only one substrate, Dacapo (Dap), the homologue of p21 and p27, is proposed 
as a substrate in flies (Dui et al., 2013). 
For identifying new substrates and thereby illuminating the role of Skp2 in the cell cycle, the phenotypes 
of Skp2 knockdown and overexpression was studied in Drosophila Schneider S2R+-cells. The effect on the 
cell cycle of Skp2 overexpression and knockdown was analyzed by flow cytometric analysis. A Skp2 mutant 
with a deleted F-Box was analyzed the same way. A closer look was given to the cause of the observed cell 
cycle effects by performing live cell imaging experiments. Finally, it was tried to reproduce a polyploidy 
phenotype in Schneider cells that is already described in wing discs (Ghorbani et al., 2011). 
5.1.2. Skp2 overexpression leads to more G1 cells caused by a prolonged G1-Phase 
Transient Skp2 overexpression in S2R+-cells was analyzed by flow cytometry. Cells were cotransfected with 
a GFP and mCherry control. In this case, the mCherry protein was used as a transfection control. Hoechst 
was used for DNA staining. Cells showed a characteristic distribution with two peaks. The first peak 
represents cells with lower DNA content and most of these cells will reside in G1 or early S-Phase. For 
simplicity, this will be referred to as “G1-peak”. The second peak represents cells with doubled DNA 
content, meaning late S-, G2- and M-Phase cells. This peak will be referred to as the “G2-peak” since most 
of these cells will reside in G2. Cells in S-Phase are not well resolved in Schneider cells, there is no distinct 
S plateau visible between the G1 and G2/M-peak (Figure 11A) 
Overexpression of 4xFLAG Skp2 led to an accumulation of cells in G1-Phase. Transfected cells showed a 
higher G1-peak and consequently a G2/M-peak with less cells (Figure 11B). This effect was quantified by 
calculating the G1 to G2 ratio of the respective cells (see 4.2.6.4). Indeed, the accumulation of G1 cells was 
statistically significant (Figure 11C, t-test for unequal variances, p < 0.01). 
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Figure 11 Skp2 overexpression in Schneider cells and wings 
Phenotypic effects of Skp2 overexpression in S2R+-cells and wings. Cells: mChe serves as the transfection control, only mChe 
positive cells are shown. (A, D) Cell cycle profile of cells transfected with a construct that results in expression of GFP and mCherry 
(mCHE-T2A-GFP). (B) Cell cycle profile of cells cotransfected with mCHE-T2A-GFP and 4xFLAG Skp2, leading to a G1 shift. (C) 
Quantification of G1/G2 ratio of control and Skp2 overexpression cells. (E) Cell cycle profile of cells cotransfected with mCHE-T2A-
GFP and Skp2 4xFLAG, also showing an accumulation in G1. (F) Quantification of the associated G1/G2 cell cycle profile. All 
presented cell cycle distributions are representative. Wings: (G) Wing morphology of control cross en:Gal4; + (H) Wing morphology 
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of UAS-driven Skp2 overexpression in the posterior part of the wing using en:Gal4. Representative pictures are shown. 
** = p < 0.01; *** = p < 0.001; t-test for unequal variances. Non-significant changes are not indicated. 
 
A biochemical interaction between Skp2 and Dap was reported (Dui et al., 2013) although in this case, the 
4xFLAG tag was located C-terminally in Skp2. Therefore, Skp2 4xFLAG was also cloned and effects on the 
cell cycle were analyzed. As with the other construct, Skp2 4xFLAG also led to a visible shift of cells into 
G1-Phase in comparison to the control (Figure 11D and E). Calculation of G1/G2 ratios showed that this 
effect was also statistically significant (Figure 11F, t-test for unequal variances, p < 0.001). 
In contrast to the effects seen in cells, Skp2 overexpression in Drosophila wings did not show any visible 
phenotype. Skp2 overexpression by the UAS-Gal4 system with the engrailed driver showed no change in 
wing morphology in comparison to the control cross, en:GAL4 crossed with w- flies (Figure 11G and H, 11 
wings for each treatment were recorded, representative pictures are shown). 
 
Figure 12 Measurement of G1 length by Skp2 overexpression 
Quantification of G1 length of Schneider cells with and without 4xFLAG Skp2 overexpression by live cell imaging. Cdt1 1-101 serves 
as a G1 cell cycle marker. The line inside the box is the median, the square the average. * = p < 0.05; Mann-Whitney U-Test. 
 
A continuative analysis of the cause of this phenotype was done by live cell imaging. The length of the G1 
cell cycle phase was measured to find out if the accumulation of G1 cells could be explained by a prolonged 
G1-Phase. It was assumed that every cell that was positive for the cell cycle marker (Cdt1 1-101) had also 
been cotransfected with Skp2. Analysis of the G1 length showed that 4xFLAG Skp2 overexpression led to 
a statistically significant prolongation of G1-Phase (Figure 12, Mann-Whitney U-Test, p < 0.05). 
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5.1.3. Changes in cell cycle distribution require the F-Box in Skp2 
Although the overexpression of Skp2 did show cell cycle effects, it was unclear if these effects were caused 
by its function as an F-Box protein or if it played further roles in the cell cycle. Therefore, a version of Skp2, 
called Skp2 dF-Box, was created that lacked the whole F-Box domain, but was otherwise identical to 
4xFLAG Skp2. 
A Co-IP was performed to ensure that Skp2 dF-Box lost its ability to bind to the SkpA-Cul1-Rbx1 complex. 
4xFLAG Skp2 or 4xFLAG Skp2 dF-Box was precipitated and the binding to HA SkpA was controlled, since 
SkpA is the adapter protein of SCF, connecting Skp2 to the SCF via the F-Box (see Figure 4). Skp2 dF-Box 
had a smaller molecular weight, which was in concordance with its missing F-Box (Figure 13A, left blot). 
Precipitation of both Skp2 versions worked well. Expression of HA SkpA was weak, yet bands could be 
observed (Figure 13A, right blot). HA SkpA showed the strongest signal when 4xFLAG Skp2 was also 
overexpressed. It turned out that HA SkpA bound unspecifically to the Protein G beads (Figure 13A, right 
blot). Yet, simultaneous overexpression of 4xFLAG Skp2 led to a stronger HA SkpA signal, indicating 
biochemical interaction of 4xFLAG Skp2 and HA SkpA. It can be ruled out that the stronger band intensity 
solely stemmed from the higher expression level of HA SkpA, since the relatively moderate increase in 
band strength in the Input could not explain the drastic effect when co-precipitatd with 4xFLAG Skp2. On 
the other hand, precipitation of 4xFLAG Skp2 dF-Box did not show a stronger signal in the HA-blot in 
comparison to the negative control. This is consistent with the notion that this Skp2 version was unable to 
form a complex with the SkpA-Cul1-Rbx1 complex. 
The cell cycle effect of Skp2 dF-Box was also studied. Overexpression of 4xFLAG Skp2 showed the already 
described shift in G1-Phase (Figure 13B, middle). Overexpression of 4xFLAG Skp2 dF-Box showed no G1 
shift (Figure 13B, right). Cell cycle distributions were again quantified by calculation of the G1/G2 ratio. 
The G1 shift of 4xFLAG Skp2 overexpression was statistically significant (Figure 13C, t-test for unequal 
variances, p < 0.01) in comparison to the control cells. The cell cycle effects of Skp2 and Skp2 dF-Box also 
differed significantly (t-test for unequal variances, p < 0.05). 4xFLAG Skp2 dF-Box showed no significant 
effect in comparison to the control (Figure 13C, t-test for unequal variances, p > 0.05), another indication 
that Skp2 dF-Box was no longer a part of a SCF-complex. 
Another advantage of this construct was that it also made another way of searching for Skp2 substrates 
possible. One way to establish that a protein is targeted by a certain SCF-complex is to analyze if a delta F-
Box version of the F-Box protein does exercise a dominant-negative effect on the potential substrate 
(Carrano et al., 1999). An F-Box protein without the F-Box will still bind to its respective substrates; 
however, it is no longer able to recruit these substrates to the SCF-complex because of the deletion. The 
substrates are therefore protected from proteasomal degradation and still functional. Overexpression of 
Skp2 dF-Box should consequently lead to protein stabilization of actual substrates. 
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Figure 13 Skp2 dF-Box phenotypes 
Co-IP experiment for interaction of Skp2 dF-Box with SkpA-Cul1-Rbx1 complex and phenotypic effects of Skp2 dF-Box in S2R+-
cells. (A) Co-IP of 4xFLAG Skp2 and 4xFLAG Skp2 dF-Box with HA SkpA. Precipitation was performed with FLAG antibody, FLAG or 
HA antibody was used for detection respectively. Skp2 dF-Box is no longer interacting with SkpA. (B) Phenotypic effect of 4xFLAG 
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Skp2 and 4xFLAG Skp2 dF-Box on cell cycle distribution in S2R+-cells. mChe serves as the transfection control, only mChe positive 
cells are shown. (C) Quantification of the G1/G2 ratio of control, Skp2 and Skp2 dF-Box overexpression. The line inside the box is 
the median, the square the average. * = p < 0.05; ** = p < 0.01; t-test for unequal variances. Non-significant changes are not 
indicated. All presented cell cycle distributions are representative. 
 
5.1.4. Skp2 knockdown leads to a G2 shift in Schneider cells, caused by a shortened 
G1-Phase 
After establishing that Skp2 overexpression led to a shift in G1-Phase (see 5.1.2), it was also of interest to 
determine the phenotype of Skp2 knockdown. Schneider cells were transfected with a GFP and mCherry 
control and incubated with Skp2 double-stranded RNA.  
Since it is necessary in knockdown experiments to ensure that activity of the Dicer/RISC system alone does 
not have any effect, incubation with a nonsense dsRNA was also performed. dsRNA against a fragment of 
β-Lactamase (the enzyme responsible for Ampicillin resistance in Escherichia coli, therefore called Amp 
dsRNA) was synthesized as a control. Incubation with Schneider cells showed a shift in G1-Phase in this 
case (see Figure 14A,B) but quantification of various replications showed that this effect was not significant 
(Figure 14D, t-test for unequal variances, p > 0.05). The second control was Hygro dsRNA (against a 
fragment for the hygromycin-resistance gene). Hygro dsRNA did also show no significant changes in cell 
cycle distribution (t-test for unequal variances, p > 0.05, Figure 14E,F,G). Both controls were usable, 
therefore.  
Skp2 dsRNA on the other hand caused a drastic effect. Schneider cells showed a strong change in cell cycle 
distribution with an accumulation of cells in G2 (Figure 14C). This shift was significant in comparison to 
cells without treatment (Figure 14D, t-test for unequal variances, p < 0.01) and to Amp dsRNA control 
knockdown (t-test for unequal variances, p < 0.01). Functionality of the Skp2 dsRNA, especially that it was 
directed against Skp2, was tested beforehand (Jan Polz, 6-week internship).  
Again, live cell imaging was used to analyze the cause of this shift into G2-Phase. G1 length was again 
measured but this time with Skp2 knockdown. Through preliminary experiments, it was estimated that 
dsRNA needed about 50 hours to unfold its full effect (data not shown). For this reason, cells were analyzed 
after 50 hours of dsRNA application. In case of the Hygro dsRNA control treatment, data was recorded 
both before and after this mark to ensure that the dsRNA did not have any effect over the complete time 
span. There was no significant difference detectable in G1 length after Hygro dsRNA application before 
and after 50 hours (Figure 15, Mann-Whitney U-Test, p > 0.05). Skp2 knockdown on the other hand led to 
a significant shorter G1-Phase, resulting in the described shift into G2-Phase (Figure 15, Mann-Whitney U-
Test, p < 0.001). 
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Figure 14 Skp2 knockdown effect 
Phenotypic effect of Skp2 dsRNA on cell cycle distribution. mChe serves as the transfection control, only mChe positive cells are 
shown. (A, E) Cell cycle distribution of S2R+-cells. (B) Amp dsRNA has no significant effect on cell cycle distribution. (C) Skp2 dsRNA 
leads to a strong G2 shift. (D) Quantification of G1/G2 ratio upon application of Skp2 and Amp dsRNA. (F) Hygro dsRNA has no 
73 
 
effect on cell cycle distribution. (G) Quantification of G1/G2 ratio upon application of Hygro dsRNA. n.s = p > 0.05; ** = p < 0.01; 
t-test for unequal variances. Non-significant changes are not indicated. All depicted cell cycle distributions are representative. 
 
 
Figure 15 Length of G1-Phase upon Skp2 knockdown 
Measurement of G1 length in Schneider cells upon Skp2 knockdown with dsRNA. Double stranded RNA needs around 50 hours 
incubation time to cause an effect. Impact of control Hygro dsRNA was analyzed before and after this mark to rule out any effect. 
Effect of Skp2 dsRNA was only analyzed in cells with an incubation time longer than 50 hours. Cdt1 1-101 serves as a G1 cell cycle 
marker. The line inside the box is the median, the square the average. n.s = p > 0.05; *** = p < 0.001; Mann-Whitney U-Test. 
 
Knockdown by Skp2 dsRNA showed strong effects. Nonetheless, a disadvantage of this method was that 
it affected all cells in a well. This was problematic for flow cytometric protein stability analysis, since 
untransfected cells served here as a control to sort the cells in G1-, S- and G2-Phase (see 4.2.6.5). Double 
stranded RNA would have led to shifts in this control, which would made comparison between different 
knockdowns unreliable. 
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To overcome this obstacle, hairpin constructs were created. These constructs consisted in principal of two 
identical sequences of the gene of interest that should be downregulated, with one fragment in the usual 
orientation and the other in a 3’ to 5’ direction. Because of this reverse complement sequence, the 
transcribed RNA will anneal and build a hairpin structure after transcription that activates the Dicer/RISC 
system and knocks down the gene of interest. In this case though, only transfected cells showed this effect. 
 
Figure 16 Cell cycle effects of the hairpin constructs 
Phenotypic effects on cell cycle distribution of hairpin constructs. mChe serves as the transfection control, only Che positive cells 
are shown. (A) Cell cycle of S2R+-cells. (B) Effect of Hygro hairpin, serving as a control knockdown. (C) Effect of Skp2 hairpin. (D) 
Quantification of G1/G2 ratio of S2R+-cells alone and after transfection of Hygro and Skp2 hairpin. ** = p < 0.01; *** = p < 0.001; 
t-test for unequal variances. Non-significant changes are not indicated. All presented cell cycle distributions are representative.  
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Besides Skp2 hairpin, a Hygro hairpin construct was also created as a control and the cell cycle effects of 
both constructs were analyzed. Expression of the Hygro hairpin construct did not lead to a visible 
difference in cell cycle distribution (Figure 16A,B,D, t-test for unequal variances, p > 0.05). On the other 
hand, the Skp2 hairpin construct led to a shift into G2/M-Phase (Figure 16C) that was also statistically 
significant in comparison to S2R+-cells (Figure 16D, t-test for unequal variances, p < 0.001) and the control 
knockdown with Hygro hairpin (t-test for unequal variances, p < 0.01). This effect was weaker than the G2 
shift caused by Skp2 dsRNA.  
5.1.5. Skp2 knockdown over a prolonged time period leads to overreplication 
It is already known that knockdown of Skp2 leads to overreplicating cells in wing imaginal discs (Ghorbani 
et al., 2011). This was not seen in S2R+-cells, which only showed a shift in G2-Phase, albeit a strong one if 
dsRNA was used (Figure 14C). A possible explanation for this discrepancy was that cells might first 
accumulate in G2 and only after a prolonged time span under knockdown conditions start to overreplicate. 
To find out if Skp2 knockdown can cause overreplication in S2R+-cells, Amp and Skp2 dsRNA incubation 
was performed for six instead of only three days. Cell cycle distribution was analyzed afterwards. 
Schneider cells without any knockdown showed a strong shift into a G2 population after six days of 
incubation in a well (Figure 17A). This was expected, since prolonged time of growth results in cells that 
are overcrowding leading to an accumulation in G2. Incubation with Amp dsRNA showed a similar effect 
(Figure 17B). However, Skp2 dsRNA after six days led to an even stronger G2 shift and importantly to a 
higher number of cells beyond the G2-peak, corresponding with overreplicating cells (Figure 17C). Note 
also that the overall cell number in the experiment with Skp2 dsRNA was profoundly lower in comparison 
with the two controls (compare the two y-axes). All cell cycle distributions are overlaid in Figure 17D and 
normalized to the G2-peak. 
Overreplication inevitably leads to cells bigger than normal. Therefore, cell size between all three 
treatments was also compared. The forward scatter (FSC) is a parameter for cell size, the higher the FSC 
signal, the bigger are the cells. Amp dsRNA treatment for six days did not lead to cells with a greater size 
in comparison to control cells. In fact, Amp dsRNA led to smaller cells, though the difference was only 
marginal. Skp2 knockdown however resulted in bigger cells (Figure 17E). Also note that the x-axis of this 
figure is logarithmic. Hence, the difference between Skp2 dsRNA and the two control treatments may 
seem modest, but it represents in fact an increase of around 300 units. 
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Figure 17 Overreplication of Schneider cells after prolonged Skp2 knockdown 
Cell cycle distribution and cell size after six days of incubation with dsRNA. (A) Schneider cells show a G2 shift after six days of 
incubation. (B) Treatment with Amp dsRNA does not lead to obvious changes in comparison to untreated cells (C) Treatment with 
Skp2 dsRNA for six days leads to an enhanced G2 shift and a decreased cell number, overreplicating cells occur. (D) Overlay of the 
cell cycle distributions of control, Amp dsRNA and Skp2 dsRNA cells. Histograms are normalized to the G2-peak. (E) Comparison 
of forward scatter (FSC) between Schneider cells, Amp dsRNA and Skp2 dsRNA treatment as a parameter of cell size. Skp2 dsRNA 
leads to bigger cells in comparison. Histograms are normalized. All depicted graphs are representative. 
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5.2. Skp2 overexpression or knockdown does not lead to indirect changes of protein 
stability 
Overexpression or knockdown of proteins can lead to tremendous changes in a cell. Not all of these 
changes have to be a direct effect mediated by enhanced or diminished protein activity. Instead, some of 
them could be side effects by flooding the cell with a protein or depleting it. Overexpression and 
knockdown studies – used extensively in this thesis – should therefore always consider and monitor these 
indirect effects. 
Overexpression of Skp2, or any other F-Box protein, might be problematic if abundance of the SkpA-Cul1-
Rbx1 complex (SC-complex) is a rate-limiting factor. In this case, overexpression of Skp2 will lead to a 
pronounced formation of the SCFSkp2 complex, other F-Box proteins will be pushed aside from SkpA-Cul1-
Rbx1 and their substrates will no longer be ubiquitinated. Knockdown of Skp2 on the other side will lead 
to a greater amount of free SC-complex that is ready to receive other F-Box proteins. An enhanced 
ubiquitination of the substrates of these F-Box proteins is the result. These indirect effects may result in 
wrong conclusions of cell cycle effects and substrates of Skp2. 
An assay was developed to sort out if modulation of Skp2 levels has any unwanted indirect effects. 
Determination of GFP stability by flow cytometry and targeted degradation of GFP by slmb-vhhGFP4 was 
combined for this assay. Slmb-vhhGFP4 is a fusion construct consisting of the F-Box domain of the Slmb F-
Box protein and the sequence of the vhhGFP4 nanobody. Nanobodies are antibodies consisting only of a 
monomeric heavy chain. Vhh is a nanobody derived from camels (Arbabi Ghahroudi et al., 1997) and 
vhhGFP4 is specifically directed against GFP. Therefore, slmb-vhhGFP4 is specifically developed for 
ubiquitination and consequent degradation of GFP-fusion proteins (Caussinus et al., 2011). This system 
was used in this thesis to mimic the degradation of a substrate by means of ubiquitination through an F-
Box protein. Simultaneous overexpression, respectively knockdown of Skp2 can elucidate indirect effects, 
since Skp2 is not targeting GFP. 
Figure 18A shows the principle of this assay. Slmb-vhh and GFP will be overexpressed in Schneider cells. If 
enough free SkpA-Cul1-Rbx1 complex will be present, SCFslmb-vhh will be formed and ubiquitinate GFP 
resulting in GFP degradation (Figure 18A, middle). Depletion of Skp2 could lead to a greater amount of 
free SC-complex that could be inhabitated by slmb-vhh. As a result, GFP would be more unstable (Figure 
18A, left side). Skp2 overexpression on the other hand could lead to more competition for the SC-complex 
in this case. Less SCFslmb-vhh is built and hence, GFP gets stabilized (Figure 18A, right side). If Skp2 and slmb-
vhh are not competing for the SkpA-Cul1-Rbx1 complex, a change in Skp2 levels should not result in varying 
GFP stability. 
GFP protein stability was measured by flow cytometric analysis. Since the protein of interest was GFP, the 
ratio between GFP fluorescence and mCherry fluorescence was calculated. This ratio served as the stability 
index. Since the data was normalized, a stability index lower than 1 is synonymous to protein 
destabilization and an index higher than 1 means stabilization. Statistical analysis revealed, if changes of 
the stability index upon the various treatments were significant. Analysis was performed on all transfected 
cells. For detailed information, see 4.2.6.5. 
A control experiment showed that neither Skp2 overexpression nor knockdown did have any significant 
effect on GFP stability (Figure 18B, left, Mann-Whitney U-Test, p > 0.05). Hygro knockdown served as a 
control for the knockdown experiment and did likewise not have any statistically significant effect (Mann-
Whitney U-Test, p > 0.05).  
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Figure 18 Test of indirect effects of Skp2 overexpression or knockdown 
Principle and result of the assay for direct or indirect effects of changing Skp2 levels. (A) Principle of the assay. Slmb-vhh degrades 
GFP. If slmb-vhh competes with Skp2 for binding to the SkpA-Cul1-Rbx1 complex (SC-complex), Skp2 depletion should lead to 
stronger GFP degradation (left). Likewise, Skp2 overexpression, re-enacting the massive overexpression of two F-Box proteins, 
could lead to displacement of slmb-vhh and GFP stabilization (right). (B) Left: Skp2 overexpression (OE), Skp2 knockdown and 
Hygro knockdown alone does not have a significant effect on GFP-stability. Right: GFP is degraded upon overexpression of slmb 
vhh. Overexpression of two F-Box proteins (slmb-vhh and Skp2) leads to GFP stabilization. Skp2 knockdown and Hygro knockdown 
does not alter the ability of slmb-vhh to degrade GFP. n.s. = p > 0.05, * = p < 0.05, ** = p < 0.01, Mann-Whitney U-Test. 
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Degradation of GFP by slmb-vhh in this setup was significant, underlining that the assay was functional 
(Figure 18B, right, Mann-Whitney U-Test, p < 0.01). Indeed, this test showed that substrates are degraded 
by overexpression of an F-Box protein. For the remaining assays, all data was normalized to GFP stability 
with slmb-vhh already overexpressed. Combined overexpression of slmb-vhh and Skp2 did indeed increase 
GFP stability significantly (Figure 18B, right, Mann-Whitney U-Test, p < 0.05). Contrary, Skp2 knockdown 
and Hygro knockdown did not have an effect of the GFP stability (Mann-Whitney U-Test, p > 0.05, for more 
detailed information about the display of the data, see 4.2.6.5). 
According to these findings, any effect seen in Skp2 overexpression or knockdown studies were direct and 
not caused by competition of Skp2 and other F-Box proteins for the SkpA-Cul1-Rbx1 complex, excluding 
this source for misinterpretation. Competition between F-Box proteins can occur, but according to the 
results only under extreme conditions when two F-Box proteins were overexpressed under strong 
promotors. This effect was probably not occurring in the experiments presented in the rest of this thesis. 
5.3. Dacapo is not destabilized by SCFSkp2 activity 
5.3.1. Overview 
Skp2 targets p21, p27 and p57 for degradation in mammalians (Heo et al., 2016). Though it seems only 
logical that this would also be the case in D. melanogaster, the literature is not clear in this respect. While 
at first it was found that the fly homologue Dacapo (Dap) is not a substrate of SCFSkp2 (Ghorbani et al., 
2011), a later analysis indeed did reveal the ability of SCFSkp2 to mark Dap for degradation (Dui et al., 2013). 
The results of this publication are questionable however and could be explained by side effects of the used 
assays and not directly by Skp2. Therefore, the influence of SCFSkp2 on Dap is still not well resolved. 
To illuminate the answer to this question, Dacapo stability was assayed by flow cytometric analysis. In 
contrast to the former publications, not only wild type Dacapo was used but in addition versions that did 
no longer have the ability to alter the cell cycle, thereby excluding any effect on stability that purely 
resulted by shifts into certain cell cycle phases. Furthermore, the alternative degradation pathway in 
S-Phase via CRL4Cdt2 was also shut off. Co-immunoprecipitation studies were also performed to analyze 
biochemical interaction between Skp2 and Dap. Finally, rescue experiments were undertaken to analyze 
changes in the Dap overexpression phenotype if Skp2 was overexpressed.  
5.3.2. Cell cycle effects of different Dacapo mutants 
The cell cycle effects of the different Dacapo versions used in this thesis will be shown first. These versions 
were created and characterized by former group members. Cell cycle effects of mCHE-tagged Dap versions 
are shown that are representative of the effects of all tested Dap versions regardless of their respective 
tag. 
Overexpression of Dap full length in a T2A vector led to a G1 shift of the cell cycle in comparison to the 
control T2A construct (Figure 19, compare A and B, C is an overlay of both), which was also seen by other 
researchers (Frank, 2013; Swanson et al., 2015). Dap dCDI (Figure 19E) contained deletions that prevented 
the interaction with CycE/Cdk2, resulting in an unaltered cell cycle in comparison to the control (compare 
D and E, F is an overlay of both). Dap dCDI dPIPa (Figure 19H) further contained a deletion in the PIP-Box 
region, preventing it from degradation by CRL4Cdt2. This Dap version also did not have any influence on the 
cell cycle (compare G and H, I is an overlay of both). All shown cell cycle distributions are representative 
for all experiments. Overlaid distributions are normalized to the G1-peak. 
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Figure 19 Cell cycle effects of different Dacapo versions 
Cell cycle distributions of cells transfected with different Dacapo versions. GFP serves as the transfection control, only GFP cells 
are shown. (A,D,G) Cell cycle distribution of the control T2A construct. (B) Overexpression of Dap leads to more cells in G1-Phase. 
(C) Overlay of A and B. (E) Dap dCDI does not have any visible effect on the cell cycle. (F) Overlay of D and E. (H) Dap dCDI dPIPa 
overexpression also has no visible effect. (I) Overlay of G and H. For all overlays, histograms are normalized to the G1-peak. All 
depicted cell cycle distributions are representative. 
 
5.3.3. Dacapo stability remains constant with changing Skp2 levels 
Flow cytometric stability analysis for Dap was performed with overexpression of different Skp2 versions. 
Stability was analyzed for all transfected cells, regardless of their cell cycle stage, and for the three distinct 
cell cycle phases (G1, S and G2), determined by Hoechst staining. Since results became unreliable if the 
T2A system is expressed either too weak or too strong, only cells with a medium expression level range 
were analyzed that were determined by the fluorescent level of the reference protein (in this case the 
range of the logarithmic GFP fluorescence values between 2.00 and 2.75, see 4.2.6.5 for more details). All 
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stability data was normalized to the stability of the tested Dacapo constructs. Influence of the 
overexpressed components on GFP and mCherry was checked in all cases; it was found that no 
overexpression changed the mCherry stability (data not shown) except for the Cks85A overexpression 
(Figure 20C). 
In the beginning, the influence of Skp2 overexpression on Dap full length stability was investigated. 
Surprisingly, Skp2 overexpression did lead in all cases to a slight stabilization of the Dacapo protein. 
Destabilization of Dap was not observed by Skp2 overexpression. Yet, it has to be said that these changes 
were not significantly different (Figure 20A, one sample t-test, p > 0.05), with the notable exception of the 
G2-Phase. In this case, the stabilization of Dap was significant (one sample t-test, p < 0.05). 
It is well known that substrates of Skp2, for example the Dap homologue p27, need to be phosphorylated 
to be recognized (Montagnoli et al., 1999). Overexpressing Dacapo does not automatically ensure that it 
is phosphorylated in the cell and thereby marked for Skp2 binding. Since phosphorylation may be a critical 
factor, it was also incorporated in the assay. For this reason, CycE overexpression was also applied. An 
excess amount of CycE leads to an increased formation of the CycE/Cdk2 complex, since the amount of 
Cdk2 is higher than CycE, resulting in a portion of unbound, inactive Cdk2 molecules (Arooz et al., 2000). 
CycE overexpression results in binding of this inactive Cdk2 population and enhanced activity. This can be 
seen by the marked change in the cell cycle profile. The increased CycE/Cdk2 activity, in analogy to the 
human system, should result in intensified phosphorylation of Dap as well (de Nooij et al., 2000; 
de Nooij et al., 1996). 
CycE overexpression, and subsequent Dap phosphorylation, did lead to higher stability of Dap. Yet, all 
these changes were statistically not significant. Therefore, CycE alone was not influencing Dap stability to 
a great extent (Figure 20A, one sample t-test, p > 0.05).  
Combined overexpression of Skp2 and CycE should lead to a degradation of Dap. Indeed, it can be observed 
that Dap stability was diminished in this case. Yet, all changes were again not significant and an effect of 
Skp2 on Dap stability could not be seen (one sample t-test, p > 0.05). 
Biochemical interaction between Skp2 and Dap was already shown by Co-IP studies and published (Dui et 
al., 2013). In this case, Skp2 4xFLAG was used; it may well be that an N-terminal FLAG tag is preventing 
interaction between Skp2 and Dap. Therefore, the experiment was repeated with Skp2 4xFLAG 
overexpression.  
Overexpression of Skp2 4xFLAG had a slightly different effect in comparison to the N-terminal tag. The 
modest, non-significant stabilization seen before vanished and Dap stability was indifferent in comparison 
to Dacapo alone. As before, no significant difference could be observed (Figure 20B, one sample t-test, 
p > 0.05). Again, Dap stability was analyzed with CycE overexpression alone. In this case, Dap was actually 
significantly stabilized for all cells (one sample t-test, p < 0.05). Broken down into the distinct cell cycle 
phases, no significant difference could be observed. Just like above, combined overexpression of Skp2 
4xFLAG and CycE did not show any significant change in Dap overexpression (one sample t-test, p > 0.05).  
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Figure 20 Dacapo stability upon overexpression of different Skp2 versions plus CycE and Cks85A 
Results of the Dacapo protein stability analysis with flow cytometry. (A) Dap stability is not significantly altered by overexpression 
of 4xFLAG Skp2 or/and CycE. Only Skp2 overexpression leads to stabilization in G2-Phase. (B) Dap stability is not significantly 
influenced by Skp2 4xFLAG or/and CycE, with the exception of CycE overexpression in all cells where it is stabilized. (C) 
Overexpression of Cks85A and 4xFLAG Skp2 does result in stabilization of mCherry in all and G1 cells. (D) Dap stability is not 
significantly influenced by overexpression of 4xFLAG Skp2, CycE or/and Cks85A. n.s. = p > 0.05, * = p < 0.05, one-sample t-test. 
Only significant changes are indicated. 
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Another factor that may influence Skp2 substrate binding is the availability of Cks85A. Cks85A supports 
Skp2 by binding its substrates, indeed the homologue Cks1 is necessary for Skp2 mediated degradation of 
p27 (Ganoth et al., 2001; Spruck et al., 2001). This is in concordance with the fact that Skp2 precipitates 
Dap more efficiently with a simultaneous overexpression of Cks85A (Dui et al., 2013). Cks85A may 
therefore be a limiting factor and overexpression may influence Dap stability in combination with Skp2 
and CycE. 
Surprisingly, Cks85A overexpression did significantly alter the stability of mCherry in all and G1 if combined 
with Skp2 overexpression (Figure 20C, one sample t-test, p < 0.05). This was not observed in the other 
experiments with Dap full length.  
Overexpression of Cks85A did not have a significant effect on Dap stability (Figure 20D, one sample t-test, 
p > 0.05). Moreover, even simultaneous overexpression of Skp2, CycE or both combined did not lead to 
any significant change in protein stability (one sample t-test, p > 0.05). Importantly, all observed 
tendencies were hinting to a stabilization of Dap by overexpression of the various components. Instability 
was never observed. 
Additionally, the effect of Skp2 dF-Box was also tested. A missing F-Box should have prevented Skp2 from 
binding to the SkpA-Cul1-Rbx1 complex. Yet, this construct still had the capability to bind its substrates, 
since the leucine rich repeats, responsible for substrate binding, were not touched by this deletion. 
Substrate binding to the dF-Box version should therefore lead to protection, since intact F-Box proteins 
could no longer bind them. A dominant negative effect should be visible. However, neither Skp2 nor Skp2 
dF-Box overexpression led to a significant change in Dap stability (Figure 21, one sample t-test, p > 0.05).  
 
Figure 21 Dacapo stability upon overexpression of Skp2 dF-Box 
Results of the flow cytometric analysis of Dap protein stability. Stability is not significantly influenced by either overexpression of 
Skp2 or Skp2 dF-Box. n.s. = p > 0.05, one-sample t-test.  
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In conclusion, Dacapo full-length stability was for the most part not affected by different overexpression 
treatments. Furthermore, any significant effects seen showed stabilization of Dap, destabilization was 
never seen on a statistically significant level. Dap stability seemed to be indifferent concerning Skp2 
overexpression. 
It was also analyzed what happened to Dacapo full-length if Skp2 was downregulated by hairpin 
constructs. A Skp2 hairpin construct was used for the knockdown. The Hygro hairpin construct served as 
the control. Neither Skp2 hairpin nor Hygro hairpin had a significant effect on GFP and mCherry alone (data 
not shown). In case of this experiment, the difference between Dap stability with Skp2 knockdown and 
the control Hygro knockdown was analyzed. 
 
Figure 22 Dacapo stability upon Skp2 knockdown 
Dacapo full length protein stability measured by flow cytometry under Skp2 knockdown conditions. Skp2 knockdown does lead 
to Dap stabilization in S-Phase cells in comparison to Hygro control knockdown. In all other cases, Skp2 knockdown does not have 
an effect. * = p < 0.05, t-test for equal variances. Only significant changes are indicated. 
 
Skp2 knockdown did not significantly change the stability of Dap in comparison to the control Hygro 
knockdown in all, G1 or G2 cells (Figure 22, t-test for equal variances, p > 0.05). The knockdown led to 
significant stabilization in S-Phase, however (t-test for equal variances, p < 0.05). 
So far, Dacapo did not seem to be prominently influenced by changing Skp2 levels. This held true even if 
Skp2 substrate recognition was enhanced in theory by CycE and Cks85A overexpression. According to 
these assays, full length Dacapo was not a substrate for SCFSkp2, yet it has to be said that this Dap version 
still contained another mechanism for degradation by a PIP-degron and led also to a shift in the cell cycle 
when overexpressed, which may have obscured any Skp2 related effects. 
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5.3.4. Dap is not regulated by Skp2, regardless of its impact on the cell cycle 
Though Dacapo seemed to be not influenced by Skp2 overexpression (even combined with CycE and 
Cks85A overexpression) or knockdown, one has to consider the cell cycle effects of this protein. As already 
demonstrated Dap full-length overexpression did lead to a stop in G1-Phase (Figure 19B). This was 
disadvantageous for experiments, since the cell cycle was deeply disturbed in this case. Indirect effects 
may lead to wrong interpretation of results and furthermore, Skp2 dependent degradation may well be 
hindered in this case. Therefore, Dap dCDI stability was analyzed. Dap dCDI contained deletions, primarily 
in the CDI domain, that made the binding to CycE/Cdk2 impossible. Though still degraded like wild type 
Dap, this construct did have no longer an effect on the cell cycle (Figure 19D,E). 
Dap dCDI was significantly stabilized upon 4xFLAG Skp2 overexpression in all, G1- and S-Phase cells (Figure 
23A, one sample t-test, p < 0.05). There seemed to be no effect in G2-Phase (one sample t-test, p > 0.05). 
Likewise, CycE overexpression did lead to a significant decrease in protein stability (one sample t-test, p < 
0.05 or p < 0.01) with the exception of the G2-Phase (one sample t-test, p > 0.05). Combined 
overexpression of both, 4xFLAG Skp2 and CycE, resulted in Dacapo protein stability that was not 
significantly changed (one sample t-test, p > 0.05), excepting G2-Phase where it was significantly stabilized 
(one sample t-test, p < 0.05). 
Similar effects could also be observed when Skp2 4xFLAG was used. Overexpression of Skp2 4xFLAG led to 
a significant stabilization of the Dap dCDI protein in the four analyzed cell cycle states (Figure 23B, one 
sample t-test, p < 0.001 or p < 0.05). CycE overexpression (a direct reproduction of the experiments in 
Figure 23A) showed a similar result, a significant destabilization of Dap dCDI in all and G1 (one sample t-
test, p < 0.05), however, unlike in the first experiment, CycE was not influencing protein stability in S-Phase 
(one sample t-test, p > 0.05). Combined overexpression did only have a stabilizing effect in G2-Phase (one 
sample t-test, p < 0.05) in concordance with the previous result. 
The effect of Cks85A overexpression was also measured. Cks85A led to a significant stabilization of Dap 
dCDI in S- and G2-Phase (Figure 23C, one sample t-test, p < 0.05), stability in all and G1 cells remained 
unaffected (one sample t-test, p > 0.05). Simultaneous overexpression of Skp2 did lead to more stable Dap 
dCDI in all, S and G2 cells but not in S-Phase. However, note that this experiment was only performed once, 
results are not reliable and statistical analysis could not be performed therefore. Cks85A and CycE 
overexpression did lead to a change in stability: while it got unstable in all and G1 cells (one sample t-test, 
p < 0.05 or p < 0.01), it did show no effect in S-Phase cells (one sample t-test, p > 0.05) and even 
stabilization in G2-Phase (one sample t-test, p < 0.05). Overexpression of all three components did not 
affect Dap dCDI stability in all and G1 cells (one sample t-test, p > 0.05), yet it led to stabilization in S- and 
G2-Phase (one sample t-test, p < 0.01 or p < 0.05). 
Dap dCDI stability was also tested with Skp2 dF-Box overexpression. In this set of experiments, Skp2 
overexpression showed the same stabilizing effect as already observed in Figure 23A. In this case, though 
Dap dCDI was stabilized even in G2 (Figure 23D, one sample t-test, p < 0.01 or p < 0.05). Skp2 dF-Box did 
also lead to protein stabilization (one sample t-test, p < 0.01, p < 0.001 or p < 0.05), with the exception of 
G1-Phase were stability remained indifferent (one sample t-test, p > 0.05). 
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Figure 23 Dacapo dCDI stability upon overexpression of different Skp2 versions plus CycE and Cks85A 
Results of the Dacapo dCDI protein stability analysis with flow cytometry. (A) Dap dCDI stability is significantly stabilized by 4xFLAG 
Skp2 and destabilized by CycE overexpression in all, G1- and S-cells. Combined overexpression leads to stabilization only in G2. (B) 
Overexpression of Skp2 4xFLAG and CycE does lead to similar results as in A. (C) Overexpression of 4xFLAG Skp2, CycE and Cks85A 
does lead to Dap dCDI stabilization in S and G2. (D) Overexpression of either Skp2 dF-Box or 4xFLAG Skp2 does lead to stabilization 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001, one-sample t-test. Only significant changes are indicated. 
 
Just like before, knockdown studies were also performed. Dap dCDI showed no reaction to the Skp2 
knockdown in comparison to the control knockdown (Figure 24, t-test for equal variances, p > 0.05).  
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To conclude this section, Dap dCDI showed significant changes of stability by overexpression of Skp2, CycE 
and Cks85A. It was degraded by CycE overexpression; yet, it was never observed that Dap dCDI was 
degraded by Skp2 overexpression. Indeed, the opposite was true: Skp2 overexpression seemed to stabilize 
this mutant. This effect was also observed by Skp2 dF-Box overexpression. Dap dCDI showed also no effect 
upon Skp2 knockdown.  
Using Dap dCDI eliminated any influences of cell cycle changes that are inevitable by performing 
overexpressions with Dap full length. Yet this Dap version is still degraded efficiently by another E3 
ubiquitin ligase (CRL4Cdt2) in S-Phase by its PIP-degron motif (Swanson et al., 2015). This PIP dependent 
degradation pathway may have disguised any effects that Skp2 may had on Dap, especially if the Skp2 
mediated degradation was not the main way of Dacapo degradation. 
 
Figure 24 Stability of Dap dCDI upon Skp2 knockdown 
Flow cytometric analysis of Dap dCDI stability with Skp2 downregulation. In comparison to Hygro hairpin, Skp2 hairpin does not 
influence Dap dCDI stability. n.s. = p > 0.05, t-test for equal variances. 
 
5.3.5. Dap is not regulated by Skp2, even if the PIP mediated degradation pathway 
is eliminated 
Since Dap dCDI is still degraded by CRL4Cdt2 via the PIP-degron in S-Phase and since this is probably the 
principal way of its degradation, any effects that Skp2 may have are probably hard to detect. To overcome 
this issue, Dap dCDI dPIPa was used. This Dap version still lacked the ability to interact with CycE/Cdk2 and 
did not influence the cell cycle (Figure 19 compare E and F). Furthermore, the N-terminal part of the PIP-
Box was deleted, resulting in a construct that was no longer degraded in S-Phase. Importantly though, 
earlier results in the lab showed it is still unstable in G1, a potential Skp2 degradation may still be in place 
(Christina Grasmüller, 6-week internship). 
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Dap dCDI dPIPa was significantly stabilized by 4xFLAG Skp2 overexpression (Figure 25A, one sample t-test, 
p < 0.05) with the exception of G2-Phase, where levels stayed normal (one sample t-test, p > 0.05). CycE 
overexpression did not change Dap dCDI dPIPa stability in a significant way (one sample t-test, p > 0.05). 
Overexpression of both components led to a significant stabilization in all, S and G2 cells (one sample t-
test, p < 0.05) but not in G1-Phase (one sample t-test, p > 0.05). 
Using Skp2 4xFLAG led to similar results. Dap dCDI dPIPa stability was significantly stabilized in all and G1 
cells (Figure 25B, one sample t-test, p < 0.05 or p < 0.01), but not in S and G2 cells (one sample t-test, p > 
0.05). CycE overexpression did not significantly change the stability (one sample t-test, p > 0.05) in 
concordance with the results obtained from 4xFLAG Skp2. Combined overexpression stabilized Dap dCDI 
dPIPa in S and G2 cells (one sample t-test, p < 0.05), but not in all and G1 cells (one sample t-test, p > 0.05). 
 
Figure 25 Dap dCDI dPIPa stability upon overexpression of 4xFLAG Skp2, Skp2 4xFLAG and CycE 
Flow cytometric protein stability data of Dap dCDI dPIPa. (A) 4xFLAG Skp2 and 4xFLAG Skp2 plus CycE overexpression stabilizes 
Dap dCDI dPIPa, CycE overexpression has no effect. (B) Skp2 4xFLAG also has a stabilizing effect on Dap dCDI dPIPa in all and G1 
cells, CycE does also have no effect and the combined overexpression leads to stabilization in S and G2. * = p < 0.05, ** = p < 0.01, 
one sample t-test. Only significant changes are indicated. 
 
Dap dCDI dPIPa stability was also measured under Skp2 knockdown conditions. Skp2 knockdown led to a 
significant stabilization in comparison to the control knockdown with Hygro Hairpin in all and G1 cells 
(Figure 26, t-test for equal variances, p < 0.05). 
Dap dCDI dPIPa neither did influence the cell cycle, nor did CRL4Cdt2 mark it for degradation in S-Phase. 
Since any disturbing effects were shut down in this construct, possible degradation effects by Skp2 should 
have been easily visible. Yet, even in this case, Dacapo was not degraded by Skp2 overexpression. Instead, 
just as before, the only effect that Skp2 overexpression had was a stabilizing one. Skp2 knockdown on the 
other hand did lead to a stabilization of Dap dCDI dPIPa. 
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Figure 26 Stability of Dap dCDI dPIPa upon Skp2 knockdown 
Measurement of Dap dCDI dPIPa stability with flow cytometry under Skp2 knockdown conditions. Skp2 knockdown significantly 
stabilizes Dap dCDI dPIPa in all and G1 cells in comparison to the control knockdown. * = p < 0.05, t-test for equal variances. Only 
significant changes are indicated. 
 
5.3.6. Tests for biochemical interaction between Dacapo and Skp2 are ambiguous 
According to the flow cytometric data, Skp2 was not responsible for Dacapo degradation. However, 
biochemical interaction between Skp2 and Dap has been reported previously (Dui et al., 2013). 
Biochemical interaction was therefore also analyzed. This was performed by co-immunoprecipitations. 
Tagged versions of both proteins were overexpressed in S2R+-cells. After 48 hours incubation, cells were 
lysed and one of the two proteins was precipitated with antibodies and agarose beads. Western Blot 
analysis showed if the precipitation was successful and if the other protein was co-immunoprecipitated.  
Dui et al. (2013) showed that Skp2 FLAG interacted with 4xMyc Dap. This interaction is boosted if Cks85A 
is also overexpressed. It was tried to reproduce this result using differently tagged Skp2 constructs and 
HA-tagged Dap. Different combinations of tags, constructs and pull downs were tested. Figure 27 shows 
the used constructs. Full length Dacapo was either tagged with 4xFLAG or HA, Dap dCDI was tagged with 
4xFLAG. Myc Dacapo, used in Dui et al, 2013, could not be used, since Myc antibody was not present in 
the lab. Skp2 was tagged either N-terminally with HA or 3xHA, or C-terminally with 4xFLAG. Cks85A was 
always used untagged. In all experiments, positive controls were always performed, but are not shown 
here for reasons of clarity. 
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Figure 27 Different constructs used for Co-IP studies 
Skp2, Dap and Cks85A constructs with various different immunotags used for Co-IP interaction studies. 
 
In the beginning, it was tried to reproduce the experiment of Dui et al. (2013). Skp2 4xFLAG was pulled 
down by a FLAG antibody and HA Dap was detected by an HA antibody. Cks85A was also overexpressed 
for reproduction of the boosting effect. Skp2 4xFLAG was expressed and precipitation worked well (Figure 
28, left side). Dacapo was also expressed, yet the detected amounts were low. The co-precipitation 
showed a smear of bands, especially in the negative control, where only HA-Dap was overexpressed. 
Luckily, though, it could be observed that HA-Dap was not binding unspecifically to the beads. Nonetheless, 
HA-Dap bands could not be detected when Skp2 4xFLAG was overexpressed. This was also not changed by 
overexpression of Cks85A that should actually boost the interaction between Skp2 and Dap (Figure 28, 
right side). According to this experiment, Skp2 and Dap did not interact with each other. 
Since it was not possible to reproduce the biochemical interaction of Skp2 and Dap in this way, the 
experiment was modified. This time, the tags were switched, Skp2 was N-terminally tagged with 3xHA 
(3xHA Skp2) and the 4xFLAG tag was used on Dap (4xFLAG Dap). Since the FLAG antibody is stronger, the 
advantage was an enhanced signal intensity for the target protein. Furthermore, the HA-tag on Dap could 
prevent the interaction with Skp2. In this case, precipitation of Skp2 was performed with HA antibody. 
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Figure 28 Co-IP between Skp2 4xFLAG and HA Dap 
Co-Immunoprecipitation of Skp2 4xFLAG and HA Dacapo for testing of biochemical interaction. FLAG antibody was used for 
precipitation, FLAG or HA antibody for detection. Left: FLAG Blot for control of expression and precipitation of Skp2 4xFLAG. Right: 
HA Blot for expression and interaction test of HA Dap. Cks85A overexpression should strengthen the interaction. No biochemical 
interaction is detectable. 
 
3xHA Skp2 was well expressed and precipitated (Figure 29, left). 4xFLAG Dacapo was also expressed well, 
in this case though, unspecific binding occurred in the negative control (Figure 29, right, first lane of the 
IP). Co-immunoprecipitation of 4xFLAG Dap with 3xHA Skp2 did not result in a band that was stronger than 
the background level, excluding interaction. Simultaneous overexpression of Cks85A did also not show a 
change in band intensity (Figure 29, right). Therefore, Skp2 and Dap were not interacting with each other, 
even with changed immuno-tags. 
Finally, a different setup was tried. Instead of Skp2, Dap was precipitated and Skp2 was used as the target 
protein. Furthermore, besides full length Dacapo, Dap dCDI was also used. The Dap G1 stop may influence 
potential binding to Skp2, a factor that was turned off with Dap dCDI. Besides, Dap dCDI allowed to draw 
a conclusion if the potential interaction with Skp2 was direct or indirect (see 6.3). 
4xFLAG Dap or 4xFLAG Dap dCDI was overexpressed together with HA Skp2. Precipitation was performed 
with FLAG-antibody. Expression of both Dap versions was relatively low. Yet, precipitation worked well 
(Figure 30, left). Skp2 expression was moderate and unfortunately HA Skp2 also bound unspecifically to 
the Protein G beads. However, the band intensity was stronger when Dap or Dap dCDI was also expressed 
(Figure 30, right), indicating biochemical interaction. 
Together, these results indicated that Skp2 and Dap might have interacted with each other, but such an 
interaction was only seen in one experiment. In all other experiments, using differently tagged versions, 
no specific interaction was detected. Importantly, all tagged versions of Skp2 and Dap showed biological 
activity (data not shown). Overall, a specific interaction between Dap and Skp2 remained questionable. 
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Figure 29 Co-IP between 3xHA Skp2 and 4xFLAG Dap 
Co-Immunoprecipitation of 3xHA Skp2 and 4xFLAG Dacapo. HA antibody was used for precipitation, HA or FLAG antibody for 
detection. Left: HA Blot for control of expression and precipitation of 3xHA Skp2. Right: FLAG Blot for expression and interaction 
test of 4xFLAG Dap. 4xFLAG Dap shows unspecific binding to the Protein G beads. Cks85A overexpression should strengthen the 
interaction. No biochemical interaction is detectable. 
 
 
Figure 30 Co-IP between 4xFLAG Dap or 4xFLAG Dap dCDI and HA Skp2 
Co-Immunoprecipitation of 4xFLAG Dap or 4xFLAG Dap dCDI and HA Skp2. FLAG antibody was used for precipitation, FLAG or HA 
antibody for detection. Left: FLAG Blot for control of expression and precipitation of both Dap constructs. Right: HA Blot for 
expression and interaction test of HA Skp2. HA Skp2 shows unspecific binding to the Protein G beads. Skp2 bands are stronger 
with simultaneous Dap or Dap dCDI overexpression, indicating biochemical interaction between Dap or Dap dCDI and Skp2. 
 
5.3.7. Skp2 overexpression does not rescue, but enhance the Dap G1-stop 
Besides flow cytometric protein stability determination and tests for biochemical interaction, it was also 
analyzed if Skp2 overexpression did influence the Dap phenotype in cells. Dacapo overexpression, under 
a strong promotor, did lead to a stop in G1-Phase (Figure 19B,C). Likewise, Skp2 overexpression resulted 
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in a slight shift to G1-Phase (Figure 11B,E). It was analyzed what effect both overexpressions had on the 
cell cycle. If Skp2 would play a role in the degradation of Dap, its overexpression should have resulted in 
reduced Dap levels and would thereby have diminished the G1-arrest phenotype caused by the 
overexpression of Dap. 
Strong overexpression of Dacapo results in cells residing mostly in G1. Any effects that Skp2 may have, 
especially if they are not strong, may be masked by the Dap overexpression phenotype. Therefore, a 
situation was searched for, in which Dap levels are high enough to see a significant accumulation of cells 
in G1 without causing a complete G1-arrest. In order to achieve this situation, a GFP-tagged version of Dap 
was cloned into a vector with a shortened actin promoter, resulting in lower expression levels. 3xCherry 
served as the transfection control in this experiment, only cherry positive cells are shown.  
Figure 31A shows the characteristic cell cycle distribution of S2R+-cells. Overexpression of Skp2 led to the 
already described effect of a weak cell accumulation in G1 (Figure 31B). As planned, Dap expression under 
the control of the short actin promoter did lead to an accumulation into G1, but only weakly (Figure 31C). 
Most importantly, combined overexpression did lead to even more cells in G1, a result that is not 
consistent with Skp2 downregulating Dap protein levels (Figure 31D). Figure 31E shows all four cell cycle 
distributions overlaid and normalized to their respective G1-peaks for oversight.  
To conclude this chapter, Dacapo protein stability was not diminished upon Skp2 overexpression as 
measured by flow cytometric protein stability analysis. This held also true if components were 
overexpressed that should enhance the ability of Skp2 to recognize its substrate (CycE and Cks85A). 
Conversely, Skp2 seemed to have a stabilizing effect on the Dacapo protein in some cases. Skp2 dF-Box, a 
Skp2 version with a deleted F-Box, did also not exert a dominant-negative effect on Dap stability. 
Furthermore, usage of Skp2 knockdown did not alter Dap stability, with the exception of Dap dCDI dPIPa 
that was more stable in certain cell cycle phases if Skp2 was knocked down. Experiments were performed 
with different Dap versions that should diminish any disturbing effects of Dap (either cell cycle effects or 
alternate degradation pathways). Yet, overall the results stayed the same, regardless of the used Dap 
construct. Biochemical interaction was not easy to determine and a reproduction of the literature turned 
out impossible. Finally, Skp2 did not reduce an intermediate Dap overexpression phenotype in Schneider 
cells but actually enhanced it. 
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Figure 31 Skp2 does not rescue the Dap phenotype 
Cell cycle distributions of Skp2 and/or Dap overexpression. 3xChe serves as the transfection control, only Cherry cells are shown 
(A) Cell cycle profile of 3xCherry positive cells. (B) Skp2 overexpression leads to a shift in G1-Phase. (C) Dap overexpression leads 
to a shift in G1-Phase. This construct was specifically created to cause a weaker Dap phenotype. (D) Skp2 and Dap overexpression 
does not lead to a rescue but rather to a stronger G1-shift. (E) Overlay of all cell cycle distributions. Histograms are normalized to 
the G1-peak. All presented cell cycle distributions are representative. 
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5.4. Cdt1 stability is regulated by SCFSkp2 depending on its phosphorylation 
5.4.1. Overview 
The experiments so far have not provided a biologically relevant substrate of the SCFSkp2 ubiquitin ligase. 
The aim of this thesis was to understand the phenotype of Skp2 in Schneider cells and to identify relevant 
substrates of SCFSkp2. Cdt1 was one of the most promising candidates: it is a substrate of the human SCFSkp2 
complex (Heo et al., 2016) and its role in DNA replication seemed in agreement with the observed 
phenotypes of Skp2. 
Cdt1 has a homologue in D. melanogaster, the gene double parked or Dup. Dup is conserved in flies and 
fulfills the same molecular function in directing the MCM-complex to the origins of replications (Whittaker 
et al., 2000). Just like its human homologue, Dup has a Geminin-binding and an MCM-binding domain. 
Geminin binds and inhibits Dup, thereby regulating its function. The MCM-binding domain is responsible 
for transporting the MCM helicase to the origin of replications. Finally, Dup also possesses a PIP-degron 
that is responsible for degradation in S-Phase by CRL4Cdt2, just like Dacapo. Since Dup had extensive 
influence on the cell cycle and was degraded in S-Phase, a version was created that minimized the effects 
on the cell cycle and was not degraded by CRL4Cdt2. This was necessary to diminish the disturbances on the 
cycle by Dup overexpression and to concentrate only on the effects that Skp2 may had in degradation, an 
approach identical to the Dap experiments. 
To prevent confusion between Dup (double-parked) and Dap (Dacapo), from now on only Cdt1 will be used 
in the text for the Dup protein if not explicitly mentioned otherwise. 
Cdt1 protein stability was analyzed by flow cytometry in dependence of Skp2, Skp2 dF-Box and CycE 
overexpression or Skp2 knockdown respectively. This analysis indicated that Cdt1, if phosphorylated, was 
indeed a substrate of SCFSkp2. In a next step, it was tried to map the important phosphorylation sites 
responsible for Cdt1-Skp2 binding. This was done by truncation of the protein and site directed mutation 
of conserved phospho-sites. Furthermore, biochemical interaction between Skp2 and Cdt1 was analyzed 
by Co-IP studies and finally the phenotypic effects on the cell cycle of Cdt1 and Skp2 overexpression and 
knockdown was examined. 
5.4.2. Cell cycle effects of different Cdt1 versions 
Cdt1 overexpression had a strong effect on the cell cycle of Schneider cells. Overexpressing full length Cdt1 
led to overreplicating cells in comparison to the cell cycle of the control construct (Figure 32A and B, note 
the cell distribution after fluorescence unit 2024 on the x-axis). Interestingly, deletion of the N-terminal 
PIP-degron (created by truncating the first 15 amino acids) changed the phenotype. In this case, a G2-peak 
was no longer visible but only one single peak. The maximum of this peak was shifted to the right in 
comparison to the control, indicating an elevated number of S-Phase cells, therefore this population 
probably consisted of very late G1-/early S-Phase cells (Figure 32C). Figure 32D shows the overlay of all 
three cell cycle distributions, normalized to the G1-peak. 
Just like in the case of Dap, it was advantageous to work with a Cdt1 version with a diminished influence 
on the cell cycle. Otherwise, any seen effects might be the result of the abnormal cell cycle phases and not 
of Skp2. Therefore, the last 143 amino acids, comprising the MCM-binding domain, were deleted, resulting 
in the construct Cdt1 15-600. Since this construct was no longer able to recruit MCM to the ORCs, the 
phenotypic effect of the overexpression should be turned off. 
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Figure 32 Cell cycle effects of different Cdt1 versions 
Cell cycle distribution of cells transfected with different Cdt1 versions. GFP serves as the transfection control, only GFP positive 
cells are shown. (A,E) Cell cycle distribution of the control T2A construct. (B) Overexpression of Cdt1 full length leads to 
overreplicating cells. (C) Overexpression of Cdt1 15-763 (lacking the N-terminal PIP-degron) leads to accumulation of cells in very 
late G1-/S-Phase. (D) Overlay of cell cycle curves of control, Cdt1 full length and Cdt1 15-763 overexpression. (F) Overexpression 
of Cdt1 15-600 (lacking the C-terminal MCM-binding domain) leads to an accumulation of cells in G1. (G) Overlay of the cell cycle 
of control and Cdt1 15-600. Overlays are normalized to the G1-peak. All presented cell cycle distributions are representative. 
 
Cdt1 15-600 did not show the overreplication of cells compared to Cdt1 full length. However, 
overexpression of Cdt1 15-600 resulted in a slight accumulation of cells in G1 in comparison to the control 
(Figure 32E, F and G). Nonetheless, since the cell cycle effects were modest, this construct was the starting 
point of Cdt1 flow cytometric protein stability analysis. 
5.4.3. GFP Cdt1 1-600 is destabilized by Skp2 
In order to analyze if Skp2 destabilized Cdt1, the relative stability of GFP Cdt1 1-600 was analyzed by flow 
cytometry. This construct still contained the PIP-degron, in theory resulting typically in S-Phase 
degradation. This degradation pathway may have covered any effect that Skp2 may had on Cdt1 stability. 
However, since the PIP-degron is positioned right at the beginning of the N-terminus, any major N-terminal 
tag (in this case HA-NLS-GFP) is disturbing the function of the PIP-degron (Senga et al., 2006); S-Phase 
degradation was probably not working. 
The analysis of relative protein stability experiments was already described in the Dacapo section (see 
5.3.3). The four distinct conditions (all, G1-Phase, S-Phase, and G2-Phase) were again analyzed. Expression 
levels of the reference protein between logarithmic fluorescence units 2.00 – 2.75 were used. Data was 
normalized to the stability of Cdt1 1-600. Influence of the overexpressed components on GFP and mCherry 
was checked in all cases, yet no influence could be detected. 
GFP Cdt1 1-600 showed the same G1 shift of cells as mChe Cdt1 15-600 (Figure 33A,B,C). GFP Cdt1 1-600 
stability was reduced upon Skp2 overexpression in all, G1 and G2 cells (Figure 33D, one sample t-test, p < 
0.01), but not in S-Phase (one sample t-test, p > 0.05). However, the Cdt1 version seemed to be indifferent 
to CycE overexpression, protein stability remained stable in all cases (one sample t-test, p > 0.05). 
Combined overexpression of Skp2 and CycE did also lead to decreased protein stability of all and G1 cells 
(one sample t-test, p < 0.01); however, the effect was not increased in comparison to Skp2 overexpression 
alone. Furthermore, in this case Cdt1 instability was visible even in S cells (one sample t-test, p < 0.01). In 
G2 cells however, no significant effect was seen upon coexpression of Skp2 and CycE (one sample t-test, 
p > 0.05).  
It was also analyzed what effect a Skp2 knockdown on the GFP Cdt1 1-600 stability had. In comparison to 
the control knockdown with the Hygro Hairpin construct, the Skp2 Hairpin construct led to a statistically 
significant stabilization of Cdt1 in all, G1- and S-Phase cells (Figure 34, t-test for unequal variances, p < 0.01 
or p < 0.05) but not in G2 cells (t-test for unequal variances, p > 0.05). 
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Figure 33 Cell cycle effects and stability of GFP Cdt1 1-600 
Cell cycle distribution and stability data of GFP Cdt1 1-600. (A) Cell cycle of the control vector. (B) GFP Cdt1 1-600 shows cell 
accumulation in G1. (C) Overlay of control and GFP Cdt1 1-600 overexpression. Overlay is normalized to the G1-peak. In all cases, 
only mCherry positive cells are shown. All presented cell cycle distributions are representative. (D) Skp2 overexpression 
destabilizes Cdt1 1-600 in all, G1 and G2. CycE overexpression alone does not influence the stability. Combined overexpression 
leads to instability in all, G1 and S but not in G2. However, CycE does not enhance the Skp2 degradation in all and G1. 
** = p < 0.01, one sample t-test. Only significant changes are indicated. 
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Figure 34 GFP Cdt1 1-600 stability with Skp2 knockdown 
Protein stability analysis of GFP Cdt1 1-600 under Skp2 knockdown conditions. Skp2 knockdown significantly destabilizesGFP Cdt1 
1-600 in all, G1 and S if compared to the control knockdown. * = p < 0.05, ** = p < 0.01, t-test for unequal variances. Only significant 
changes are indicated. 
 
5.4.4. Che Cdt1 15-600 is destabilized by Skp2 in dependency of CycE dependent 
kinase activity 
The results of GFP Cdt1 1-600 indicated that it was indeed a substrate of SCFSkp2: Skp2 overexpression led 
to destabilization, Skp2 knockdown to stabilization. It has to be considered though that the GFP tag is not 
optimal for these analysis since the Hoechst signal, used for determination of the single cell cycle phases 
(see 4.2.6.5), partly emits light into the GFP fluorescence channel. This weakens the explanatory power of 
this assay. In addition, GPF Cdt1 1-600 still contained the PIP-sequences, even though the PIP degron was 
likely inactivated by the GFP fusion. To overcome these issues, Cdt1 was tagged N-terminally with mChe 
and the PIP degron sequence was deleted, resulting in the mCHE Cdt1 15-600 construct. 
All subsequent experiments were performed with N-terminally mChe tagged Cdt1 versions. Surprisingly, 
two effects emerged that complicated the analysis and interpretation of the data. First, in few cases, 
control experiments showed that the stability of the control proteins GFP and mChe alone were slightly 
influenced by overexpression of Skp2, Skp2 dF-Box and CycE. In these cases, the controls are also shown 
to document this effect (the same approach as in Figure 20B). Second and more surprising, it turned out 
that the observed effects varied in dependency of the expression level used for analysis. Routinely, all data 
was analyzed with two expression level ranges of the reference fluorescence protein, a higher range 
between 2.00 – 2.75 and a lower range between 1.25 – 2.00 logarithmic fluorescent units. In all previous 
shown data, the results between these two expression ranges were similar; however, the spread of the 
data was much lower in case of the higher level, which is the reason that exclusively this was shown. Since 
results differed strongly according to the expression level ranges in case of the mChe Cdt1 constructs, it 
was considered necessary to present the results of both expression levels. Hence, the subsequent figures 
show the protein stability of both levels as indicated. 
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First, the stability of mChe Cdt1 15-600 was analyzed upon Skp2 and Skp2 dF-Box overexpression. In case 
of the expression level 1.25 – 2.00, controls showed significant stabilization of mChe in G1- and S-Phase 
upon Skp2 dF-Box overexpression (Figure 35A, one-sample t-test, p < 0.05). Skp2 overexpression did lead 
to a significant destabilization of mChe Cdt1 15-600 in G1- and G2-Phase (Figure 35B, one-sample t-test, p 
< 0.01), but to stabilization in S (one-sample t-test, p < 0.05). Skp2 dF-Box led to stabilized Cdt1 in all and 
S-Phase cells (one-sample t-test, p < 0.01). 
 
Figure 35 mChe Cdt1 15-600 stability with overexpression of Skp2 and Skp2 dF-Box  
Flow cytometric protein stability analysis of mChe Cdt1 15-600 upon overexpression of Skp2 or Skp2 dF-Box. Expression level 1.25 
– 2.00: (A) Skp2 dF-Box stabilizes mChe in G1 and S. (B) mChe Cdt1 15-600 is destabilized by Skp2 in G1 and G2 and stabilized in 
S, Skp2 dF-Box stabilizes Cdt1 15-600 in all and S. Expression level 2.00 – 2.75: (C) Skp2 stabilizes mChe in G1. (D) mChe Cdt1 15-
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600 is destabilized in G1 upon Skp2 overexpression. Skp2 dF-Box leads to stabilization in all, S and G2 cells. * = p < 0.05, ** = p < 
0.01, *** = p < 0.001, one sample t-test. Only significant changes are indicated. 
 
The expression range 2.00 – 2.75 showed a significant stabilization of mChe protein upon Skp2 
overexpression in G1 (Figure 35C, one-sample t-test, p < 0.05). Under these conditions, Cdt1 15-600 
showed a significant destabilization only in G1-Phase if Skp2 was overexpressed (Figure 35D, one-sample 
t-test, p < 0.05). Skp2 dF-Box overexpression led to a stabilization in all, S and G2 cells (one-sample t-test, 
p < 0.01, p < 0.001 and p < 0.05).  
Next, the stability in dependency of CycE dependent kinase activity was tested by overexpressing CycE. All 
data was normalized to the stability of mChe Cdt1 15-600 plus CycE overexpression for experimental 
reasons. In this case, control fluorescent proteins were not influenced by any overexpressed components 
(data not shown). With the expression range of 1.25 – 2.00, Skp2 overexpression did lead to a statistically 
significant decline of mChe Cdt1 15-600 stability in all distinct cases (Figure 36, one-sample t-test, p < 
0.001). Expression of Skp2 dF-Box led conversely to a significant stabilization in all, G1 and S (one-sample 
t-test, p < 0.05), but not in G2 cells (one-sample t-test, p > 0.05). 
 
Figure 36 mChe Cdt1 15-600 stability upon overexpression of Skp2 or Skp2 dF-Box and CycE 
Flow cytometric protein stability analysis of mChe Cdt1 15-600 upon overexpression of Skp2 or Skp2 dF-Box with CycE. (A) 
Expression level 1.25 – 2.00. Skp2 destabilizes mChe Cdt1 15-600, Skp2 dF-Box stabilizes Cdt1, excluding G2-Phase. (B) Expression 
level 2.00 – 2.75. Skp2 destabilizes mChe Cdt1 15-600 in all and S cells, Skp2 dF-Box stabilizes Cdt1, excluding G2-Phase. 
* = p < 0.05, *** = p < 0.001, one sample t-test. Only significant changes are indicated. 
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Analysis with the expression level 2.00 – 2.75 showed destabilization of mChe Cdt1 15-600 in all and in S-
Phase under Skp2 overexpression (Figure 36B, one-sample t-test, p < 0.05 and p < 0.001). Just like before, 
Skp2 dF-Box stabilized mCdt1 15-600 in all, G1 and S (one-sample t-test, p < 0.001 and p < 0.05). CycE 
overexpression seemed to strengthen the effect that Skp2 had on Cdt1 15-600 stability. 
Finally, the effect of Skp2 knockdown on mChe Cdt1 15-600 stability was analyzed. Analysis of the lower 
expression range showed a statistically significant stabilization of mChe Cdt1 15-600 upon Skp2 
knockdown in comparison to the control (Figure 37A, t-test for unequal variances, p < 0.001). Likewise, if 
expression level 2.00 – 2.75 was analyzed, Skp2 hairpin showed stabilization of Cdt1 15-600 in all, S- and 
G2-Phase (Figure 37B, t-test for unequal variances, p < 0.01). 
 
Figure 37 mChe Cdt1 15-600 stability upon Skp2 knockdown 
Flow cytometric protein stability analysis of mChe Cdt1 15-600 upon Skp2 knockdown. (A) Analysis with expression level 1.25 – 
2.00. Skp2 knockdown stabilizes Cdt1 15-600 in comparison to the control. (B) Analysis with expression level 2.00 – 2.75. Skp2 
knockdown does also stabilize Cdt1 15-600 in this case. ** = p < 0.01, *** = p < 0.001, t-test for unequal variances. Only significant 
changes are indicated. 
 
As a conclusion, Cdt1 stability seemed to be dependent upon Skp2 levels. Skp2 overexpression destabilized 
Cdt1, Skp2 dF-Box expression stabilized and protected Cdt1 from instability, CycE overexpression 
enhanced these effects and a Skp2 knockdown did lead to protein stabilization, all in concordance with 
Skp2 marking Cdt1 for degradation. The fact that CycE was necessary for an enhanced destabilization 
effect indicated that phosphorylation was important for Skp2 mediated degradation. In the following 
sections, different Cdt1 truncations and mutations were tested with the aim to localize phosphorylation 
sites important for Skp2 recognition.  
5.4.5. Skp2 mediated Cdt1 degradation is independent of Geminin binding 
In a straightforward approach for the identification of the phospho-sites, truncations of Cdt1 were created 
to confine the important regions for degradation by Skp2. The first tested truncation was Cdt1 15-300, 
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which did not contain the Geminin binding site any longer. As a side effect, it was also possible to analyze 
if Geminin binding influenced the degradation with this construct. 
 
Figure 38 Cdt1 15-300 cell cycle effects and stability upon overexpression of Skp2 or Skp2 dF-Box 
Cell cycle distribution and stability data of mChe Cdt1 15-300. (A) Cell cycle of the control vector. (B) Cdt1 15-300 shows 
accumulation of cells in G1. (C) Overlay of control and Cdt1 15-300 overexpression. Overlay is normalized to the G1-peak. In all 
cases, only GFP positive cells are shown. All presented cell cycle distributions are representative. (D) Expression level 1.25 – 2.00. 
Skp2 destabilizes Cdt1 15-300 in G1 and G2. Skp2 dF-Box expression leads to stabilization in all and S-Phase cells. (E) Expression 
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level 2.00 – 2.75. Skp2 destabilizes Cdt1 15-300 in G1 and G2. Skp2 dF-Box expression leads to stabilization in S-Phase and 
destabilization in G2-Phase. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, one sample t-test. Only significant changes are indicated. 
 
mChe Cdt1 15-300 showed a similar cell cycle effect than Cdt1 15-600, a shift into the G1-Phase (Figure 
38A,B,C). By using expression level 1.25 – 2.00, Skp2 overexpression, destabilized Cdt1 15-300 only in G1 
and G2-Phase (Figure 38D, one-sample t-test, p < 0.001 and p < 0.01), but not in all and S-Phase cells (one-
sample t-test, p > 0.05). Skp2 dF-Box expression led to stabilization only in all and S-Phase cells (one-sample 
t-test, p < 0.05). Analysis of the higher range showed also a decrease in protein stability of Cdt1 15-300 in 
G1 and G2-Phase if Skp2 was overexpressed (Figure 38E, one-sample t-test, p < 0.05 and p < 0.01). 
Expression of Skp2 dF-Box on the other hand led to stabilization of Cdt1 15-300 in S-Phase (one-sample t-
test, p < 0.05) and destabilization in G2-Phase (one-sample t-test, p < 0.05). 
As it was the case with Cdt1 15-600, CycE overexpression did also strengthen the effects of Skp2 or Skp2 
dF-Box respectively. With expression level 1.25 – 2.00, Cdt1 15-300 stability was statistically significant 
decreased upon Skp2 overexpression in all four distinct cases if CycE was simultaneously overexpressed 
(Figure 39A, one-sample t-test, p < 0.01 and p < 0.05). Cdt1 was stabilized in all, G1 and S if Skp2 dF-Box 
was used (one-sample t-test, p < 0.01 and p < 0.05), but there was no change in G2-Phase (one-sample 
t-test, p > 0.05). Using the higher expression level for analysis, Skp2 overexpression did result in reduced 
Cdt1 15-300 stability only in all, S and G2 cells (Figure 39B, one-sample t-test, p < 0.05 and p < 0.01), but 
not in G1-Phase Phase (one-sample t-test, p > 0.05). Skp2 dF-Box expression led to stabilization in all, S 
and G2 (one-sample t-test, p < 0.01). 
 
Figure 39 Cdt1 15-300 stability upon overexpression of Skp2 or Skp2 dF-Box and CycE 
Protein stability of mChe Cdt1 15-300 with overexpressed Skp2, Skp2 dF-Box and CycE. (A) Expression level 1.25 – 2.00. Skp2 
destabilizes mChe Cdt1 15-300 in all, G1, S and G2 cells. Skp2 dF-Box stabilizes Cdt1 15-300 in all, G1 and S. (B) Expression level 
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2.00 – 2.75. Skp2 destabilizes mChe Cdt1 15-300 in all, S and G2 cells. Skp2 dF-Box stabilizes Cdt1 15-300 in all, S and G2. 
* = p < 0.05, ** = p < 0.01, one sample t-test. Only significant changes are indicated. 
 
To sum it up, Cdt1 15-300 did also show protein degradation in dependency of Skp2. The effects seen were 
similar to the observed effects of Cdt1 15-600 (degradation upon Skp2 overexpression, stabilization upon 
Skp2 dF-Box expression, intensified effects upon CycE overexpression). Important regions for degradation 
by Skp2 were not found yet and Cdt1 will be truncated further. 
5.4.6. Stability of Cdt1 15-225 is regulated by Skp2 only weakly 
Since Cdt1 15-300 was still destabilized by Skp2 and this destabilization was enhanced by CycE 
overexpression, crucial phospho-sites were likely present in this fragment. It is already known that 
phosphorylation dependent degradation relies upon one, some or all of 10 phospho-sites located in the 
first 300 amino acids of the protein. Mutation of all of these phospho-sites to alanine turns off the 
phospho-dependent degradation pathway (Thomer et al., 2004). Cdt1 was further truncated to narrow 
down the number of potential sites that would be mutated in a second step. The first version created was 
Cdt1 15-225, excluding the last six optimal phospho-sites. 
Just like the other two constructs, mChe Cdt1 15-225 led to a shift of the cell cycle into G1 (Figure 40A,B,C). 
Analysis with expression level 1.25 – 2.00 surprisingly showed that Skp2 overexpression stabilized Cdt1 15-
225 in all, G1 and S-Phase cells (Figure 40D, one-sample t-test, p < 0.01 and p < 0.05). Expression of Skp2 
dF-Box did only in S-Phase lead to a significant stabilization (one-sample t-test, p < 0.01). Using expression 
level 2.00 – 2.75 changed this picture. Conversely, Skp2 overexpression led to destabilization but only in 
G2 (Figure 40E, one-sample t-test, p < 0.05), while Skp2 dF-Box did not affect the stability at all (one-sample 
t-test, p > 0.05). 
Together with CycE overexpression, Skp2 did no longer significantly affect the stability of mChe Cdt1 15-
225 at expression level 1.25 – 2.00. However, since the “stability index” (logarithmic mChe Cdt1 15-225 
fluorescence intensity divided by the logarithmic GFP fluorescence intensity) was actually lower than one 
in this case, Skp2 indeed had a tendency of destabilisation on this Cdt1 version, although the effect was 
not statistically significant (Figure 41A, one-sample t-test, p > 0.05). Skp2 dF-Box did also not influence the 
stability in a significant way (one-sample t-test, p > 0.05). Nonetheless, this led to a tendency of protein 
stabilization, though again the difference was not significant. With expression level 2.00 – 2.75, Skp2 
overexpression led to a statistically significant lower protein stability of Cdt1 15-225 in all cases (Figure 
41B, one-sample t-test, p < 0.05 and p < 0.01). Skp2 dF-Box on the other hand did not influence the protein 
stability (one-sample t-test, p > 0.05). 
Taken together, the data showed that the degradation of Cdt1 15-225 by Skp2 was weaker than Cdt1 15-
300. Analysis without CycE overexpression showed no effect of Skp2 overexpression or even stabilization 
and the effects of Skp2 dF-Box did become no longer statistically significant for the most part. CycE 
overexpression eliminated the stabilization effect of Skp2, though destabilization of Cdt1 was not as 
pronounced and clear as with the other constructs. Again, Skp2 dF-Box did not execute any significant 
effect on the stability. According to these experiments, the residues between 225 and 300 were required 
for Skp2 mediated destabilization of Cdt1. 
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Figure 40 Cdt1 15-225 cell cycle effects and stability upon overexpression of Skp2 and Skp2 dF-Box 
Cell cycle distribution and stability data of mChe Cdt1 15-225. (A) Cell cycle of the control vector. (B) Cdt1 15-225 shows G1 
accumulation of cells. (C) Overlay of control and Cdt1 15-225 overexpression. Overlay is normalized to the G1-peak. All presented 
cell cycle distributions are representative. Only GFP positive cells are shown. (D) Expression level 1.25 – 2.00. Skp2 stabilizes Cdt1 
15-225 in all, G1 and S. Skp2 dF-Box acts stabilizing only in S-Phase. (E) Expression level 2.00 – 2.75. Skp2 destabilizes Cdt1 15-225 
in G2. Skp2 dF-Box does not influence protein stability. * = p < 0.05, ** = p < 0.01, one sample t-test. Only significant changes are 
indicated. 
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Figure 41 Cdt1 15-225 stability upon overexpression of Skp2 or Skp2 dF-Box and CycE 
Protein stability of mChe Cdt1 15-225 with overexpressed Skp2, Skp2 dF-Box and CycE. (A) Expression level 1.25 – 2.00. Neither 
Skp2 nor Skp2 dF-Box changes Cdt1 15-225 stability in a significant way. The tendency of Skp2 overexpression is protein 
degradation and of Skp2 dF-Box expression stabilization, however. (B) Expression level 2.00 – 2.75. Skp2 destabilizes Cdt1 15-225 
in all cases, while Skp2 dF-Box does not have any effect. n.s. = p > 0.05, * = p < 0.05, ** = p < 0.01, one sample t-test. Only significant 
changes are indicated. 
 
5.4.7. Cdt1 15-263 is still a target for Skp2 regulation 
In the region between 225 and 300 three optimal Cdk2 consensus phosphorylation sites are present. To 
identify potential phospho-sites important for Skp2 mediated degradation further, the version Cdt1 15-
263 was created, lacking the last three known sites. 
The cell cycle effect of mChe Cdt1 15-263 overexpression was similar to the other constructs, a G1 
accumulation (Figure 42A,B,C). The stability of Cdt1 15-263 after Skp2 overexpression or Skp2 dF-Box 
expression was unaffected at the lower expression level (Figure 42D, one-sample t-test, p > 0.05). If the 
higher expression level was used, stability of Cdt1 15-263 was lowered only in G1 at Skp2 overexpression 
(Figure 42E, one-sample t-test, p < 0.05). Skp2 dF-Box did not seem to influence this truncation (one-
sample t-test, p > 0.05). 
Simultaneous CycE overexpression restored the ability of Skp2 to mark Cdt1 15-263 for degradation. At 
expression level 1.25 – 2.00 protein stability was significantly lower in all, S- and G2-Phase cells (Figure 
43A, one-sample t-test, p < 0.05 and p < 0.001). Likewise, CycE overexpression resulted in stabilization of 
Cdt1 15-263 at Skp2 dF-Box expression in all and S cells (one-sample t-test, p < 0.05 an p < 0.01). Analysis 
with expression level 2.00 – 2.75 showed that Skp2 overexpression still significantly reduced Cdt1 15-263 
stability in all, S and G2 cells (Figure 43B, one-sample t-test, p < 0.05 and p < 0.01), although Skp2 dF-Box 
did not affect the stability any more (one-sample t-test, p > 0.05). 
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Figure 42 Cdt1 15-263 cell cycle effects and stability upon overexpression of Skp2 and Skp2 dF-Box 
Cell cycle distribution and stability data of mChe Cdt1 15-263. (A) Cell cycle of the control vector. (B) Cdt1 15-263 shows G1 
accumulation of cells. (C) Overlay of control and Cdt1 15-225 overexpression. Overlay is normalized to the G1-peak. All presented 
cell cycle distributions are representative. Only GFP positive cells are shown. (D) Expression level 1.25 -2.00. Skp2 and Skp2 dF-
Box overexpression do not alter Cdt1 15-263 stability. (E) Expression level 2.00 – 2.75. Skp2 degrades Cdt1 15-263 only in G1. Skp2 
dF-Box does not influence the stability. n.s. = p > 0.05, * = p < 0.05, one sample t-test. Only significant changes are indicated. 
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Unlike Cdt1 15-225, 15-263 again showed the regulation by Skp2, however only after CycE overexpression. 
This construct still contained six optimal phosphorylation sites, which were, according to these results, 
potentially important for degradation through SCFSkp2. In a next step, a Cdt1 version with a truncated N-
terminus was created to screen for phospho-sites necessary for degradation in the N-terminus of the 
protein. 
 
Figure 43 Cdt1 15-263 stability upon overexpression of Skp2 or Skp2 dF-Box and CycE 
Protein stability of mChe Cdt1 15-263 with overexpressed Skp2, Skp2 dF-Box and CycE. (A) Expression level 1.25 – 2.00. Cdt1 15-
263 is destabilized by Skp2 in all, S and G2. Skp2 dF-Box leads to stabilization in all and S. (B) Expression level 2.00 – 2.75. Skp2 
destabilizes Cdt1 15-263 in all, S and G2. Skp2 dF-Box does not have any effect. * = p < 0.05, ** = p < 0.01, one sample t-test. Only 
significant changes are indicated. 
 
5.4.8. The N-terminus of Cdt1 is necessary for Skp2 mediated degradation 
To find out if the N-terminal 170 amino acids are important for the regulation, Cdt1 170 – 300 was created. 
This version excluded the first four of the already identified optimal phospho-sites.  
Cdt1 170-300 also showed the G1-accumulation of Schneider cells (Figure 44A,B,C). With an expression 
level of 1.25 – 2.00, Cdt1 170-300 was not degraded upon Skp2 overexpression (Figure 44D, one sample 
t-test, p > 0.05). The only significant change was a stabilization of the protein in S-Phase (one sample 
t-test, p < 0.05). Skp2 dF-Box overexpression led to a statistically significant stabilization of the construct 
in all distinct phases (one sample t-test, p < 0.01 and p < 0.05). Analysis of expression level 2.00 – 2.75 
showed that neither Skp2 nor Skp2 dF-Box overexpression resulted in a significant change of Cdt1 170-300 
stability (Figure 44E, one sample t-test, p > 0.05), the only exception was a stabilization of the truncation 
in S-Phase with Skp2 dF-Box expression (one-sample t-test, p < 0.05). 
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Figure 44 Cdt1 170-300 cell cycle effects and stability upon overexpression of Skp2 and Skp2 dF-Box 
mChe Cdt1 170-300 cell cycle distribution and stability data. (A) Cell cycle of the control vector. (B) Cdt1 170-300 shows G1 
accumulation of cells. (C) Overlay of control and Cdt1 170-300 overexpression. Overlay is normalized to the G1-peak. All presented 
cell cycle distributions are representative. Only GFP positive cells are shown. (D) Expression level 1.25 – 2.00. Skp2 overexpression 
has no effect on Cdt1 170-300, except a stabilization in S-Phase. Skp2 dF-Box stabilizes in all, G1, S and G2 cells. (E) Expression 
level 2.00 – 2.75. Skp2 does have no effect on Cdt1 170-300 stability. Skp2 dF-Box stabilizes Cdt1 170-300 only in S-Phase. * = p < 
0.05, ** = p < 0.01, one sample t-test. Only significant changes are indicated. 
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Simultaneous CycE overexpression did not result in enhanced Skp2 effects. On the opposite, Skp2 showed 
no effect with expression level 1.25 – 2.00 (Figure 45A, one sample t-test, p > 0.05). Skp2 dF-Box 
overexpression showed stabilization in all and S-Phase cells (one sample t-test, p < 0.05). Expression level 
2.00 – 2.75 showed also no significant effect of Skp2 overexpression on protein stability (Figure 45B, one 
sample t-test, p > 0.05). Skp2 dF-Box showed under these circumstances surprisingly a destabilization of 
Cdt1 170-300, although this happened only in G2 (one sample t-test, p < 0.05). 
According to these results, Cdt1 170-300 was not a target for Skp2 mediated ubiquitination. Accordingly, 
the phospho-sites, deleted in this version, seemed to play a role for the recognition by Skp2. After 
evaluation of the truncated Cdt1 versions, it was decided to concentrate further on Cdt1 15-263, since it 
still showed degradation upon Skp2 overexpression if CycE was also overexpressed. Cdt1 170-300 and Cdt1 
15-225 conversely showed no consistent degradation by Skp2 and CycE overexpression, and in some cases 
even a significant protein stabilization that did not fit into the data already gathered. These two 
truncations were consequently dropped from further analysis and only the phosphorylation sites in Cdt1 
15-263 were analyzed.  
 
Figure 45 Cdt1 170-300 stability upon overexpression of Skp2 or Skp2 dF-Box and CycE 
Protein stability of mChe Cdt1 170-300 with overexpressed Skp2, Skp2 dF-Box and CycE. (A) Expression level 1.25 – 2.00. Skp2 
overexpression does not change the stability of Cdt1 170-300. Skp2 dF-Box overexpression leads to stabilization in all and S-Phase. 
(B) Expression level 2.00 – 2.75. Skp2 overexpression does not exhibit any effect on Cdt1 170-300. Skp2 dF-Box leads to a significant 
destabilization, but only in G2-Phase. * = p < 0.05, one sample t-test. Only significant changes are indicated. 
 
Cdt1 15-263 contains seven possible phospho-sites, important for the ubiquitination by Skp2 (Thomer et 
al., 2004). The first one of these (S37) was excluded from further analysis, since it only has the minimal 
consensus site for phosphorylation (S-P). The remaining six amino acids (S111, T158, S168, S226, S249 and 
T256) have an optimal consensus sequence for phosphorylation (S/T-P-X-R/K) and it was decided to 
investigate their role for Cdt1 stability further. 
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5.4.9. Neither phospho-sites S111, S168 nor S226 are influencing the Cdt1 stability 
in dependency of Skp2  
The region of Cdt1 between amino acids 15 and 263 harbors six optimal consensus Cdk phosphorylation 
sites (S/T-P-X-K/R sites; see Figure 46) according to Thomer et al. (2004). To illuminate the role of the six 
single phospho-sites, in vitro mutagenesis was performed to change these amino acids to alanine, which 
should prevent any phosphorylation. This was successful for S111, T158, S168 and S226. Unfortunately, 
mutations in the phospho-sites S249 and T256 could not be obtained by the in-vitro mutagenesis 
approach, despite several attempts and had to be dropped from the analysis because of time reasons. 
Additionally, T158 had to be excluded from the analysis, since expression of Cdt1 15-263 T158A resulted 
in a loss of GFP and mCherry signal over several consecutive trials (data not shown). 
 
Figure 46 Schema of Cdt1 15-263 with the examined phospho-sites 
Cdt1 fragment 15-263 with the six optimal phospho-sites (S111, T158, S268, S226, S249 and T256) considered important for 
degradation through SCFSkp2. Mutation of T158 (red) resulted in a loss of GFP and mCherry fluorescence and could not be analyzed. 
S249 and T256 (grey) could not be mutated. 
 
The stability of the remaining three constructs (S111, S168 and S226) was analyzed by flow cytometry. 
Analysis was performed with the respective construct under CycE overexpression conditions and with 
simultaneous overexpression of Skp2. If the mutated phospho-site would be important for Skp2 mediated 
degradation, Skp2 overexpression should not change the stability any longer if CycE is also overexpressed 
at the same time. Just like before, working with Cdt1 showed different results in dependency of the used 
expression levels. Therefore, again both levels are presented. 
The first analyzed construct was Cdt1 15-263 S111A. At expression level 1.25 – 2.00, no influence of the 
expressed components on mCherry was visible, stability of the controls was inconspicuous (Figure 47A, 
one-sample t-test, p > 0.05). The Cdt1 mutation itself showed a statistically significant destabilization if 
Skp2 was overexpressed in all four cases (Figure 47B, one-sample t-test, p < 0.01, p < 0.05 and p < 0.001). 
If level 2.00 – 2.75 was analyzed, control experiments showed a significant effect on mChe upon Skp2 
overexpression: mCherry was significantly destabilized in all and G1 cells (Figure 47C, one-sample t-test, 
p < 0.05). Cdt1 15-263 S111A showed a significant reduction of stability in all cells, as well as in S- and G2-
Phase (Figure 47D, one-sample t-test, p < 0.001 and p < 0.01), but not in G1-Phase (one-sample t-test, p > 
0.05). 
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Figure 47 Stability of Cdt1 15-263 S111A upon CycE and Skp2 overexpression  
Protein stability of Cdt1 15-263 S111A with overexpressed CycE and Skp2. Expression level 1.25 – 2.00: (A) Skp2 overexpression 
does not influence the stability of mCherry. (B) Skp2 overexpression leads to destabilization of Cdt1 15-263 S111A in all four cases. 
Expression level 2.00 – 2.75: (C) Skp2 overexpression results in a lower stability of mCherry in all and G1 cells. (D) Cdt1 15-263 
S111A is destabilized in all, S- and G2-Phase cells upon Skp2-overexpression. n.s. = p > 0.05, * = p < 0.05, ** = p < 0.01, *** = p < 
0.001, one sample t-test. Only significant changes are indicated. 
 
The experiments with Cdt1 15-263 S168A showed that Skp2 overexpression had no influence on the 
controls, although the same vectors were used as above (data not shown). Skp2 destabilized Cdt1 15-263 
S168A significantly in all, S and G2 cells (Figure 48A, one-sample t-test, p < 0.01) if analyzed with level  
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1.25 – 2.00 and under CycE overexpression conditions. The higher expression level showed a similar 
destabilization in all, S- and G2-Phase (Figure 48B, one-sample t-test, p < 0.01 and p < 0.001). 
 
Figure 48 Stability of Cdt1 15-263 S168A upon CycE and Skp2 overexpression 
Stability of Cdt1 15-263 S168A with overexpression of CycE and Skp2. (A) Expression level 1.25 – 2.00. Overexpressing Skp2 leads 
to increased instability of Cdt1 15-263 S168A in all, S and G2. (B) Expression level 2.00 – 2.75. Skp2 overexpression showed a 
similar degradation of the Cdt1 mutant in all, S and G2. ** = p < 0.01, *** = p < 0.001, one sample t-test. Only significant changes 
are indicated. 
 
The last mutation tested was Cdt1 15-263 S226A. The control experiments showed no effect of Skp2 on 
mCherry under CycE overexpression conditions (data not shown). Analysis of the lower expression level 
showed that Cdt1 15-263 S226A was destabilized upon Skp2 overexpression in all and S-Phase (Figure 49A, 
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one-sample t-test, p < 0.05 and p < 0.01). Expression level 2.00 – 2.75 on the other hand showed a 
statistically significant degradation in all four cases (Figure 49B, one-sample t-test, p < 0.05 and p < 0.01).  
 
Figure 49 Cdt1 15-263 S226A stability upon CycE and Skp2 overexpression 
Cdt1 15-263 S226A stability by CycE and Skp2 overexpression. (A) Expression level 1.25 – 2.00. Cdt1 15-263 is statistically 
significant destabilized in all and S. (B) Expression level 2.00 – 2.75. Skp2 overexpression destabilizes the Cdt1 mutant in all, G1, S 
and G2. * = p < 0.01, ** = p < 0.01, one sample t-test. Only significant changes are indicated. 
 
To summarize these experiments, mutation of three phospho-sites alone (S111A, S168A and S226A) did 
not result in a different degradation pattern of Cdt1 upon Skp2 overexpression if CycE was also 
overexpressed. 
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5.4.10. Cdt1 shows biochemical interaction with Skp2 
Flow cytometric protein stability analysis of Cdt1 suggested that it was a target of the SCFSkp2 complex in 
dependency of phosphorylation. To test for biochemical interaction between Cdt1 and Skp2, co-
immunoprecipitation was performed. An HA-tagged version of Cdt1 15-600 was used to prevent any 
unwanted disturbances in the cell cycle and to exclude the PIP-mediated degradation. The pull down was 
performed with 4xFLAG Skp2. 
Expression of 4xFLAG Skp2 in Schneider cells worked well. Skp2 was also efficiently precipitated (Figure 
50, left). HA Cdt1 15-600 expression was also detectable. Cdt1 did not bind unspecifically to the IgG beads. 
The Co-IP itself showed a slight but visible Cdt1 band (Figure 50, right). Biochemical interaction between 
Cdt1 15-600 and Skp2 existed, therefore. 
 
Figure 50 Co-IP between 4xFLAG Skp2 and HA Cdt1 15-600 
Co-immunoprecipitation of 4xFLAG Skp2 and HA Cdt1 15-600 for analysis of biochemical interaction. FLAG antibody was used for 
precipitation, FLAG or HA antibody for detection. Left: FLAG Blot for control of expression and precipitation of 4xFLAG Skp2. Right: 
HA Blot for control of expression and interaction of HA Cdt1 15-600. Biochemical interaction is detected. 
 
5.4.11. Skp2 modulates Cdt1 phenotypes in cells 
According to the stability data and the Co-IP assays, Cdt1 was a substrate for the SCFSkp2 complex. If this 
was indeed the case, any Cdt1 phenotypes should have been susceptible to a modulation of the Skp2 
levels. Cell cycle phenotypes of Cdt1 and Cdt1 dPIP overexpression were already described (see Figure 
32B,C and D). Consequently, the effect of Skp2 overexpression or knockdown on these phenotypes was 
analyzed by flow cytometry. 
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Figure 51 Cell cycle distributions of the Cdt1-Skp2 rescue experiments if Cdt1 is overexpressed 
Effects of Skp2 overexpression or knockdown if Cdt1 or Cdt1 dPIP is overexpressed. (A) Control experiment, Skp2 overexpression 
exhibits the already described G1 shift. (B) Skp2 overexpression reduces the amount of overreplicating cells caused by Cdt1 
overexpression. (C) Skp2 overexpression weakens the effect of the Cdt1 dPIP overexpression. Distinct G1- and G2-peaks can be 
observed again. (D) Control experiment, Skp2 knockdown exhibits the already described G2 shift. (E) Skp2 knockdown enhances 
the G2 cell accumulation caused by Cdt1 overexpression. (F) Skp2 knockdown enhances the G1 shift caused by Cdt1 dPIP 
overexpression. GFP serves as the transfection control, only GFP cells are shown. All overlays are normalized to the G1-peaks. All 
presented cell cycle distributions are representative.  
 
Cell cycle distribution of the control samples showed the already observed accumulation of G1 cells in 
comparison to the control if Skp2 is overexpressed (Figure 51A). Cdt1 overexpression led to overreplication 
of Schneider cells (Figure 51B) as described before. Skp2 overexpression rescued this phenotype, the 
amount of overreplicating cells was restored to the level in the control experiment. 
An even more interesting result was achieved by using Cdt1 dPIP. As already observed, Cdt1 dPIP resulted 
in an accumulation of cells in very late G1 or probably in early S-Phase (Figure 51C). Skp2 overexpression 
also rescued this phenotype. The maximum of the peak shifted back, restoring the G1-peak. Most 
importantly, a distinct G2-peak emerged, that was not seen when Cdt1 dPIP was overexpressed. It is 
important to point out that this Skp2 overexpression effect was very unusual. Skp2 overexpression showed 
in all observed cases in this thesis always cell cycle shifts in the direction of the G1-Phase. Only if Cdt1 dPIP 
was overexpressed, a Skp2 overexpression led to a more pronounced G2-Phase. This speaks strongly for a 
rescue effect of Skp2 on the Cdt1 dPIP cell cycle distribution phenotype. 
Beside these rescue experiments, it was also analyzed what happened to the Cdt1 phenotypes if Skp2 was 
knocked down. If Cdt1 is a substrate of SCFSkp2, this knockdown should lead to stronger effects. Again, the 
control experiments showed the already described phenotype of the Skp2 knockdown, an accumulation 
of cells in G2-Phase in comparison to a Hygro knockdown (Figure 51D). 
The control Hygro knockdown did not influence the effects of Cdt1 overexpression (Figure 51E). 
Knockdown of Skp2 led to an increased accumulation of cells in G2-Phase if Cdt1 was overexpressed, 
although there was no increase in the amount of overreplicating cells visible. The Cdt1 dPIP phenotype 
was also not influenced by the Hygro knockdown (Figure 51F). In this case, though, the Skp2 knockdown 
resulted in a stronger shift into late G1-/S-Phase, an enhancement of the Cdt1 dPIP effect. Again, this effect 
of modulated Skp2 levels under Cdt1 dPIP overexpression conditions was unique, since knockdown of Skp2 
led typically to a G2 shift of cells in this thesis. 
It was also tested if the effects of a Cdt1 knockdown were influenced by changing Skp2 levels. Cdt1 
knockdown was performed by in vitro synthesized dsRNA and not by a hairpin construct. Hence, Amp 
dsRNA was used as a control. The S2R+-cells in this experiment showed a slight G2-shift for unknown 
reasons (Figure 52A). Nonetheless, the control Amp knockdown did not show any effect on this cell cycle. 
Cdt1 knockdown showed a cell shift into G1-Phase. Even sub-G1 cells (cells with a DNA content smaller 
than 2C) could be observed (Figure 52B). Skp2 knockdown resulted in the already familiar shift into G2 
cells (Figure 52C). Consequently, it was tested what effects an additional Skp2 knockdown or 
overexpression had if Cdt1 was knocked down. The Skp2 knockdown rescued the effect partially. The 
number of sub-G1 cells was reduced and more G2 cells were visible (Figure 52D). The effects of Skp2 
overexpression in this case was mixed however. Though in theory, this constellation should lead to a 
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stronger effect, the number of sub-G1 cells was decreased instead (Figure 52E). Conversely, the number 
of G2 cells was also decreased in this case, showing a stronger effect than Cdt1 knockdown alone. 
 
Figure 52 Cell cycle distributions of the Cdt1-Skp2 rescue experiments if Cdt1 is knocked down 
Effects of Skp2 knockdown or overexpression if Cdt1 is knocked down. (A) Amp knockdown exhibits no effect on the cell cycle. (B) 
Cdt1 knockdown results in a G1 cell shift and cells with a DNA content smaller than 2C (Sub-G1 cells). (C) Skp2 knockdown shows 
the already observed shift into G2-Phase. (D) Simultaneous knockdown of Cdt1 and Skp2 weakens the Cdt1 effects, less Sub-G1 
cells and more G2 cells could be observed. (E) If Skp2 is overexpressed, the number of Sub-G1 cells is also reduced, but the G2 
effect is exacerbated. All overlays are normalized, A and C to the G2-peak, B,D and E to the G1-peak. All presented cell cycle 
distributions are representative. 
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As a conclusion, the performed experiments hinted that Cdt1 was a substrate of SCFSkp2 in D. melanogaster. 
Cdt1 was degraded in S2R+-cells if CycE was also overexpressed, indicating that phosphorylation was 
important for Skp2 dependent degradation. Overexpression of Skp2 dF-Box stabilized Cdt1. This was in 
accordance with a dominant negative effect that F-Box proteins with a deleted F-Box have on their 
substrates. Furthermore, Skp2 knockdown did lead to a stabilization of Cdt1. 
Experiments were also performed to identify the phospho-sites in Cdt1 important for its binding to Skp2. 
Cdt1 truncations narrowed the analysis down to the amino acids S111, T158, S168, S226, S249 and T256. 
Mutations ruled out that S111, S168 or S226 alone were responsible for the recognition by Skp2.  
Cdt1 did also show biochemical interaction with Skp2, as seen by a Co-IP experiment. 
Finally, effects of Cdt1 overexpression or knockdown could be rescued or enhanced by Skp2 knockdown 
or overexpression, respectively.  
5.5. Regulation of CycE through Skp2 is questionable 
5.5.1. Overview 
Besides Dacapo and Cdt1, CycE was another potential substrate that was tested. CycE is responsible for 
the entry into S-Phase. CycE overexpression shows very strong effects on the cell cycle. Furthermore, it is 
also efficiently degraded in S-Phase by SCFAgo. These factors make working with CycE difficult. Therefore, 
the analysis of CycE was only basic and far from complete. CycE stability was analyzed by flow cytometry 
and a Co-IP study was also performed. 
5.5.2. Cell cycle effects of CycE and artificial stop in G1  
Overexpression of mChe CycE resulted in a dramatic shift of cells into G2-Phase (Figure 53, compare cell 
cycle curves of A and C). Furthermore, Figure 53C shows that CycE was extremely unstable. There was 
almost no signal detectable in the Cherry fluorescence channel. It is unreliable to perform the flow 
cytometric protein stability analysis in this case. The massive effect of CycE on the cell cycle prevented a 
precise determination of the distinct cell cycle phases and the extremely low basic stability made detection 
and calculation of the stability difficult. 
A solution was found to overcome these issues. Cells were artificially kept in G1-Phase. The G1-Stop was 
performed by overexpression of Dacapo under a strong promotor (Figure 53B). This resulted in a cell cycle 
with distinct G1-, S- and G2/M-Phases that were again possible to define (Figure 53D). Since cells did not 
transit rapidly into S-Phase any longer, the degradation of CycE by SCFAgo was also diminished and a mChe 
CycE signal was detectable (Figure 53D). A positive side effect of this assay was that mostly effects of Skp2 
on CycE were analyzed since the competing SCFAgo degradation pathway was not able to target its 
substrates in G1-Phase. 
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Figure 53 Cell cycle effects of CycE with and without artificial G1 arrest 
Cell cycle distributions of mChe CycE and simultaneous Dap overexpression. (A) Left: Cell cycle of control cells. Right: intensity of 
the corresponding Cherry signal (B) Left: Cell cycle of cells overexpressing Dap, resulting in a G1 arrest. Right: intensity of the 
corresponding Cherry signal (C) Left: CycE leads to a strong G2-shift. Right: mChe-CycE is efficiently degraded during the cell cycle, 
almost no signal is detectable in the red fluorescent channel. (D) Left: simultaneous overexpression of CycE and Dap still arrests 
the cells in G1. Right: the G1 arrest stabilizes mChe-CycE, the Cherry signal is again detectable. GFP serves as the transfection 
control, only GFP cells are shown All depicted graphs are representative. 
 
5.5.3. Stability of CycE is not influenced by Skp2 levels 
Flow cytometric stability analysis was conducted with and without Dap G1 arrest. If the G1 arrest was not 
used, stability was only analyzed for all cells (regardless of the cell cycle phases) and G2-Phase, since G1- 
and S-Phase were no longer identifiable with the used method. Stability data was stabilized to CycE or 
CycE + Dap respectively. GFP and mCherry controls were not influenced by overexpression of Skp2. Only 
expression level 2.00 – 2.75 is depicted. 
Stability of CycE was not influenced by Skp2 overexpression (Figure 54, one-sample t-test, p > 0.05) neither 
in all cells nor in G2-Phase. This still held true if cells were arrested in G1, regardless of the cell cycle phase 
(one-sample t-test, p > 0.05). It has to be noted that standard deviation in some of these cases was 
unusually high. 
 
Figure 54 Stability of CycE upon Skp2 overexpression and G1 arrest 
Flow cytometric stability data of CycE. Skp2 overexpression does not change the stability of CycE. This is also the case if cells are 
arrested in G1-Phase by Dap overexpression. n.s. = p > 0.05, one-sample t-test 
 
CycE stability was also analyzed if Skp2 was knocked down. Analysis was performed as described above. 
In case of the G1 arrest, no control Hygro Hairpin tests were performed because there were not enough 
wells on the 12-well plate available.  
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CycE stability was not changed upon Skp2 knockdown in comparison to the Hygro knockdown (Figure 55, 
t-test for equal variances, p > 0.05). The Dap G1 arrest did also not change this result: CycE stability was 
not influenced by Skp2 knockdown (t-test for equal variances, p > 0.05). Since the Hygro Hairpin control 
was lacking, the comparison was performed between CycE and CycE + Skp2 Hairpin in this case. 
 
Figure 55 Stability of CycE upon Skp2 knockdown and G1 arrest 
CycE protein stability data upon Skp2 knockdown. Skp2 knockdown has no influence on the CycE stability, regardless of a G1 
arrest created by Dap overexpression. n.s. = p > 0.05, t-test for equal variances 
 
5.5.4. CycE interacts biochemically with Skp2 
A Co-IP was performed to test for interaction between CycE and Skp2. Skp2 was tagged N-terminally with 
4xFLAG. CycE was tagged with GFP and expressed under an actin promotor instead of a polyubiquitin 
promotor. 4xFLAG Skp2 was again well expressed and precipitated efficiently (Figure 56, left). Expression 
of GFP CycE was visible though weaker than 4xFLAG Skp2, corresponding to the weaker promotor. A weak, 
but visible band could be seen if GFP CycE was co-immunoprecipitated with 4xFLAG Skp2, indicating a 
biochemical interaction between both proteins (Figure 56, right). 
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Figure 56 Co-IP between 4xFLAG Skp2 and GFP CycE 
Co-immunoprecipitation of 4xFLAG Skp2 and GFP CycE for testing of biochemical interaction. FLAG antibody was used for 
precipitation, FLAG and GFP antibody was used for detection. Left: FLAG Blot for control of expression and precipitation of 4xFLAG 
Skp2. Right: GFP Blot for control of expression and interaction of GFP CycE. Biochemical interaction is detected. 
 
To summarize this chapter, a definite conclusion if CycE is a substrate of SCFSkp2 could not be made. Flow 
cytometric stability analysis did not show an effect of Skp2 overexpression or knockdown on CycE stability. 
However, the validity of these assays is questionable because of the dramatic interventions on the cell 
cycle that had to be undertaken. On the other hand, biochemical analysis indeed showed interaction 
between CycE and Skp2. 
5.6. Mass spectrometric analysis of Skp2 binding partners did not show any obvious 
substrates for cell cycle regulation 
So far, substrates for Skp2 were tested if homologues showed Skp2 mediated regulation in higher 
eukaryotes. Mass-spectrometric analysis however was also performed. This could potentially not only 
confirm already obtained results, but also lead to new potential substrates. 4xFLAG Skp2 was 
overexpressed in Schneider cells and precipitated. As a control, wild type cells were also lysed and treated 
with FLAG-tagged agarose beads. These samples were analyzed by mass-spectrometry (see 4.2.5). The 
resulting hits were compared to the Drosophila proteins in the UniProt database. 
Originally, 222 proteins were found in the 4xFLAG Skp2 sample that could be identified without reasonable 
doubt. After comparison with the control, to exclude unspecifically bound proteins, 154 remained (see 
Table 27). These potential hits were identified in the FlyBase database and ordered according to the 
biological processes they are involved in. The most prominent categories were proteins related to 
ubiquitin-proteasomal degradation (14 hits), ribosomal proteins (12 hits) and cell cycle proteins (7 hits). A 
large amount (24 hits) were proteins involved in as yet unidentified processes.  
Some important hits are specified here: Skp2, as the bait protein, was found in first place with a score of 
6115.9, proving that precipitation indeed worked. SkpA was found with a score of 498.5. This showed that 
at least some portion of the precipitated Skp2 was incorporated into the SCF-complex. The finding of Cul1 
(score 273.6, under the name lin19-RC) hinted also in this direction. Another interesting hit was Cdk2 with 
a score of 103. Table 18 does summarize these hits. 
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Table 18 Interesting proteins identified in mass spec analysis 
Protein Score No. of peptides Sequence coverage (%) 
Skp2 (Bait) 6115.9 58 62.1 
SkpA 498.5 7 54.9 
Cul1 (= lin19) 273.6 5 8.8 
Cdk2 103.0 3 14.0 
 
It is important to note that neither Dap, nor Cdt1 or CycE could be found in the mass spec analysis. 
Furthermore, the number of cell cycle proteins were altogether low, only 7 of 154 hits (or 4.5%) were 
connected to the cell cycle. To sum it up, mass spectrometric analysis did not help to identify new 
substrates of Skp2 regarding cell cycle control. 
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6 Discussion 
6.1. Establishment of Skp2 phenotypes in Schneider cells 
6.1.1. Skp2 overexpression 
The aim of this thesis was to identify new substrates of the SCFSkp2 complex in Drosophila melanogaster. 
Schneider cells were primarily used for this purpose, since they could be easily genetically manipulated, 
and results could be obtained rapidly. In the beginning of the investigation, Skp2 phenotypes in the cell 
culture were observed and analyzed as a basis for further analysis. This was necessary, since up to now 
only effects of Skp2 knockdown are described in Drosophila tissues (Dui et al., 2013; Ghorbani et al., 2011). 
Cell cycle profiles of Schneider cells with changed Skp2 levels are as to this date not published. 
Fluorescence-activated cell scanning (FACS) analysis of cell cycle distributions revealed that Skp2 
overexpression led to an accumulation of Schneider cells in G1-Phase (Figure 11B,E). In most of the 
presented experiments, Skp2 was tagged with the 4xFLAG tag. The cell cycle shift was present, regardless 
if the tag was positioned N- or C-terminally. In mammalian cells, the effects of Skp2 overexpression are 
different. For example, in Rat-1 cells, Skp2 overexpression leads to an accumulation of cells in G2-Phase 
(Sutterluty et al., 1999). This is also true for Rat-6 cells when they are in a non-adherent state (Carrano and 
Pagano, 2001). In CCD18-Co cells, Skp2 overexpression leads to accumulation in S-Phase (Fujita et al., 
2008). It seems that Skp2 has different roles in cell cycle regulation in different cell types.  
A potential Skp2 overexpression phenotype was also analyzed in Drosophila wings using the engrailed 
driver for expression in the posterior part of the wing. In this case, Skp2 overexpression had no visible 
effect on wing morphology in comparison to the control. Wing area as well as direction, number and 
distance between the wing hairs all were inconspicuous upon Skp2 overexpression (Figure 11G,H). 
However, all these parameters show an effect upon Skp2 knockdown (Ghorbani et al., 2011). As 
mentioned, Skp2 overexpression showed only a weak G1 accumulation in S2R+-cells. Further experiments 
in the Sprenger group showed that cell cycle effects of Skp2 overexpression in wing imaginal disc cells are 
comparable; the accumulation of cells in G1 is also not a strong phenotype (Hirsch, 2018). The absence of 
an associated phenotype in wing morphology and wing hairs is probably explainable by compensation of 
cell cycle regulatory mechanisms in the course of the wing development.  
The overexpression phenotype was analyzed further, and live cell imaging experiments resulted in a 
possible explanation for the cell accumulation in G1-Phase (Figure 12). Cells remained in G1 for a longer 
time if Skp2 is overexpressed, the transition to S-Phase was procrastinated, resulting in a G1 cell cycle shift. 
Skp2 is a well-known F-Box protein, though it could not be ruled out that it still has more tasks in the cell. 
It was important to ascertain that the described effects were indeed dependent on the F-Box of Skp2 that 
is responsible for the binding to the SkpA-Cul1-Rbx1 complex (Hao et al., 2005; Yu et al., 1998). Since Skp2 
dF-Box did not show a change in the cell cycle profile (Figure 13B), it is reasonable that the Skp2 
overexpression phenotype was caused by the ubiquitination activity of the SCFSkp2 complex. Furthermore, 
Skp2 dF-Box was also used later for the analysis of possible Skp2 substrates. 
6.1.2. Skp2 knockdown 
Overexpression studies are always challenging. Though easy to perform, the interpretation of the results 
has to be done carefully. Overexpression of Skp2 means to flood the cell with Skp2 molecules, which could 
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have unforeseen effects on various cell mechanisms (some of these issues will be discussed later, see 6.2). 
Therefore, besides overexpression studies Skp2 was also knocked down in cells.  
Skp2 knockdown resulted in a shift into G2-Phase, regardless if dsRNA (Figure 14) or a hairpin construct 
(Figure 16) was used. The effect of the Skp2 hairpin construct was weaker in comparison to the dsRNA. 
There are two explanations for this outcome. First, the used parts of the Skp2 sequence for the different 
kinds of knockdowns varied in position and size. The dsRNA was transcribed from the C-terminal Skp2 
coding region and was 893 bp long. The hairpin construct on the other hand was created from the first 500 
bp of the N-terminus. It may be possible that length and position of the knockdown fragments influenced 
the efficiency of downregulation. The second explanation is that the promotor of the hairpin construct, 
though a polyubiquitin promotor, the strongest promotor available in the lab, is too weak to precisely 
imitate the effect of the high concentrated dsRNA. Regardless of this observation, both approaches 
resulted in principal in the same effect. It was also confirmed that knockdown with both methods is 
directed against Skp2, since both methods resulted in a downregulation of GFP-Skp2 in control 
experiments (Jan Polz, 6-week internship; Damian Mikietyn, 6-week internship).  
The specificity of the knockdown was controlled with Amp dsRNA, Hygro dsRNA or Hygro Hairpin, in 
dependency of the respective experiment. These control knockdowns did not show a significant effect on 
the cell cycle distribution or stability of GFP and mCherry, indicating that the observed effects are specific. 
One caveat might be that the Hygro Hairpin construct had a weaker promotor (metallotheonine promoter) 
than the Skp2 hairpin construct (polyubiquitin promotor). However, recently in the course of a bachelor 
thesis, a polyubiquitin Hygro Hairpin was successfully cloned, and expression of this hairpin does at least 
not change the cell cycle distribution of S2R+-cells (Tremmel, 2018). According to the dsCheck program 
(Naito et al., 2005) neither the used dsRNAs nor the hairpins had any off-target effects. 
The reason for the G2-shift under knockdown conditions was a shortened G1-Phase, as determined by live 
cell imaging (Figure 15). 
The G2-shift upon Skp2 knockdown is the reciprocal effect of the G1-shift upon Skp2 overexpression. These 
effects are also typical for a tumor suppressor that induce G1-S transition and subsequent cell 
accumulation in G2 when mutated. Therefore, potential substrates of Skp2 in D. melanogaster will likely 
induce or support a transition from G1 to S. The effect of Skp2 knockdown in wing imaginal discs is also a 
cell accumulation in G2/M-Phase (Liang et al., 2014), in concordance with the knockdown effect in S2R+-
cells. In contrast to these results, Skp2 knockdown in higher eukaryotes leads to an accumulation of cells 
in G0/G1 and not in G2 (Ding et al., 2017; Liu and Yamauchi, 2009; Schuler et al., 2011; Wei et al., 2004). 
However, other reports state the opposite, a shift into G2-Phase upon Skp2 knockdown (Hu and Aplin, 
2008). Again, it seems that the role that Skp2 plays depends upon the cell type. 
According to the results presented here, the effect of both Skp2 overexpression and knockdown does 
differ between different species and cell types. Skp2 seems to have many targets in mammalians, affecting 
different processes from cell cycle control, to DNA replication, DNA repair, gene transcription and more 
(Frescas and Pagano, 2008). Conversely, in flies only the CKI Dacapo is a proposed target (Dui et al., 2013), 
though data presented here argue against Dap being a substrate (discussed in 6.3). One may speculate 
that Skp2 has primordial substrates that are targeted in both flies and mammals. During evolution, Skp2 
may have earned additional substrates and functions in higher organisms, resulting in different effects that 
Skp2 exercises on the cell cycle. More data needs to be gathered to pursue this theory though. 
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Another explanation is that, as already noted, Skp2 function seems to differ in different cell - or tissue 
types. Another peculiarity from the mammalian system hints in this direction. In mammalians, Skp2 
substrates are both, positive and negative regulators of the cell cycle. Indeed, it was shown recently that 
Skp2 has different effects on cell cycle distribution and gene transcription in dependency of the observed 
cell line (Krishnan et al., 2017). The authors speculate that Skp2 plays a role in different checkpoints in 
strong dependency of the used cells. The effects on the Drosophila cell cycle of Skp2 are at least similar in 
Schneider cells (this thesis) and wing imaginal discs (Hirsch, 2018). Therefore, it is possible that the results 
presented here are not strictly restricted to S2R+-cells.  
Knockout of Skp2 does lead to polyploidy in cells of the wing imaginal disc (Ghorbani et al., 2011). Skp2 
knockdown did not show any visible overreplication effect in S2R+-cells when analyzed 48 hours after 
addition of dsRNA (Figure 14C). One possibility was that Skp2 knockdown had to be conducted for a longer 
time period to observe any effects. Indeed, a prolonged exposure of cells to Skp2 dsRNA led to an increase 
of overreplication (Figure 17). Besides, cells were also enlarged in this case. Furthermore, it has to be said 
that the cell number in these experiments were altogether low (compare the scale of the y-axes of control, 
Amp dsRNA and Skp2 dsRNA in this figure). This may be a hint that Skp2 knockdown led to more cell death 
or apoptosis, which is in accordance with results seen in wing imaginal discs if Skp2 is knocked out 
(Ghorbani et al., 2011). 
Polyploidy associated with Skp2 depletion is also described in mammalians: mouse hepatocytes showed 
distinct peaks with 8C and 16C if Skp2 is knocked out (Nakayama et al., 2000). Skp2 knockdown in fly 
imaginal discs was also analyzed in the Sprenger group, with the result of overreplication in these cells 
(Hirsch, 2018). Thus, Skp2 knockdown does lead to overreplication in Drosophila, altogether. The data 
from the S2R+-cells suggest that reduction of Skp2 results in the beginning in accumulation in G2. The 
observed overreplication might then originate from uncoordinated DNA-replication starting in G2. This 
results in overerreplicating cells and finally polyploidy for reasons as yet unknown. A possible mechanism 
may involve Cdt1. The results of this thesis allow the conclusion that Skp2 regulates Cdt1 (see 6.4), which 
is indeed important for DNA replication. Consequently, Skp2 knockdown will lead to higher Cdt1 levels in 
the cell. This may result in refiring of replication origins, especially in G2-Phase, where low Cdk activity 
allows Cdc6 to reaccumulate in the cell cycle, which is the second factor besides Cdt1 that regulates origin 
licensing. Perhaps, apoptosis is also induced in these cells, resulting in a lower density which could lead to 
the described wing hair spacing phenotype (Ghorbani et al., 2011). 
6.2. Change of Skp2 levels in cells does not influence the availability of free SkpA-
Cul1-Rbx1 complex 
Overexpression or knockdown experiments can be tricky to interpret. Flooding or depletion of cells with 
proteins may lead to observable effects. However, if these effects are a direct result of the changed protein 
levels or only experimental artifacts for example by influencing the availability of certain complexes has to 
be considered. F-Box proteins are part of the SCF-complex. The SCF is able to bind various different F-Box 
proteins (Skp2, Rca1, Morgue, Slimb and many more) which means that it plays a role in many different 
cellular processes. 
Overexpression or knockdown of F-Box proteins could influence the availability of free SkpA-Cul1-Rbx1- 
complex. Therefore, the ability of other F-Box proteins to bind to SkpA-Cul1-Rbx1 and fulfill their respective 
roles in the cell may be altered. Any observed effect in this case would not be caused by the changed level 
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of the protein of interest but more by a different composition of SCF-complexes in comparison to a wild 
type situation.  
Since the focus of this thesis was Skp2, it was analyzed if the overexpression or knockdown of this F-Box 
protein was problematic in this respect. The ability of the artificial F-Box protein slmb-vhhGFP4 to 
specifically bind and ubiquitinate GFP or GFP-tagged proteins was used (Caussinus et al., 2011). 
Overexpression of both slmb-vhhGFP4 and GFP re-enacted the regulation of a protein by the SCF-complex. 
Indeed, GFP stability was lowered if slmb-vhhGFP4 was expressed simultaneously (Figure 18B). This result 
showed that there was enough unoccupied SkpA-Cul1-Rbx1 complex in Schneider cells, so that the 
overexpression of slmb-vhhGFP4 can perform GFP degradation. It seems that the amount of unoccupied 
SkpA-Cul1-Rbx1 complex is not the rate limiting factor, at least if only one F-Box protein is overexpressed. 
Conversely, the overexpression of two F-Box proteins, slmb-vhhGFP4 and Skp2, did result in stabilization 
of GFP. One conclusion is that the massive overexpression of two F-Box proteins creates a situation in 
Schneider cells, where competition for the binding to the SkpA-Cul1-Rbx1 complex occurs. Slmb-vhhGFP4 
is no longer able to degrade GFP under these circumstances. It has to be said that all experiments 
presented in this thesis regarding overexpression studies were done by overexpression of only one F-Box 
protein. Therefore, it can be assumed that competition for SkpA-Cul1-Rbx1 was not a disturbing factor in 
these experiments.  
Knockdown of Skp2 on the other hand did not result in a statistically significant change of GFP stability in 
comparison to the control knockdown. Probably, there already is enough unoccupied SkpA-Cul1-Rbx1 so 
that the knockdown of an F-Box protein does not create opportunities for other F-Box proteins to bind to 
the complex and perform their functions to a higher degree.  
A caveat of these experiments that is already stated in the original publication is that GFP alone is only 
inefficiently degraded by slmb-vhhGFP4 (Caussinus et al., 2011). The reason is that either GFP cannot be 
tagged easily by ubiquitin due to its structure, or because the protein is too small to span the gap between 
the F-Box Protein and the E2-ubiquitin-ligase bound to SCF. To resolve this issue, a GFP-tagged protein can 
be used, being more susceptible for ubiquitination and bigger. This protein would however need certain 
requirements for the presented assay: it must not influence the cell cycle and cannot be a substrate of 
SCFSkp2. It has to be said that GFP-tagged proteins, namely GFP-CycB and GFP-Dap, were already tested, 
but did only show small improvements on the degradation-ability of slmb-vhhGFP4 (Serena Herzinger, 6-
week internship). Nonetheless, usage of a GFP tagged protein that may be degraded by slmb-vhh even 
stronger than GFP alone, could lead to more accurate results. 
To conclude this section, neither the overexpression nor the knockdown of an F-Box protein did influence 
the availability of free SkpA-Cul1-Rbx1. Competition seemed to occur only if two F-Box proteins were 
overexpressed simultaneously, which was never done in the presented experiments. Therefore, all 
observed effects of both overexpression and knockdown were considered direct effects that Skp2 had on 
cell cycle distribution or protein stability. 
6.3. Dacapo stability is not negatively regulated by Skp2 
The first potential Skp2 substrate tested was Dacapo (Dap) the Drosophila homologue of p21, p27 and 
p57. Dap is a cyclin dependent kinase inhibitor (CKI), responsible for inhibition of CycE/Cdk2 activity (Lane 
et al., 1996). Overexpression of Dap leads to a stop of the cell cycle in G1-Phase since the transition from 
G1 to S is no longer taking place (de Nooij et al., 1996; Lane et al., 1996; Reis and Edgar, 2004). This well-
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known stop in G1-Phase was also visible in the analyzed S2R+-cells (Figure 19B). In mammalian cells, p21, 
p27 and p57 are targets of Skp2 and their degradation causes a shift into S-Phase. 
In Drosophila, Skp2 overexpression resulted in a transition of the cell cycle distribution to G1-Phase. Skp2 
knockdown had the adverse effect of shifting the cells towards G2. The overexpression effect is not 
comprehensible with Dap degradation that should result in more CycE/Cdk2 activity and consequently 
entry into S-Phase. Likewise, Skp2 knockdown should lead under these circumstances to more Dap and 
consequently to cells remaining in G1-Phase. Thus, the results seen in Drosophila are the exact opposite 
to the expected effects if Dap would be regulated by Skp2. This suggests that Dap is not a target of Skp2 
in D. melanogaster.  
Stability analysis of Dap full length by flow cytometry did also not show any hints for Skp2 mediated 
degradation. To get an overview, Table 19 summarizes the results of all experiments with Dap full length. 
A destabilization of Dap is marked by “-” and a black box, stabilization by “+” and a white box and if no 
statistically significant effect was seen a “0” is inserted into the table and the box was colored grey.  
Table 19 Summary of flow cytometric protein stability analysis of Dacapo 
+ and white box = stabilization; 0 and grey box = no effect 
Dacapo full length 
Expressed constructs all G1 S G2 
4xFLAG Skp2  0 0 0 + 
CycE 0 0 0 0 
4xFLAG Skp2 + CycE 0 0 0 0 
Skp2 4xFLAG 0 0 0 0 
CycE + 0 0 0 
Skp2 4xFLAG + CycE 0 0 0 0 
Cks85A 0 0 0 0 
4xFLAG Skp2 + Cks85A 0 0 0 0 
CycE + Cks85A 0 0 0 0 
4xFLAG Skp2 + CycE + Cks85A 0 0 0 0 
4xFLAG Skp2 0 0 0 0 
4xFLAG Skp2 dF-Box 0 0 0 0 
Skp2 Hairpin vs. Hygro Hairpin 0 0 + 0 
 
Since overexpression of Dap (full length) results in a strong arrest of cells in G1-Phase, the interpretation 
of these results is challenging. The G1 stop disturbs the cell cycle and the cells do not resemble a wild type 
situation. A conclusion of the natural processes in a cell is impossible to make in this case. Therefore, the 
experiments were also performed with Dap dCDI, which is not able to inhibit the activity of CycE/Cdk2 any 
longer and thereby does not impair the cell cycle distribution. Table 20 summarizes the results of the flow 
cytometric protein stability experiments of Dap dCDI. 
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Table 20 Summary of flow cytometric protein stability analysis of Dacapo dCDI 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect; n.a. = not applicable 
Dacapo dCDI 
Expressed constructs all G1 S G2 
4xFLAG Skp2  + + + 0 
CycE - - - 0 
4xFLAG Skp2 + CycE 0 0 0 + 
Skp2 4xFLAG + + + + 
CycE - - 0 0 
Skp2 4xFLAG + CycE 0 0 0 + 
Cks85A 0 0 + + 
4xFLAG Skp2 + Cks85A n.a. n.a. n.a. n.a. 
CycE + Cks85A - - 0 + 
4xFLAG Skp2 + CycE + Cks85A 0 0 + + 
4xFLAG Skp2 + + + + 
4xFLAG Skp2 dF-Box + 0 + + 
Skp2 Hairpin vs. Hygro Hairpin 0 0 0 0 
 
While Dap dCDI does no longer have an effect on the cell cycle, it is still degraded in S-Phase by CRL4Cdt2 
because of its PIP-degron. Since this degradation mechanism may cover the effects that Skp2 might have, 
the mutant Dap dCDI dPIPa was also used. This version is no longer degraded in S-Phase by CRL4Cdt2 via its 
PIP-box, which makes it possible to emphasize on potential Skp2 effects. A summary of the results of the 
protein stability analysis can be found in Table 21. 
Table 21 Summary of flow cytometric protein stability analysis of Dacapo dCDI dPIPa 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
Dacapo dCDI dPIPa 
Expressed constructs all G1 S G2 
4xFLAG Skp2  + + + 0 
CycE 0 0 0 0 
4xFLAG Skp2 + CycE + 0 + + 
Skp2 4xFLAG + + 0 0 
CycE 0 0 0 0 
Skp2 4xFLAG + CycE 0 0 + + 
Skp2 Hairpin vs. Hygro Hairpin + + 0 0 
 
The following sections will deal with a comparison of the effects of the different treatments on the three 
Dacapo versions. Overexpression of Skp2 (regardless of the position of the FLAG tag) did not have a 
destabilizing effect on Dacapo (full length). Both Skp2 versions did also not have a destabilizing effect on 
Dap dCDI. Instead, stabilization was observed in this case. This data is not in concordance with the results 
of Dui et al. (2013), who saw reduced levels of Dap upon Skp2 overexpression. Since overexpressing Skp2 
led to longer G1-Phases in S2R+-cells, it is possible that the stabilization of Dap dCDI was derived by 
reduced degradation in S-Phase. However, the construct Dap dCDI dPIPa that is not targeted by CRL4Cdt2 
in S-Phase did also show stabilization upon Skp2 overexpression. If the stabilization of Dap by Skp2 
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overexpression was derived from the reduction of S-Phase cells, this construct should have no longer 
shown this effect. Skp2 overexpression apparently caused stabilization of Dacapo by other means. 
Another explanation for the stabilization would be that SCFSkp2 is indeed targeting Dap dCDI for 
ubiquitination, but in this case, this would not be a signal for proteasomal degradation. Instead, it may 
have another effect on Dap, perhaps activation or induction of complex formation with a Dap partner. This 
effect may have been not seen with Dap (full length) but the G1-arrested cells could have behaved 
differently. It is already known that SCFSkp2 can have other effects than marking target proteins for 
degradation. Skp2 ubiquitinates LKB1, an important kinase for various different cell processes, for example 
energy metabolism, apoptosis, proliferation and cell polarity. Ubiquitination of LKB1 by Skp2 does not 
mark the protein for proteasomal degradation but leads instead to the complex formation with activators 
of LKB1 and subsequent protein activity (Lee et al., 2015). A similar mechanism may also exist in case of 
Dacapo. 
If this would be indeed the case, overexpression of a Skp2 variant without a functional F-Box should exert 
the dominant-negative effect of either insensitivity or even destabilization on Dap. The deletion of the F-
Box does not impair the binding of the F-Box protein to its respective substrate. However, since the 
recruitment onto the SkpA-Cul1-Rbx1 complex is no longer possible and the substrates cannot be bound 
from two F-Box proteins at the same time, they are protected from ubiquitination and subsequent 
processes. The detection of a dominant-negative effect under these circumstances is one possibility to 
identify substrates of F-Box proteins (Carrano et al., 1999). In this respect, results with Skp2 dF-Box 
overexpression argue against an impact of Skp2 on Dap. The effects of Skp2 dF-Box on Dap (full length) 
and Dap dCDI were altogether comparable to the overexpression of Skp2. A dominant negative effect was 
not observed, which would be a sign for regulation by Skp2. This is another argument that Dap is not a 
substrate of Skp2. 
It is possible that Skp2 is indirectly affecting the stability of Dap by influencing mechanisms that are 
responsible for Dap degradation. The PIP-mediated degradation pathway cannot be the only way for Dap 
regulation in the cell. An initial degradation has to take place for the transition into S-Phase. Therefore, it 
may be possible that Skp2 overexpression changes activities of proteins that control Dap stability at the 
G1-S transition. 
CycE overexpression did also not have any destabilizing effect on Dap (full length). This is unexpected at 
first glance, since CycE overexpression should bring the cells in S-Phase were Dap degradation takes place, 
mediated by its PIP-degron. The explanation for the absence of this effect is that under these experimental 
conditions, Dacapo overexpression resulted in G1 cell arrest that could not be overcome by CycE 
overexpression (Figure 53D). Thus, the rapid cell cycle shift into S-Phase did not take place and the PIP-
mediated degradation pathway, that can only happen in S-Phase, was not intensified. In contrast, Dap 
dCDI was destabilized if CycE was overexpressed. This was the expected outcome, since Dap dCDI does no 
longer influence the cell cycle (Figure 19E,F) and was degraded by the PIP-degron mechanism upon the 
rapid transition into S-Phase, caused by CycE overexpression. Dap dCDI dPIPa on the other hand did no 
longer react to CycE overexpression, since the PIP-degron is no longer active. 
Biochemical analysis in Dui et al. (2013) shows that binding between Skp2 and Dap is greatly enhanced by 
Cks85A overexpression. In opposition to this result, overexpression of Cks85A neither alone, nor in 
combination with 4xFLAG Skp2 or CycE or both proteins combined did influence the stability of Dap (full 
length) measured by flow cytometry. In case of Dap dCDI, overexpressing Cks85A did also not lead to 
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protein instability. For the combined overexpression of 4xFLAG Skp2 and Cks85A only one set of data was 
available, hence, no conclusion could be drawn from this experiment. Combined overexpression of the 
three components Cks85A, CycE and 4xFLAG Skp2 did also not result in the degradation of Dap dCDI. In 
conclusion, Cks85A did not decrease the stability of the two Dap versions. Therefore, it was considered 
very unlikely that Cks85A is exerting a negative effect on Dap stability in combination with Skp2. 
Consequently, it was dropped from the stability analysis of Dap dCDI dPIPa.  
It is known that Skp2 uses phosphorylation for substrate recognition (Skaar et al., 2013). To include this 
aspect, Skp2 and CycE were simultaneously expressed. This should lead to phosphorylation of the 
expressed Dap versions, which may help to make them accessible for Skp2 recognition. However, this 
approach did also not lead to a significant change in Dap (full length) stability, regardless of the position 
of the FLAG tag at Skp2. In the experiments with Dap dCDI however, a peculiarity of the data was that the 
overexpression of both components did not change the stability any longer, while the overexpression of 
the single proteins did indeed lead to either stabilization (overexpression of Skp2 versions) or 
destabilization (CycE overexpression) respectively (Table 20). This effect was not seen for Dap dCDI dPIPa, 
where overexpression of both components all in all showed the same effect as the overexpression of Skp2, 
a stabilization of the Dap dCDI dPIPa protein. One possible interpretation of these differing results is that 
the stabilization of Skp2 overexpression and destabilization of CycE overexpression are independently 
compensating each other in the case of Dap dCDI. This cannot work any longer in the case of Dap dCDI 
dPIPa, since CycE overexpression does no longer exercise the destabilizing effect. 
Knockdown of Skp2 did not change the stability of Dap (full length), except in S-Phase, were stability 
increased. If this was a real effect or an artifact of the Dap G1 cell cycle stop or the experimental procedure 
(see later) is not sure though. In case of Dap dCDI, Skp2 knockdown did not have any significant effect on 
protein stability, speaking against Dap being a substrate for SCFSkp2. Remarkably Skp2 knockdown did lead 
to a stabilization of Dap dCDI dPIPa, at least in all and G1-cells. The stabilization of Dap dCDI dPIPa after 
Skp2 knockdown could point to Skp2 being directly involved in Dap protein stability, but all other 
experiments did not support this idea. It should be also noted that Skp2 overexpression resulted in partial 
stabilization of Dap dCDI dPIPa in S- and G2-Phase. Skp2 overexpression should have the opposite effect 
in comparison to the Skp2 knockdown, in this case destabilization of Dap dCDI dPIPa. These inconsistencies 
make the conclusion that Skp2 is responsible for direct Dap regulation doubtful. One explanation would 
be that Skp2 is degrading an unknown component, responsible for Dap stabilization. Another explanation 
can be hypothesized based on the cell cycle changes of Skp2 knockdown and regulation of stability of Dap 
dCDI dPIPa. Dap degradation probably must start in G1-Phase, since CycE/Cdk2 activity has to be strongly 
increased so that the transition to S can be performed. This thesis argues against Skp2 being responsible 
for this step. Indeed, another thesis in the Sprenger group found that the F-Box protein Rca1, the fly 
homologue to Emi1, is responsible for Dap degradation in G1 (Kies, 2017). Skp2 knockdown did lead to a 
faster transition from G1 to S. It is possible that this shortened G1-Phase did not offer enough time for a 
normal Dap degradation through SCFRca1. Consequently, the amount of Dap dCDI dPIPa was higher than 
normal. The fact that Dap dCDI did not show stabilization if Skp2 is knocked down does not speak against 
this theory, since in this case, the excess protein will be efficiently degraded by the proteasome because 
of ubiquitination by CRL4Cdt2. Since this degradation pathway was shut off in Dap dCDI dPIPa, the protein 
accumulated, resulting in “stabilization” when analyzed. One caveat of this hypothesis is that the observed 
G2-shift of the Skp2 hairpin construct was weak, making it at least questionable that the length of G1-
Phase was strongly affected. A live cell imaging experiment, as already described (see 4.2.7) might give 
deeper insight into the exact effect of Skp2 hairpin on G1-length. 
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To conclude this section about the Dacapo protein stability, determined by flow cytometric analysis, it can 
be stated that the majority of the protein stability data gathered speak against Dacapo being a substrate 
of SCFSkp2 for negative regulation. Various different approaches were undertaken to incorporate different 
factors: phenotypic effects and alternative regulatory pathways of Dap, substrate modification by 
phosphorylation and the presence of an additional supporter protein. Furthermore, not only 
overexpression experiments were performed but also knockdowns and approaches with a dF-Box version 
of Skp2. Yet, only the stabilization of Dap dCDI dPIPa under Skp2 knockdown conditions showed a hint for 
Dap being degraded upon Skp2 ubiquitination, and this result is explainable in different ways. Contrary, 
some results seemed to indicate that Skp2 activity actually contributed to Dacapo stabilization. 
These results are in contrast to the publication of Dui et al. (2013), which stated that Dap protein levels 
are diminished if Skp2 is overexpressed in Schneider cells and fly eyes. On the other hand, Ghorbani et al. 
(2011) found that Dap levels were not elevated in larvae and extracts from brain/imaginal discs of Skp2 
knock out flies, speaking against a Skp2 dependent regulation of Dap. The results of the protein stability 
assays in this thesis strengthen this notion.  
Additionally, the results regarding the cell cycle shifts of Skp2 knockdown presented here may explain 
some of the effects seen in Ghorbani et al. (2011). In this investigation, a knockout of Skp2 led to 
decreasing levels of endogenous Dap in mitotic tissues. The result of the live cell imaging experiments 
showed that cells exited G1-Phase faster under Skp2 knockdown conditions (see 6.1.2) and since Dap is 
efficiently degraded in S-Phase mediated by its PIP-degron, it seems reasonable that the faster transition 
into S-Phase results in increased Dap degradation. 
It is important to note that the determination of protein stability by flow cytometry is a new approach in 
the Sprenger group. Although the assay seems to work in principle (Polz, 2017) experience is limited and 
the method and even the handling of the flow cytometer is still improved. Future refinements will probably 
give results with greater precision. One of the critical points is the definition of the G1-, S- and G2-cell 
population. The set boundaries, based upon Hoechst intensity (see 4.2.6.5 and Figure 9), are educated 
guesses, derived from operating experience. A better approach would be to visualize directly the S-Phase 
cell population for example by EdU or BrdU assays. Specified algorithms and programs, like Modfit LT 
(Verity Software House), can then use this data to give a more sophisticated estimation of the different 
cell cycle phases. Especially the determination of S-Phase is debatable, since Schneider cells do not show 
a clear S-Phase plateau in the flow cytometer and S-Phase cells overlap with the G1- and G2-peak. This is 
possibly also the explanation of a peculiarity in the data regarding the stability of Dap dCDI. In the majority 
of these experiments, Dap dCDI was not degraded in S-Phase, which it must be, because degradation 
depends on PCNA, present exclusively in S during DNA replication. This was probably an artifact of the flow 
cytometric protein stability assay. Experiments already showed that the population of cells called “G1” 
actually also contains cells in early S-Phase, whereas the population called “S” is composed of cells in the 
middle of S-Phase in this setup (Heimbucher, 6-week internship). These inaccuracies should be kept in 
mind in the interpretation of protein stability in the three distinct cell cycle phases. 
Lastly, the statistical analysis of individual experiments with large sets of data might be improved by using 
alternative methods, for example an ANOVA (analysis of variances). The applied statistical analysis might 
also explain why the control experiments sometimes showed a statistically significant effect on mCherry 
stability upon overexpression of different components (see Figure 20C, Figure 35A and C and Figure 47C). 
In all other cases, stability of the control fluorescent proteins stayed unaltered, regardless of any 
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overexpression. Nonetheless, with the knowledge of the time point of writing this thesis, Skp2 did not 
negatively regulate Dap stability. 
Beside protein stability assays, co-immunoprecipitations with Skp2 and Dap were performed to test for 
biochemical interaction. Most Co-IPs showed no interaction between these two proteins, although many 
parameters were changed during the thesis. Interaction of Skp2 4xFLAG with HA Dap was never seen. 
Furthermore, the simultaneous overexpression of Cks85A did also not result in protein interaction. To test 
if the tags were critical for this potential interaction, they were swapped. Yet, an interaction between 3xHA 
Skp2 and 4xFLAG Dap was also not visible, regardless of the presence of Cks85A. 
This was in contrast to the published observation that Skp2 interacts with Dap in S2 cells and that 
overexpressing Cks85A does lead to a boost of this effect (Dui et al., 2013). All versions of Skp2 tested here 
showed very strong interaction with Cks85A (which was used as a positive control in all Co-IP experiments 
and not shown). Furthermore, the used versions of all proteins, regardless of Skp2 or Dap, resulted in 
principle in the expected cell cycle changes and stability. This is a hint that these proteins are in fact active, 
ruling out this potential source of misinterpretation.  
Finally, some interaction could be observed if 4xFLAG Dap or 4XFLAG-Dap-dCDI was precipitated and HA 
Skp2 detected. However, unspecific binding of HA-Skp2 was also observed and the validity of this result 
has to be considered carefully. Since both Dap and Dap dCDI showed interaction with Skp2, it can be ruled 
out that the interaction was indirect. It was a possibility that Skp2 binds indirectly to Dap through 
interaction with Cks85A (Ghorbani et al., 2011), which binds to CycE/Cdk2 (Ghorbani et al, 2011), which is 
the target of Dap binding (Lane et al., 1996). Precipitating Dap may lead to a co-precipitation of all other 
components, so that Skp2 is detectable on the Western Blot without actual direct interaction, therefore. 
Dap dCDI is no longer binding to CycE/Cdk2 however, and this theory can be rejected. 
Mass-spectrometric analysis of 4xFLAG Skp2 interaction partners also failed to detect Dap (see 6.6). In 
addition, another MS-analysis was performed the Sprenger group with the aim to identify interaction 
partners of 4xFLAG Dap dCDI dPIPa. Skp2 is also not found in this analysis with a significant score (Kies, 
2017), another hint that there does not exist an interaction between both proteins. 
In conclusion, it was not possible to detect a robust biochemical interaction between Dap and Skp2 in the 
presented results. While it is difficult to rule out technical aspects, this data is in agreement with the 
stability analysis of Dap and the biological assays (G1-rescue, see below). Furthermore, biochemical 
interaction does not automatically mean ubiquitination, and ubiquitination does not mean degradation. 
As already mentioned, it is known, at least in one case, that Skp2 mediated ubiquitination leads to protein 
activity (Lee et al., 2015). Co-IPs alone can therefore not prove negative regulation of Dap by Skp2.  
Lastly, the biological effect of Skp2 on the Dap G1 arrest also argues against an involvement of Skp2 in Dap 
degradation. The combined overexpression of Dap and Skp2 led to an even greater accumulation of cells 
in G1-Phase and not to a rescue of the accumulation in G1. It is hard to say if this result can be traced back 
to an independent function of both proteins or if both overexpressions were working synergistically to 
excel the single effects. Anyway, a rescue was by all means not detectable, speaking again against a 
degradation of Dap triggered through binding to Skp2.  
Until now, there are two sources differing in their results regarding the regulation of Dap by Skp2 in 
Drosophila. While Ghorbani et al. (2011) did not see Dap being a substrate for SCFSkp2, Dui et al. (2013) saw 
evidence for this relationship. One aim of this thesis was to solve this discrepancy. The majority of the 
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gathered results showed that it is very unlikely that Dap is negatively regulated by Skp2 in flies. The only 
result speaking for this theory, the stabilization of Dap dCDI dPIPa upon Skp2 knockdown, can be explained 
alternatively. There were minor hints for stabilization of Dap through Skp2 activity. Dap dCDI showed 
stabilization if Skp2 was overexpressed and biochemical interaction was detected, albeit this result was 
not without doubt. Therefore, it is questionable if this relationship can be confirmed. More experiments 
have to be undertaken to make a clear conclusion. Negative regulators for Dap may be, as already 
mentioned, Rca1 (Kies, 2017) or other unconsidered F-Box proteins. In this regard, it should be mentioned 
that p27 is at least in NIH 3T3 cells and mouse embryonic fibroblasts, not only degraded by SCFSkp2 and 
CRL4Cdt2 but also by the Kip1 ubiquitination-promoting complex KPC (Kamura et al., 2004), opening the 
possibility for additional regulators of Dap. 
The question remains why Dui et al. (2013) did see a Skp2 dependent degradation of Dap and biochemical 
interaction between both proteins. Some of these results can be explained in an alternative way. Since the 
authors used Dap full length for their assays, the cell cycle of the used Schneider cells was deeply disturbed. 
This may have a wide range of effects on the processes in a cell with uncontrollable outcome for the 
molecular mechanisms. For example, it is well known that the Dap homologue p27 needs to be 
phosphorylated in order to get ubiquitinated (Montagnoli et al., 1999). This may also be the case in D. 
melanogaster. Dap overexpression means less CycE/Cdk2 activity and consequently less phosphorylation 
of Dap, making it unlikely to become a target for SCFSkp2. Another example is their result that Skp2 
knockdown leads to more Dap protein. Skp2 knockdown however led to a prominent accumulation of cells 
in G2-Phase were Dap is no longer a target of degradation, resulting in stabilization. Since the results 
presented in this thesis are from Dap mutations that do not affect the cell cycle any longer and are not 
degraded by CRL4Cdt2, these possible sources of misinterpretation are diminished and the presented 
analysis is much more precise. 
One difference in the Co-IP experiments was the tag of the Dacapo protein. The experiments performed 
in this thesis were done with a HA tagged and not Myc tagged Dap as in the publication and it may be that 
the HA tag is preventing Skp2 to bind to Dap. On the other side, the HA tag does not prevent Dap from 
being recognized by Rca1, another F-Box protein (Kies, 2017). An additional aspect that differed were the 
buffer conditions, though it has to be said that positive controls in general worked with the used buffers 
and, more importantly, that interaction between Skp2 and other potential substrates could be seen with 
this setup (see 6.4 and 6.5). 
Another possible explanation is that the used cell lines are different and Skp2 behaves differently in this 
case. Dui et al. (2013) used S2 cells, while the cells used in this thesis were S2R+. This may on the first 
glance not make a big difference but it is known that different Schneider cell lines show high diversification 
and different transcription patterns (Cherbas and Gong, 2014). Furthermore, it is known that, at least in 
certain rat cells, the function of Skp2 is dependent upon cell adhesion. Skp2 overexpression did lead in 
these cells to more incorporation of BrdU, equivalent to more S-Phase cells. Yet, this effect could only be 
observed in non-adherent Rat-6 cells, adherent cells did not show any effect on Skp2 overexpression 
(Carrano and Pagano, 2001). This is interesting, since one difference between the two Drosophila cell lines 
is in fact that S2R+-cells are more adherent than S2. Non-adherent cells are not included in the assays since 
the sample preparation protocols (see 4.2.6.2) in the Sprenger group discard the medium before any 
experiments, only cells sticking on the bottom of the well are analyzed. This may also underline the 
assumption made in mammalian cells that Skp2 function is dependent of the cell type (Krishnan et al., 
2017). 
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6.4. Cdt1 stability is regulated by SCFSkp2 in D. melanogaster 
Cdt1 is an important regulator of DNA replication and a known substrate of SCFSkp2 in mammalian cells (Li 
et al., 2003). Skp2 mediated ubiquitination marks Cdt1 for proteasomal degradation, which is one way for 
regulation of Cdt1 activity during the cell cycle. Overexpression of Cdt1 results in rereplication in human 
cells (Liu et al., 2007) and fly cells (see Figure 32). Rereplicating cells were also seen upon prolonged Skp2 
knockdown (see 6.1.1), making it possible that Cdt1 is a substrate of Skp2. These hints led to an 
investigation if SCFSkp2 also targets Cdt1 in flies. 
Cdt1 overexpression showed rereplication (Figure 32B). This resembles the results of Cdt1 overexpression 
in some human cancer cell lines (H1299 and U2OS) that also exhibit rereplication under these treatments. 
It has to be said though that the effect of Cdt1 overexpression is dependent upon the used cell line. Only 
human cancer cell lines exhibit rereplication if Cdt1 is overexpressed. Non-cancer cell lines respond to Cdt1 
overexpression alone only weakly (Liu et al., 2007). Yet, a simultaneous overexpression with Cdc6 leads to 
rereplication also in these cases (Sugimoto et al., 2009). 
Overexpression of Cdt1 dPIP that is no longer targeted by CRL4Cdt2 for ubiquitination in S2R+-cells exhibited 
a stop of the cell cycle, possibly not in G1- but in early S-Phase, since the peak of the distribution curve 
was slightly shifted (Figure 32C). This hypothesis should be investigated further, for example by using S-
Phase cell cycle markers or the incorporation of BrdU in the DNA during DNA-synthesis. Both assays would 
give reassurance of the S-Phase cell cycle stop. The described Cdt1 dPIP overexpression effects in 
S2R+-cells are similar to the results of a study that also used a PIP-Box-deleted Cdt1 version in Drosophila 
embryos (Lee et al., 2010). Overexpression of this Cdt1 dPIP version did also lead to a stop of the cell cycle 
in S-Phase in epidermal cells of fly embryos. The authors speculated that turning off the PIP-mediated 
degradation of Cdt1 leads to high levels in S-Phase, resulting in reinitiation of replication origins. Thereby, 
DNA damage occurs and a checkpoint is activated, which stops the cell cycle. This study also found that 
ubiquitous expression of Cdt1 dPIP led to embryonic death and that the PIP-Box dependent degradation 
of Cdt1 is exclusively important for the proliferating tissues; cells that perform endocycles are not 
disturbed. The situation in higher eukaryotes seems to be similar. A stabilized version of Cdt1, lacking the 
first 32 amino acids including the PIP-Box, was overexpressed in HeLa cells. In this case, cells accumulate 
for a prolonged period in G1-Phase, and furthermore subsequent S-Phase is longer as well (Takeda et al., 
2005). Deactivating the prominent PIP-degradation pathway of Cdt1 probably results in protein 
accumulation. Another example are human U2OS cells, where an accumulation of Cdt1 leads to activation 
of cell cycle checkpoints, resulting in a stop in S-/G2-Phase (Klotz-Noack et al., 2012). 
Rereplication of S2R+-cells was not observed in this thesis if Cdt1 dPIP was overexpressed. This is also in 
concordance with Takeda et al. (2005), since the authors showed that the capability of their truncated 
Cdt1 version to trigger rereplicaton is abolished. 
Working with full length Cdt1 is challenging since cell cycle effects and PIP-degron dependent degradation 
are making the interpretation of the results difficult. Cdt1 15-600 was created by deleting the PIP-degron 
and the MCM binding domain, eliminating these factors. The effect of Cdt1 15-600 on the cell cycle was 
greatly diminished, yet, there still was a slight shift into G1-Phase visible (Figure 32F,G). Further truncations 
of Cdt1 with a deleted Geminin binding domain showed similar effects, excluding an involvement of 
Geminin in this cell cycle shift (Figure 38B,C). The cause of this shift therefore is unknown and requires 
further analysis.  
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In order to analyze if Skp2 mediates degradation of Cdt1 the first set of experiments were performed with 
GFP Cdt1 1-600. Table 22 summarizes the results of the flow cytometric stability analysis. In concordance 
with the assumption that Cdt1 is regulated by Skp2, stability was reduced by overexpression of Skp2 and 
Skp2 and CycE combined. Likewise, Skp2 knockdown led to stabilization of GFP Cdt1 1-600. These were 
only preliminary results, however, since Hoechst fluorescence, necessary for determining the cell cycle 
distribution, is interfering with the GFP signal, diminishing the accuracy of the stability. In this Cdt1 version, 
the N-terminal PIP-degron motive is not deleted. However, it seems reasonable that the PIP-degron is not 
active in this construct, since fusing large protein tags to the N-terminus of Cdt1 impedes this degradation 
pathway (Senga et al., 2006). To exclude this possibility completely, all further experiments with mChe 
tagged versions of Cdt1 featured a deleted PIP-Box. 
Table 22 Summary of flow cytometric protein stability analysis of GFP Cdt1 1-600 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
GFP Cdt1 1-600 
Expressed constructs all G1 S G2 
Skp2  - - 0 - 
CycE 0 0 0 0 
Skp2 + CycE - - - 0 
Skp2 Hairpin vs. Hygro Hairpin + + + 0 
 
Subsequent experiments were performed with mChe tagged versions of Cdt1. One caveat in all mChe Cdt1 
experiments was that analysis of different expression levels showed strong differences in protein stability. 
This effect had probably something to do with Cdt1, since it was not observed in any of the other 
experiments in this thesis. A speculative explanation is that the expression levels of Skp2 (or Skp2 hairpin 
in case of knockdown experiments) were not proportional to the expression of mChe Cdt1. In other words, 
the ratio of Skp2 to Cdt1 protein may not always be identical in both expression levels, which will of course 
affect the stability of Cdt1. This effect was not seen in experiments with Dacapo (see section 6.3) or CycE 
(see section 6.5) to a great extent, probably because these proteins did not show regulation by Skp2 in the 
flow cytomentric protein stability assay.  
Stability analysis of mChe Cdt1 15-600 (Table 23) showed a distinct destabilization effect of Skp2 
overexpression only if CycE was also overexpressed. CycE overexpression corresponds to more Cdk2 
activity and consequently to more phosphorylation. It is already known that Drosophila Cdt1 is 
phosphorylated by CycE/Cdk2 activity (Thomer et al., 2004). Furthermore, it could be shown that at least 
one of the used constructs (Cdt1 15-263) is phosphorylated upon CycE overexpression by using a PhosTag 
enriched SDS-PAGE gel (Heimbucher, 6-week internship). It is also well known that substrates have to be 
phosphorylated for the recognition by Skp2 (Skaar et al., 2013). 
Furthermore, Skp2 dF-Box stabilized Cdt1 15-600 under CycE overexpression conditions and exhibited a 
dominant-negative effect thereby. This is an approach used routinely for identifying new substrates of 
F-Box proteins (Carrano et al., 1999). Skp2 knockdown did also have a stabilizing effect on mChe Cdt1 15-
600, another argument for Skp2 dependent regulation. The conclusion drawn from these experiments was 
that Cdt1 is indeed a substrate for SCFSkp2 in D. melanogaster, its recognition by Skp2 dependent on the 
phosphorylation status. 
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Table 23 Summary of flow cytometric protein stability analysis of mChe Cdt1 15-600 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
Che Cdt1 15-600 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Expressed constructs all G1 S G2 all G1 S G2 
Skp2  0 - + - 0 - 0 0 
Skp2 dF-Box + 0 + 0 + 0 + + 
Che Cdt1 15-600 + CycE 
Skp2 - - - - - 0 - 0 
Skp2 dF-box + + + 0 + + + 0 
Che Cdt1 15-600 
Skp2 Hairpin vs. Hygro Hairpin + + + + + 0 + + 
 
Interestingly, the study of Cdt1 dPIP effects in embryos (Lee et al., 2010) did not find a stabilization of Cdt1 
if regulation by both degradation pathways are eliminated. By combining their PIP-Box deletion with the 
10A version of Thomer et al. (2004), which probably also eliminates the Skp2 mediated degradation, the 
authors created a Cdt1 version that should be in theory stable in the cell cycle. Yet, the result of this 
experiment is that the additional 10A mutations, eliminating the phospho-sites that are presumably 
important for the degradation by the SCFSkp2-complex, do not increase the Cdt1 stability, speaking against 
a phospho-dependent regulation through SCFSkp2. One possibility is, of course, that Cdt1 regulation differs 
in embryos in comparison to S2R+-cells. It could also be that the method to determine protein stability in 
this case was imprecise. The authors used BrdU staining to identify S-Phase cells in embryos and applied 
immunostainings against their Cdt1 versions to find out if Cdt1 is absent in S-Phase cells. This is however 
not a fitting method to determine gradual or modest changes in protein stability. The assays used in this 
thesis are probably more sensitive in this respect. 
Various truncations of Cdt1 were created with the aim to identify the phosphorylation sites necessary for 
recognition by Skp2. In a first step, mChe Cdt1 15-300 was created, deleting the Geminin-binding site. 
Results of flow cytometric protein stability analysis were for the most part comparable to Cdt1 15-600, 
destabilization was seen if Skp2 and CycE were overexpressed simultaneously (Table 24). Likewise, Skp2 
dF-Box overexpression led to stabilization of Cdt1 15-300 under these conditions. It seems that Skp2 and 
CycE overexpression did not affect Cdt1 15-600 in G2-Phase in the higher expression level, yet, Cdt1 15-
300 was degraded by the same treatment. This corresponds to the situation in human cells, were one task 
of Geminin is to protect Cdt1 from proteasomal degradation in G2 and M (Ballabeni et al., 2004). Later on, 
it was shown that Geminin protects Cdt1 explicitly from the recognition by Skp2 and degradation in mitosis 
(Tsunematsu et al., 2013). The presented data hints that this may also be the case in D. melanogaster. It 
should be noted however that this effect was only visible if higher expression levels were analyzed. The 
experiments did not show any difference in case of the lower expression level and more experiments have 
to be performed to make a clear statement about a potential protective function of Geminin in Drosophila. 
In any case, since Cdt1 15-300 still reacted to Skp2 and Skp2 dF-Box overexpression, the phosphorylation 
sites were still present in this fragment. Therefore, Geminin seems to play no part in this degradation 
pathway. 
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Table 24 Summary of flow cytometric protein stability analysis of mChe Cdt1 15-300 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
Che Cdt1 15-300 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Expressed constructs all G1 S G2 all G1 S G2 
Skp2  0 - 0 - 0 - 0 - 
Skp2 dF-Box + 0 + 0 0 0 + - 
Che Cdt1 15-300 + CycE 
Skp2 - - - - - 0 - - 
Skp2 dF-box + + + 0 + 0 + + 
 
The stability and phosphorylation sites of Drosophila Cdt1 were already investigated. As mentioned before, 
Thomer et al. (2004) found that Cdt1 stability is partly dependent upon 10 phosphorylation sites residing 
within the first 300 amino acids of the protein. Mutating all 10 phospho-sites results in partial stabilization 
of this fragment. The authors of this paper assume that a second, phosphorylation independent way of 
degradation exists. Probably, this is the degradation by CRL4Cdt2, mediated by the PIP-degron in Cdt1, since 
the function of the PIP-degron was not known back in 2004. 
Table 25 Summary of flow cytometric protein stability analysis of mChe Cdt1 15-225, Cdt1 15-263 and Cdt1 170-300 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
Che Cdt1 15-225 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Expressed constructs all G1 S G2 all G1 S G2 
Skp2  + + + 0 0 0 0 - 
Skp2 dF-Box 0 0 + 0 0 0 0 0 
Che Cdt1 15-225 + CycE 
Skp2 0 0 0 0 - - - - 
Skp2 dF-box 0 0 0 0 0 0 0 0 
Che Cdt1 15-263 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Skp2  0 0 0 0 0 - 0 0 
Skp2 dF-Box 0 0 0 0 0 0 0 0 
Che Cdt1 15-263 + CycE 
Skp2 - 0 - - - 0 - - 
Skp2 dF-box + 0 + 0 0 0 0 0 
Che Cdt1 170-300 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Skp2  0 0 + 0 0 0 0 0 
Skp2 dF-Box + + + + 0 0 + 0 
Che Cdt1 170-300 + CycE 
Skp2 0 0 0 0 0 0 0 0 
Skp2 dF-Box + 0 + 0 0 0 0 - 
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Regarding the state of knowledge, one can assume that SCFSkp2 needs either one, a subset or all of these 
10 phosphorylation sites to recognize Cdt1 as its substrate. Consequently, these 10 phospho-sites were 
closer analyzed. To minimize the mutations needed for this analysis, three truncations of the N-terminal 
part were analyzed beforehand. 
From the three tested truncations, only mChe Cdt1 15-263 showed a degradation pattern resembling that 
of Cdt1 15-600 (Table 25). mChe Cdt1 15-225 was not degraded under CycE overexpression conditions if 
the lower expression level was analyzed and stabilization upon Skp2 dF-Box expression was never seen. 
Furthermore, Skp2 overexpression alone led to stabilization, which is very unusual, disqualifying this 
fragment for further analysis. Cdt1 170-300 on the other hand was never degraded upon Skp2 
overexpression. 
Cdt1 15-263 still contained six optimal phosphorylation sites, S111, T158, S168, S226, S249 and T256 
(Thomer et al., 2004), four of which were mutated. The mutation Cdt1 15-263 T158A was not expressed 
in S2R+-cells for unknown reasons and was also dropped from analysis.  
Cdt1 15-263 S111A, S168A and S226A were analyzed and all showed destabilization after CycE and Skp2 
overexpression like Cdt1 15-600 (Table 26). 
Table 26 Summary of flow cytometric protein stability analysis of mChe Cdt1 15-263 S111A, S168A and S226A 
- and black box = destabilization; + and white box = stabilization; 0 and grey box = no effect 
Che Cdt1 15-263 S111A + CycE 
 Expression level: 1.25 – 2.00 Expression level: 2.00 – 2.75 
Expressed constructs all G1 S G2 all G1 S G2 
Skp2  - - - - - 0 - - 
Che Cdt1 15-263 S168A + CycE 
Skp2  - 0 - - - 0 - - 
Che Cdt1 15-263 S226A + CycE 
Skp2  - 0 - 0 - - - - 
 
Thus, critical phosphorylation sites responsible for recognition by Skp2 could not be identified, yet. It may 
well be that the remaining unmutated sites are responsible for the interaction with Skp2. Another 
possibility would be that beside the optimal phosphorylation sites, the minimal consensus sites (with the 
motive S/T-P) might also play a role in the recognition by SCFSkp2. On the other hand, single mutations 
might not lead to a loss of the interaction with Skp2 and stabilization. Indeed, in human Cdt1 it is assumed 
that two sites, T29 and S31, might have to be phosphorylated for Skp2 binding (Nishitani et al., 2006). T29 
is at least confirmed as important in this regard (Takeda et al., 2005). The authors of the same paper also 
state that up to their knowledge all SCFSkp2 substrates are phosphorylated at a threonine for recognition, 
making the Cdt1 T158A and T256A mutations a worthy subject of further investigation. Besides mutating 
the last two phospho-sites, another rewarding approach would be to create a Cdt1 6A version, were all six 
relevant sites are phosphorylated. This might lead to insensitivity of Cdt1 toward Skp2 overexpression, 
confirming the importance of the selected phospho-sites. Further analysis using a combination of single 
mutations or mutating other phosphorylation sites might be necessary to unravel critical phosphorylation 
sites. 
Biochemical interaction between Skp2 and Cdt1 15-600 could also be detected, though according to the 
signal intensity, this interaction was only weak (Figure 50). It is possible that the majority of ubiquitinated 
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Cdt1 is rapidly degraded by the proteasome. Using a proteasomal inhibitor (e.g. MG132 or Bortezomib) 
may stabilize Cdt1 and lead to stronger signals. However, a direct physical binding between Skp2 and its 
substrates may be extremely short and therefore hard to detect in a Co-IP assay (Frank Sprenger, personal 
communication). 
As mentioned, overexpression of Cdt1 or Cdt1 dPIP in S2R+-cells led to changes in the cell cycle 
distribution. Cdt1 overexpression resulted in accumulation in G2-Phase and rereplication, while 
overexpressing Cdt1 dPIP showed more cells in G1- or early S-Phase. Modulating the amount of Skp2 
protein did influence the cell cycle phenotypes of Cdt1 overexpression and knockdown (Figure 51 and 
Figure 52). This is a hint for genetical interaction between both proteins. Skp2 overexpression reduced the 
rereplication caused by Cdt1, possibly because the excess amount of Cdt1 could be controlled by the 
higher amount of SCFSkp2 in this case. The cell accumulation in G1 or early S-Phase upon Cdt1 dPIP 
overexpression was also weakened upon Skp2 overexpression. Remarkably, Skp2 overexpression resulted 
in a reappearance of a G2 cell peak, in accordance with an increased degradation of Cdt1 dPIP. Skp2 
overexpression effects observed in this thesis were always an accumulation of cells in G1. Therefore, the 
reappearance of G2 peak was not connected to other functions of Skp2 and a strong hint for a direct effect 
of Skp2 on Cdt1 dPIP. Both observations also underline that Skp2 regulation worked independently from 
PIP-box mediated degradation of Cdt1. Likewise, Skp2 knockdown did intensify the G2 cell accumulation 
of the Cdt1 overexpression, probably because the cell was lacking the ability to regulate Cdt1 by SCFSkp2 in 
this case. Importantly, Skp2 knockdown did also strengthen the stop at the G1/S boundary upon Cdt1 dPIP 
overexpression. This is remarkable, since Skp2 knockdown normally did always lead to more cells in the 
G2-Phase. This reversal is strong evidence for a direct effect of Skp2 on Cdt1 and in concordance with the 
equally unusual cell cycle effect of Skp2 overexpression, when Cdt1 dPIP is also overexpressed (see above). 
It cannot be explained by the effect that Skp2 knockdown may have on other cell cycle proteins since only 
under Cdt1 dPIP overexpression conditions did Skp2 knockdown led to G1 cell accumulation. 
Cdt1 knockdown led to a stop of the cell cycle in G1-Phase and to cells with a smaller DNA content than 
2C (Figure 52B). This corresponds to effects found in Drosophila Schneider 2D cells. Cdt1 knockdown does 
also lead to a sub-G1 cell population in this case (Mihaylov et al., 2002). The authors speculated that Cdt1 
knockdown leads to uncoupling of mitosis and DNA replication, leading to cell division during G1-Phase. 
As a result, unusually small cells with a DNA content smaller than 2C will occur. This is not a general 
phenomenon though, HeLa cells do not show any visible cell cycle effect upon Cdt1 knockdown (Sugimoto 
et al., 2011), though HeLa cells, as a non-cancerous cell line, may be insensitive at least to Cdt1 
overexpression. Simultaneous Skp2 knockdown rescued the Cdt1 knockdown partly (Figure 52D), another 
hint for genetic interaction between these two proteins. 
In accordance with Skp2 being a regulator of Cdt1, the overexpression strengthened the Cdt1 knockdown 
phenotype, G1 cell accumulation was more pronounced, though this was only a minor effect (Figure 52E). 
Conversely, the number of cells smaller than 2C was also reduced, although a strengthening of the effect 
was expected. Perhaps this effect was the result of Skp2 regulation of as yet unidentified cell cycle 
regulators in Drosophila.  
As a conclusion, the data presented in this thesis strongly hinted that Drosophila Cdt1 is regulated by the 
activity of SCFSkp2. As a prerequisite for this regulation, Cdt1 has to be phosphorylated by CycE/Cdk2. This 
differs from data gathered in mammalian cells, were CycA/Cdk1 is the kinase responsible for Cdt1 
phosphorylation (Pozo and Cook, 2016). However, CycE/Cdk2 is already discovered as the kinase 
responsible for Cdt1 phosphorylation in flies (Thomer et al., 2004) and this thesis underlines this fact. CycA 
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might still play a role though and further experiments may show if CycA/Cdk1 does also phosphorylate 
Cdt1 in D. melanogaster.  
Considering the effect strength of modulated Skp2 levels on Cdt1 stability, it can be argued that Skp2 is 
not the main pathway for Cdt1 regulation. Indeed, Cdt1 is strongly regulated in the cell, since it is one of 
the key regulators of DNA replication (Pozo and Cook, 2016). There exist at least three more proteasomal 
degradation pathways to regulate Cdt1 stability: ubiquitination by SCFFbxo31, regulating Cdt1 in G2. 
Regulation by APC/CCdh1, necessary if cells enter G0 state. And of course, PIP-mediated ubiquitination by 
CRL4Cdt2, responsible for S-Phase degradation or if DNA damage occurred (Hernandez-Carralero et al., 
2018). Indeed, it is already shown in HeLa cells that Skp2 mediated degradation is not the main pathway 
for Cdt1 regulation. If the Skp2 recognition of Cdt1 is excluded by mutation of the responsible phospho-
sites, Cdt1 is still efficiently degraded, probably by CRL4Cdt2 (Takeda et al., 2005). All stability data in this 
thesis was gathered with Cdt1 versions that did not possess a functioning PIP-degron to concentrate solely 
on the effect of Skp2. Skp2 represents only one of several ways of Cdt1 regulation, and may only work as 
a supporter or back-up system. Another idea that already was proposed is that ubiquitination and 
subsequent degradation of Cdt1 by CRL4Cdt2 cannot start directly in S-Phase, since it is dependent upon 
binding of PCNA on DNA. Consequently, there exists a time span until DNA replication starts and PCNA is 
recruited to the DNA, were Cdt1 would not be regulated and reinitiation of the replication origins could 
occur, with severe consequences for the replication machinery. Skp2 dependent degradation may keep 
Cdt1 activity under control in the beginning of S-Phase when DNA replication has not started and CRL4Cdt2 
cannot execute its regulatory function yet (Havens and Walter, 2011). Furthermore, Skp2 may also play a 
role to regulate Cdt1 levels after S-Phase, since uncontrolled activity may lead to origin firing and 
erroneous DNA replication. Interestingly, Ghorbani et al. (2011), the paper that identified Skp2 in D. 
melanogaster, did not see a regulation of Cdt1 by Skp2. Western Blots showed that the amount of Cdt1 
protein either in whole 3rd instar larvae or in mitotic tissue (brains and imaginal discs) is not affected by 
Skp2 knock out. This is no contradiction to the conclusions of this thesis though, since endogenous Cdt1 is 
still degraded in S-Phase by CRL4Cdt2, underlining the point that Skp2 has supporting function in Cdt1 
regulation. 
6.5. Results regarding Skp2 regulation of CycE are ambiguous 
Flow cytometric analysis showed that CycE overexpression led to a dramatic shift of the cell cycle into G2-
Phase and that CycE was unstable (Figure 53C). This shift is a result of the biological function of CycE; it 
binds and activates Cdk2, which ultimately leads to gene transcription of S-Phase genes and consequently 
to a rapid transition from G1- to S-Phase. The high instability is derived from proteasomal degradation in 
S-Phase by ubiquitination through SCFAgo (Moberg et al., 2001). Skp2 is also identified in the mammalian 
system as a cause for CycE instability (Nakayama et al., 2000). In this thesis, experiments were conducted 
to test if CycE stability is influenced by Skp2 in the fly system. According to the data of the flow cytometric 
protein stability analysis, Skp2 overexpression or knockdown did not influence the stability of CycE (Figure 
53). However, the strong instability of CycE, likely mediated by SCFAgo, and the strong influence of CycE on 
the cell cycle made this analysis difficult to interpret. 
It was tried to overcome the S-Phase dependent degradation and the CycE cell cycle effect by strong Dap 
overexpression. This resulted in a constant inhibition of CycE/Cdk2 activity and partial normalization of the 
cell cycle distribution. The possibility that Skp2 will interact with the ectopically expressed Dap was 
rejected because of the data regarding Skp2 regulation of Dacapo already gathered (see 6.3). 
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Dap overexpression did indeed lead to a cell cycle with distinguishable phases and to CycE stabilization 
(Figure 53D). However, experiments with Skp2 overexpression and knockdown in this setup did also not 
show any effect on CycE stability. It is striking that the standard deviation was unusually high in these 
cases. This may be a hint that some factor, perhaps CycE stability or Skp2 activity, was reacting differently 
to the Dap G1 arrest in the different replications. Possibly the G1 arrest was disturbing the cell cycle in 
such a fierce way that the normal processes are no longer working reliably. These data may be considered 
as also not reliable therefore. 
Conversely, it is already known that SCFSkp2 is regulating CycE in mouse and human cells (Nakayama et al., 
2000). In these cases, Skp2 targets specifically free, unbound CycE. Indeed, it was possible to detect 
biochemical interaction between Skp2 and CycE in flies with a Co-IP assay (Figure 56), which hints towards 
Skp2 dependent regulation. Furthermore, the observed cell cycle shifts upon changed Skp2 levels (Figure 
11B,E; Figure 14C) are in concordance to the theory that Skp2 regulates CycE.  
While the Co-IP experiment pointed to CycE being a substrate of Skp2, the flow cytometric protein stability 
analysis did not support this notion. A final conclusion is not possible, therefore. One way to tackle this 
challenge is to create a CycE mutant that is no longer capable of Cdk2-binding. Overexpression of this 
mutant will no longer perturb the cell cycle. Protein stability of this mutant will presumably also be higher 
than wild type CycE since cells are not progressing rapidly to S-Phase any longer, minimizing the influence 
of the SCFAgo dependent degradation. Furthermore, this CycE version would exclude the possibility that 
Cdk2 protects it from Skp2 recognition. This could help to focus solely on the Skp2 effects regarding 
stability in the analysis. Indeed, recently such CycE mutants were generated in the lab, called CycE-deltaN-
E340A and CycE-deltaN-K311A. Preliminary experiments showed that these versions are showing slight 
stabilization upon Skp2 knockdown (Serena Herzinger, personal communication), indicating that Skp2 may 
after all play a role in the regulation of CycE in D. melanogaster. 
6.6. Mass spectrometric analysis revealed interaction of Skp2 with Cdk2 but did not 
identify interaction partners 
Mass spectrometric analysis of 4xFLAG Skp2 binding partners showed that SkpA and Cul1 were interacting 
with this Skp2 version (Table 18). This is important, since it proved that the ectopically expressed 4xFLAG 
Skp2 was indeed incorporated in a SCF-complex. 4xFLAG Skp2 can perform its biological function of binding 
substrates to an E3 ubiquitin ligase therefore.  
Another interesting hit was Cdk2. Indeed, it is already known that Skp2 biochemically interacts with Cdk2 
through a Co-IP assay in Drosophila (Ghorbani et al., 2011). It is unlikely that Cdk2 is a target of SCFSkp2 
ubiquitination and proteasomal degradation. In general, Cdks are stable proteins that are not regulated in 
the course of a cell cycle. Instead, Cdk activity is regulated by binding of cyclins and cyclins are the primary 
target of various cell cycle regulation mechanisms. Cdk2 is marked by the E3 ubiquitin ligase KLHL6 
however, leading to proteasomal degradation. Yet, this does not happen during the cell cycle. Instead, 
proteasomal degradation of Cdk2 is a way for a cell to permanently exit the cell cycle and start cell 
differentiation (Ying et al., 2018). It is highly unlikely therefore, that Skp2 targets Cdk2 for ubiquitination 
and consequent proteasomal degradation during the cell cycle. 
Another hypothesis is that Skp2 binds to Cdk2 to efficiently find and bind its targets. As already mentioned, 
Skp2 targets normally have to be phosphorylated. This phosphorylation is at least partly performed by the 
CycE/Cdk2 complex. If Skp2 is bound to Cdk2 during the phosphorylation of the substrate, Skp2 and its 
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substrate are located close together, allowing for efficient binding and ubiquitination of the substrate. This 
leads to a maximization of the ability of Skp2 to regulate its substrates. The fact that F-Box protein 
substrates need to be bound on a cyclin/Cdk complex for ubiquitination is indeed already known. I-κB for 
example can only be recognized by F-Box proteins if complexed with a cyclin/Cdk complex (Yaron et al., 
1997). More interestingly, that kind of mechanism is also already known for p27 and Skp2 in HeLa cells. In 
order for p27 being recognized by Skp2, this protein has to be not only phosphorylated but also bound to 
Cyclin E/Cdk2 (Montagnoli et al., 1999). Later on, a model was created of how this mechanism works. p27 
is bound to Cyclin E/Cdk2 and phosphorylated (Xu et al., 2007). Cks1 (human homologue to Cks85A in flies) 
is also interacting with CycE/Cdk2, were it helps to recruit substrates to the complex (Bourne et al., 1996). 
Skp2 can be recruited to the complex by binding to Cks1, indeed Cks1 has three distinct binding sites, one 
for phosphorylated substrates, one for binding to cyclin/Cdks and one for interaction with Skp2 (Bourne 
et al., 1996; Hao et al., 2005). Furthermore, it is already shown that it is not uncommon for human Skp2 
to bind to Cyclin/Cdk complexes. Skp2 can interact with the Cyclin A/Cdk2 complex through a novel Cyclin 
A binding domain. The amino acids necessary for that interaction are highly conserved, even in fly Skp2 (Ji 
et al., 2006; Ji et al., 2007). Indeed, it already is proposed that binding of p27 to Cyclin A/Cdk2 stimulates 
the ubiquitination through SCFSkp2 (Hao et al., 2005). Xu et al. (2007) proposed that after Skp2 is bound to 
the CycE/Cdk2 complex, p27 spans with its C-terminus onto Skp2 while still in contact with the cyclin-Cdk 
complex. Skp2 can therefore immediately bind its substrate after all components are grouped around Cdk2 
and the SCF complex starts the attachment of ubiquitin. 
A similar mechanism seems possible in D. melanogaster and the interaction with Cdk2 seen in this thesis 
and in Ghorbani et al. (2011) makes this a worthwhile field of study. For a start, in vitro experiments can 
show if Skp2 is principally interacting with a substrate (for example Cdt1) in the absence of Cdk2. It has to 
be said though that heterologous gene expression and purification of the various different Drosophila 
proteins necessary for this assay, may be complicated and time consuming. For in vivo studies, Co-IPs can 
be performed where it is not only tested if for example, Cdt1 co-precipitates with Skp2 but also Cdk2. 
However, these assays also have their disadvantages, since it is not possible to determine if all three 
proteins build one ternary complex or if Skp2 interacts with both Cdt1 and Cdk2 independently. 
Furthermore, it is always possible that protein interaction is lost during the process of a Co-IP (Shyu et al., 
2008). A worthwhile experiment for the detection of a ternary multi protein complex could be the 
combination of Bimolecular Fluorescence Complementation (BiFC) and Förster Resonance Energy 
Transmission (FRET). BiFC is based on two fragments of a fluorescent protein both fused to potential 
interaction partners. If the potential partners indeed interact with each other, the fragments are in close 
proximity and will form a complete, functioning fluorescence protein. Interaction can be seen by the 
appearance of a fluorescene signal therefore (Hu et al., 2002; Shyu et al., 2006). For FRET assays, two 
functioning fluorescence proteins are fused to the potential partners. If the partners interact, both 
fluorescent proteins are in close proximity to each other. One of them, the so-called donor, will be excited 
and the light that is emitted will be used by the second fluorescent protein, the so-called acceptor, for 
excitation. Consequently, interaction can be seen by the appearance of the fluorescent signal of the 
acceptor molecule (Jares-Erijman and Jovin, 2006). BiFC-FRET combines both assays, to analyze protein 
interaction in a ternary complex. Two proteins are tagged with the two fragments of the fluorescent 
protein of the BiFC assay, that itself serves as the acceptor protein. The donor protein is fused to the third 
interaction partner. If all three proteins interact, the donor protein can be excited and will transmit its 
emission energy to the now built acceptor protein, whose emission can be detected (Shyu et al., 2008). 
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This assay represents an elegant method to elucidate a potential supporting role of Cdk2 in the binding of 
Skp2 to its substrates. 
It is important to note that by comparison, only a small number of proteins were found by mass 
spectrometric analysis. An MS analysis of Rca1 binding partners performed in the same way (Kies, 2017), 
shows 1294 hits against only 154 hits in the presented data. Moreover, while 176 proteins with a function 
in the cell cycle are identified in the Rca1 assay, only seven were identified here. What is more, no 
prominent Skp2 interaction partner, neither Dap nor Cdt1, CycE or the homologues of the various 
interaction partners in vertebrates, were found. One possibility is a weak binding between Skp2 and its 
substrates making it impossible to detect the interaction with endogenous levels, rendering mass 
spectrometric analysis unfit for substrate identification. Indeed, it was already tried to strengthen the 
connection between Skp2 and its substrates by fusing Skp2 with a UBA-domain. This leads on the one hand 
to a tighter connection between both proteins and prevents on the other hand the substrates from 
proteasomal degradation (Mark et al., 2014). Results of the MS-analysis were comparable to 4xFLAG Skp2 
however and this data was not shown. It seems that MS-analysis with the constructs used in this thesis is 
not an appropriate tool for identification of new Skp2 substrates in D. melanogaster. 
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7.2. Complete results of the mass spectrometric analysis 
Table 27 Results of the mass spectrometric analysis of Skp2 binding partners 
Complete list of all hits of the mass spectrometric analysis of binding partners of Skp2. Analysis was performed as described in 
4.2.5.2. Depicted are the name of the protein, the number of found peptides, the sequence coverage (SC) in percent and the 
score. 
Protein Number of Peptides SC [%] Score 
Skp2 58 62.1 6115.9 
Hsc70-4 51 60.8 4199 
Hsp70Ab 40 55.5 3270 
Hrb98DE 31 56.0 2927.3 
Hsp70Bbb 34 55.2 2550.1 
zip 40 25.3 2415.4 
Hsp68 30 50.7 2356.8 
FI05241p 22 45.0 1577.7 
bel 24 41.7 1410.8 
CG30122 20 23.9 1362.9 
βTub56D 21 47.0 1087.8 
Hsc70-3 15 21.3 1024.1 
Hsp23 14 66.7 987.5 
αTub84D 15 44.2 879.6 
Act5C 13 43.1 757.6 
msk 15 18.8 708 
βTub60D 12 23.8 635.7 
Lam 11 24.8 618.6 
Chc 13 10.8 544.9 
His2A 5 54.8 532.7 
Karyβ3 12 16.5 529.2 
Hsp26 8 53.4 525.9 
Rpt5 11 32.5 504.6 
SkpA 7 54.9 498.5 
14-3-3ε 8 32.4 487.2 
lig 7 7.5 487.1 
Rpt2 9 26.7 484.4 
Act57B 9 30.3 481.4 
hyd 12 6.0 478.9 
Rpn2 10 16.6 461.5 
ZAP3 9 14.1 442.5 
Rpn1 11 17.3 431.1 
ref(2)P 6 15.7 411.8 
cher 10 6.0 393.8 
Hsp27 6 35.2 374.8 
Rpn5 8 19.9 368.3 
CG5787 8 11.5 356.7 
Rpt4 7 26.2 349 
Hsc70Cb 7 13.7 331.8 
Ubi-p63E 5 61.8 330.2 
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Rpn9 5 18.3 320.4 
Rpn3 6 17.0 309.1 
eIF4G1 7 6.5 302.1 
nop5 8 23.9 302 
Rm62 6 11.0 299.3 
RpL3 4 17.5 297.4 
tral 5 13.3 288 
Rpn13 6 30.7 281.6 
lin19 (Cul1) 5 8.8 273.6 
DnaJ-1 5 20.4 271.4 
Pp2A-29B 5 12.0 268.9 
Tep4 6 5.4 268.1 
Rpt6 6 14.6 267.4 
fmt 7 11.6 260.3 
Rpt1 5 17.3 251.6 
eIF4a 7 22.8 248.4 
Rpt3 5 25.4 234.8 
CCT3 6 14.9 233.7 
CG9590 4 23.2 231.5 
Kap-α3 3 8.8 223.4 
RpA-70 4 8.5 217.5 
Klp61F 6 8.3 210.1 
rin 5 11.7 203.7 
eIF2α 4 15.0 198.4 
RpL30 5 53.2 197.7 
RpS15Aa 4 40.8 196.8 
RpL4 4 16.5 195.2 
Rpn6 5 18.0 193.5 
CG32165 5 5.5 190.6 
Prosα6 4 23.7 186.6 
Strica 4 10.4 182.4 
rept 4 9.6 181.9 
CG8963 3 7.1 179.9 
CG5728 5 4.7 179.8 
CG4747 5 12.5 178.7 
ssx 4 10.9 177.8 
Rpn8 5 22.8 174 
Hsp22 3 21.8 170 
Gfat2 3 5.7 166.9 
RpS2 4 21.0 166 
CG9684 3 7.0 162.1 
eIF3m 3 10.1 161.4 
CCT2 4 12.9 161.2 
Rpn7 5 15.2 160.3 
Rpn12 2 11.0 154.4 
GEO07404p1 4 29.1 153.9 
Pen 4 14.4 153.5 
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RpL23A 3 13.0 152.9 
RpL23 2 18.6 147.4 
Nup75 3 7.0 141.1 
sqh 3 12.6 139.6 
Rack1 3 10.1 139.6 
Tom70 3 8.0 138.9 
αCOP 4 3.6 137.6 
RpL12 2 21.2 136.2 
CNBP 2 22.4 133.8 
RpS24 2 20.6 132.8 
ACC 3 2.1 132.7 
blp 2 22.7 131.4 
awd 2 20.3 128.6 
Gapdh1 2 4.2 127.7 
sds22 3 14.4 124.6 
blanks 3 11.5 124.4 
CaMKII 3 9.4 124.2 
Unc-76 3 14.9 123.4 
RpS11 3 23.8 123.1 
RpS6 3 13.3 122.7 
Usp7 3 3.8 122.4 
Rpn10 3 14.1 122 
l(2)37Cc 3 13.8 120.4 
CG2396 3 6.8 120 
CG7546 3 5.0 119.8 
Top2 3 2.8 119.2 
Nup358 4 2.7 117.6 
CCT7 3 7.7 115.4 
Nop56 2 12.6 115.1 
stwl 2 2.7 113.9 
RpL22 3 7.7 113.3 
Tnpo 2 4.4 112.1 
tyf 3 3.1 112 
Prosα4 3 16.5 110 
Prosβ1 2 14.7 108.1 
CG3071 2 5.2 107.8 
Atx2 2 5.4 107.4 
koi 2 3.4 107.2 
Vap33 2 15.7 106.9 
RpL36 2 17.4 106.4 
RpL5 3 10.4 106.4 
pod1 3 7.2 105.7 
GEO11434p1 1 12.5 105.4 
Nap1 3 12.2 105.3 
GEO10457p1 2 15.5 104.9 
MED17 3 8.6 104.7 
SdhA 2 3.8 104.5 
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eIF4E1 1 9.3 104.2 
Cdk2 3 14.0 103 
RpL18 3 23.4 102.5 
Gp210 2 1.5 101.5 
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